362538	O
||||	O
20145	O
||||	O
25015	O
||||	O
radiology	O
_	O
report	O
||||	O
2016	O
-	O
06	O
-	O
21	O
10	O
:	O
45	O
:	O
00	O
.	O
0	O
||||	O
c11	O
chest	O
(	O
pa	O
&	O
lat	O
)	O
||||	O
||||	O
clip	O
#	O
374	O
-	O
8750	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2016	O
-	O
06	O
-	O
21	O
*	O
*	O
]	O
10	O
:	O
45	O
am	O

chest	O
(	O
pa	O
&	O
lat	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
2148	O
*	O
*	O
]	O
reason	O
:	O
ct	O
to	O
h2o	O
seal	O
,	O
r	O
/	O
o	O
ptx	B
admitting	O
diagnosis	O
:	O
chest	B
pain\cath	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

64	O
year	O
old	O
man	O
with	O
copd	B
,	O
3vd	B
on	O
cath	O
,	O
h	O
/	O
o	O
multilobar	B
pna	I
at	O
osh	O

reason	O
for	O
this	O
examination	O
:	O

ct	O
to	O
h2o	O
seal	O
,	O
r	O
/	O
o	O
ptx	B
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
copd	B
,	O
cad	B
,	O
status	O
post	O
cabg	O
.	O

evaluate	O
pneumothoraces	B
.	O

pa	O
and	O
lateral	O
chest	O
:	O
compared	O
to	O
the	O
prior	O
day's	O
film	O
.	O

there	O
remains	O
tiny	O
biapical	O
pneumothoraces	B
,	O
not	O
significantly	O
changed	O
.	O

there	O
is	O
a	O
small	O
lateral	O
and	O
basal	O
component	O
of	O
the	O
pneumothorax	B
on	O
the	O
right	O
.	O

left	O
ij	O
line	O
remains	O
unchanged	O
in	O
position	O
.	O

there	O
is	O
worsening	O
of	O
underlying	O
subcutaneous	B
emphysema	I
since	O
the	O
prior	O
day	O
study	O
.	O

the	O
right	O
-	O
sided	O
chest	O
tube	O
remains	O
unchanged	O
in	O
position	O
,	O
crossing	O
the	O
midline	O
and	O
overlying	O
the	O
left	O
upper	O
lung	O
zone	O
.	O

interval	O
clearing	O
of	O
left	O
retrocardiac	B
opacity	I
,	O
likely	O
representing	O
atelectasis	B
.	O

persisting	O
small	O
bilateral	B
effusions	I
.	O

background	O
emphysematous	B
changes	I
.	O

impression	O
:	O

1	O
)	O
persisting	O
tiny	O
apical	O
pneumothoraces	B
.	O

2	O
)	O
chest	O
tube	O
remains	O
crossing	O
the	O
midline	O
to	O
opposite	O
hemithorax	O
.	O

3	O
)	O
increase	O
in	O
underlying	O
subcutaneous	B
emphysema	I
.	O

4	O
)	O
persisting	O
bilateral	B
pleural	I
effusions	I
with	O
interval	O
clearing	O
of	O
left	O
retrocardiac	O
atelectasis	B
.	O

27184	O
||||	O
20288	O
||||	O
23795	O
||||	O
discharge	O
_	O
summary	O
||||	O
2014	O
-	O
08	O
-	O
25	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
08	O
-	O
18	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2014	O
-	O
08	O
-	O
25	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1933	O
-	O
05	O
-	O
12	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
3610	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

type	B
b	I
aortic	I
dissection	I

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

none	O
.	O

history	O
of	O
present	O
illness	O
:	O

81	O
yr	O
old	O
with	O
aortic	B
dissection	I
involving	O
distal	O
ascending	O
and	O
arch	O
and	O
desending	O
aorta	O
here	O
for	O
bp	O
control	O
.	O

monday	O
morning	O
patient	O
c	O
/	O
o	O
severe	O
back	B
pain	I
.	O

went	O
to	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
3992	O
*	O
*	O
]	O
where	O
ct	O
scan	O
revealed	O
type	B
b	I
aortic	I
dissection	I
.	O

no	O
chest	B
pain	I
or	O
shortness	B
of	I
breath	I
during	O
this	O
time	O
.	O

patient	O
was	O
admitted	O
[	O
*	O
*	O
08	O
-	O
18	O
*	O
*	O
]	O
to	O
ct	O
surgery	O
where	O
they	O
were	O
medically	O
managing	O
his	O
bp	O
with	O
esmolol	O
and	O
nipride	O
drips	O
.	O

he	O
was	O
transferred	O
to	O
ccu	O
team	O
today	O
for	O
continued	O
medical	O
management	O
.	O

family	O
reports	O
that	O
patient	O
has	O
been	O
undergoing	O
"neuro"	O
eval	O
for	O
progressive	O
memory	B
loss	I
over	O
past	O
year	O
or	O
so	O
.	O

past	O
medical	O
history	O
:	O

-	O
copd	B

-	O
prostate	B
ca	I

-	O
back	B
pain	I

-	O
?	O
aneurysm	B
of	I
carotid	I
artery	I

social	O
history	O
:	O

-	O
ex	O
-	O
smoker	O
,	O
quit	O
3	O
years	O
ago	O
,	O
no	O
alcohol	O
,	O
lives	O
with	O
wife	O
,	O
4	O
children	O

physical	O
exam	O
:	O

vs	O
t	O
97	O
.	O
3	O
,	O
p	O
74	O
,	O
bp	O
134	O
/	O
75	O
,	O
17	O
,	O
96%	O
on	O
2l	O
,	O
i	O
/	O
o	O
1700	O
/	O
700	O

gen	O
-	O
nad	O
,	O
alert	O
,	O
oriented	B
to	I
person	I
only	I

heent	O
-	O
perrl	O
(	O
2	O
mm	O
)	O
,	O
7	O
mm	O
diam	O
white	B
plaque	I
on	O
r	O
soft	O
palate	O
neck	O
-	O
no	O
lad	B
,	O
no	O
jvd	B

heart	O
-	O
nl	O
s1s2	O
,	O
irreg	O
irreg	O
,	O
no	O
mrg	B

lungs	O
-	O
ctab	O

abd	O
-	O
soft	O
,	O
distended	O
,	O
nontender	O
,	O

ext	O
-	O
no	O
edema	B

neuro	O
-	O
moves	O
all	O
4	O
extremities	O
spontaneously	O

pertinent	O
results	O
:	O

ct	O
torso	O
with	O
contrast	O
[	O
*	O
*	O
2014	O
-	O
08	O
-	O
20	O
*	O
*	O
]	O
:	O

impression	O
:	O

1	O
.	O
findings	O
consistent	O
with	O
a	O
type	B
b	I
intramural	I
hematoma	I
of	O
the	O
intrathoracic	O
aorta	O
.	O

this	O
process	O
does	O
not	O
involve	O
the	O
intra	O
-	O
abdominal	O
aorta	O
.	O

2	O
.	O
extensive	O
atherosclerotic	B
disease	I
of	O
the	O
intrathoracic	O
and	O
intra	O
-	O
abdominal	O
aorta	O
,	O
with	O
a	O
focal	O
area	O
of	O
mural	B
thrombus	I
within	O
the	O
mid	O
abdominal	O
aorta	O
,	O
which	O
extends	O
into	O
the	O
proximal	O
portion	O
of	O
an	O
aneurysmal	O
left	O
renal	O
artery	O
,	O
as	O
detailed	O
above	O
.	O

the	O
more	O
distal	O
left	O
renal	O
artery	O
is	O
widely	O
patent	O
.	O

there	O
is	O
also	O
aneurysmal	B
dilatation	I
of	O
the	O
aortic	O
arch	O
.	O

3	O
.	O
heterogeneously	O
enhancing	O
4	O
.	O
6	O
x	O
3	O
.	O
5	O
cm	O
right	O
renal	B
mass	I
,	O
concerning	O
for	O
a	O
primary	B
renal	I
neoplasm	I
.	O

4	O
.	O
7	O
x	O
5	O
mm	O
noncalcified	B
nodule	I
within	O
the	O
left	O
upper	O
lobe	O
.	O

while	O
this	O
may	O

represent	O
a	O
benign	O
entity	O
such	O
as	O
a	O
noncalcified	B
granuloma	I
,	O
close	O
follow	O
-	O
up	O
is	O
warranted	O
given	O
the	O
above	O
findings	O
within	O
the	O
right	O
kidney	O
.	O

5	O
.	O
partially	O
calcified	B
nodules	I
within	O
the	O
right	O
lobe	O
of	O
the	O
thyroid	O
gland	O
.	O

clinical	O
correlation	O
is	O
recommended	O
.	O

6	O
.	O
cholelithiasis	B
.	O

brief	O
hospital	O
course	O
:	O

a	O
/	O
p	O
:	O
81	O
yo	O
man	O
admitted	O
with	O
newly	O
diagnosed	O
type	B
b	I
aortic	I
dissection	I
.	O

1	O
)	O
aortic	O
dissection	O
/	O
intramural	O
hematoma	O
-	O
type	O
b	O
(	O
no	O
involvement	O
of	O
ascending	O
aorta	O
)	O
.	O

will	O
medically	O
manage	O
with	O
tight	O
control	O
of	O
bp	O
(	O
goal	O
sbp	O
110	O
-	O
120	O
)	O
.	O

initially	O
was	O
on	O
esmolol	O
and	O
nitro	O
gtt	O
but	O
these	O
were	O
easily	O
titrate	O
off	O
.	O

ct	O
surgery	O
does	O
not	O
feel	O
patient	O
needs	O
surgery	O
.	O

-	O
con't	O
labetolol	O
600	O
mg	O
bid	O
and	O
lisinopril	O
10	O
mg	O
po	O
qd	O

2	O
)	O
copd	B
-	O
con't	O
home	O
prednisone	O
10	O
mg	O
po	O
qd	O
with	O
nebulizers	O
prn	O
.	O

con't	O
flovent	O
bid	O
.	O

will	O
need	O
to	O
discuss	O
prednisone	O
taper	O
and	O
other	O
copd	B
management	O
with	O
pcp	O
.	O

3	O
)	O
r	O
renal	B
mass	I
-	O
4	O
.	O
6	O
cm	O
diameter	O
,	O
likey	O
renal	B
cell	I
cancer	I
.	O

urine	O
cytology	O
showed	O
atypical	B
uroepithelial	I
cells	I
.	O

patient	O
and	O
family	O
aware	O
.	O

will	O
discuss	O
further	O
with	O
urologist	O
.	O

4	O
)	O
h	O
/	O
o	O
prostate	B
cancer	I
-	O
con't	O
lupron	O
outpatient	O
management	O
.	O

5	O
)	O
code	O
-	O
full	O

6	O
)	O
lul	O
nodule	B
-	O
found	O
incidentally	O
on	O
ct	O
.	O

needs	O
f	O
/	O
u	O
ct	O
per	O
pcp	O
.	O

medications	O
on	O
admission	O
:	O

-	O
claratin	O

-	O
lupron	O

-	O
prednisone	O
10	O

-	O
flovent	O
2	O
puffs	O
bid	O

discharge	O
medications	O
:	O

1	O
.	O
prednisone	O
10	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

2	O
.	O
fluticasone	O
propionate	O
110	O
mcg	O
/	O
actuation	O
aerosol	O
sig	O
:	O
two	O
(	O
2	O
)	O
puff	O
inhalation	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

3	O
.	O
docusate	O
sodium	O
100	O
mg	O
capsule	O
sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

4	O
.	O
senna	O
8	O
.	O
6	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

5	O
.	O
albuterol	O
sulfate	O
0	O
.	O
083	O
%	O
solution	O
sig	O
:	O
one	O
(	O
1	O
)	O
inhalation	O
q6h	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

6	O
.	O
labetalol	O
200	O
mg	O
tablet	O
sig	O
:	O
three	O
(	O
3	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

7	O
.	O
acetaminophen	O
325	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q4	O
-	O
6h	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
for	O
pain	B
.	O

8	O
.	O
lisinopril	O
10	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
2	O
*	O

discharge	O
disposition	O
:	O

extended	O
care	O

facility	O
:	O

sliver	O
lake	O

discharge	O
diagnosis	O
:	O

aortic	B
dissection	I

discharge	O
condition	O
:	O

stable	O
.	O

discharge	O
instructions	O
:	O

return	O
to	O
the	O
emergency	O
room	O
or	O
call	O
your	O
primary	O
care	O
physcian	O
if	O
you	O
have	O
increasing	O
shortness	B
of	I
breath	I
,	O
chest	B
pain	I
,	O
back	B
pain	I
,	O
or	O
any	O
other	O
symptom	B
that	O
bothers	O
you	O
.	O

take	O
your	O
medications	O
as	O
directed	O
.	O

followup	O
instructions	O
:	O

1	O
)	O
please	O
call	O
your	O
primary	O
care	O
physician	O
for	O
[	O
*	O
*	O
name	O
initial	O
(	O
pre	O
)	O
*	O
*	O
]	O
follow	O
up	O
appointment	O
within	O
the	O
next	O
1	O
-	O
2	O
weeks	O
.	O

2	O
)	O
you	O
also	O
need	O
to	O
be	O
seen	O
by	O
your	O
urologist	O
regarding	O
the	O
mass	O
in	O
your	O
right	O
kidney	O
.	O

[	O
*	O
*	O
firstname	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
3616	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
3617	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
3993	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
3994	O
*	O
*	O
]	O
[	O
*	O
*	O
2014	O
-	O
08	O
-	O
25	O
*	O
*	O
]	O
@	O
1336	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
firstname	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
doctor	O
first	O
name	O
145	O
*	O
*	O
]	O
[	O
*	O
*	O
2014	O
-	O
08	O
-	O
28	O
*	O
*	O
]	O
1	O
:	O
33	O
pm	O
(	O
end	O
of	O
report	O
)	O

49875	O
||||	O
20400	O
||||	O
6126	O
||||	O
ecg	O
_	O
report	O
||||	O
2013	O
-	O
03	O
-	O
25	O
09	O
:	O
39	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

atrial	B
fibrillation	I

ant	O
/	O
septal	O
+	O
lateral	O
t	B
wave	I
changes	I

low	I
qrs	I
voltages	I
in	O
limb	O
leads	O

since	O
previous	O
tracing	O
,	O
no	O
significant	O
change	O

104709	O
||||	O
20807	O
||||	O
14417	O
||||	O
echo	O
_	O
report	O
||||	O
2015	O
-	O
03	O
-	O
02	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
dilated	B
cardiomyopathy	I
.	O
vf	B
.	O

height	O
:	O
(	O
in	O
)	O
68	O

weight	O
(	O
lb	O
)	O
:	O
158	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
85	O
m2	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2015	O
-	O
03	O
-	O
02	O
*	O
*	O
]	O
at	O
10	O
:	O
10	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
complete	O
pulse	O
and	O
color	O
flow	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
the	O
left	O
atrium	O
is	O
mildly	O
dilated	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
the	O
right	O
atrium	O
is	O
mildly	O
dilated	O
.	O

a	O
catheter	O
or	O
pacing	O
wire	O
is	O
seen	O
in	O
the	O
right	O
atrium	O
and	O
/	O
or	O
right	O
ventricle	O
.	O

left	O
ventricle	O
:	O
the	O
left	O
ventricular	O
cavity	O
is	O
severely	O
dilated	O
.	O

there	O
is	O
severe	O
global	O
left	O
ventricular	O
hypokinesis	B
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
severely	O
depressed	O
.	O

right	O
ventricle	O
:	O
the	O
right	O
ventricular	O
cavity	O
is	O
mildly	O
dilated	O
.	O

right	O
ventricular	O
systolic	O
function	O
appears	O
depressed	O
.	O

aorta	O
:	O
the	O
aortic	O
root	O
is	O
normal	O
in	O
diameter	O
.	O

aortic	O
valve	O
:	O
the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
.	O

mitral	O
valve	O
:	O
the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

moderate	O
(	O
2	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

tricuspid	O
valve	O
:	O
moderate	O
to	O
severe	O
[	O
3	O
+	O
]	O
tricuspid	B
regurgitation	I
is	O
seen	O
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
the	O
pulmonic	O
valve	O
leaflets	O
appear	O
structurally	O
normal	O
with	O
physiologic	O
pulmonic	B
regurgitation	I
.	O

pericardium	O
:	O
there	O
is	O
no	O
pericardial	B
effusion	I
.	O

conclusions	O
:	O

1	O
.	O
the	O
left	O
atrium	O
is	O
mildly	O
dilated	O
.	O

2	O
.	O
the	O
left	O
ventricular	O
cavity	O
is	O
severely	O
dilated	O
.	O

there	O
is	O
severe	O
global	O
left	O
ventricular	O
hypokinesis	B
to	O
akinesis	B
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
severely	O
depressed	O
.	O

3	O
.	O
the	O
right	O
ventricular	O
cavity	O
is	O
mildly	O
dilated	O
.	O

right	O
ventricular	O
systolic	O
function	O
appears	O
depressed	O
.	O

4	O
.	O
the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
.	O

5	O
.	O
the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

moderate	O
(	O
2	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

6	O
/	O
moderate	O
to	O
severe	O
[	O
3	O
+	O
]	O
tricuspid	B
regurgitation	I
is	O
seen	O
.	O

105850	O
||||	O
20996	O
||||	O
25341	O
||||	O
echo	O
_	O
report	O
||||	O
2019	O
-	O
06	O
-	O
07	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
cardiac	B
defects?	O

fever	B
,	O
hypotension	B
,	O
sepsis	B
.	O

height	O
:	O
(	O
in	O
)	O
68	O

weight	O
(	O
lb	O
)	O
:	O
136	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
74	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
89	O
/	O
56	O

hr	O
(	O
bpm	O
)	O
:	O
75	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2019	O
-	O
06	O
-	O
07	O
*	O
*	O
]	O
at	O
15	O
:	O
36	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
normal	O
la	O
size	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
normal	O
ra	O
size	O
.	O

left	O
ventricle	O
:	O
normal	O
lv	O
wall	O
thickness	O
.	O

normal	O
lv	O
cavity	O
size	O
.	O

overall	O
normal	O
lvef	O
(	O
>55%	O
)	O
.	O

no	O
resting	B
lvot	I
gradient	I
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

aorta	O
:	O
normal	O
aortic	O
diameter	O
at	O
the	O
sinus	O
level	O
.	O

normal	O
ascending	O
aorta	O
diameter	O
.	O

aortic	O
valve	O
:	O
normal	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
.	O

no	O
as	B
.	O

no	O
ar	B
.	O

mitral	O
valve	O
:	O
normal	O
mitral	O
valve	O
leaflets	O
with	O
trivial	O
mr	B
.	O

tricuspid	O
valve	O
:	O
mildly	O
thickened	O
tricuspid	O
valve	O
leaflets	O
.	O

mild	O
to	O
moderate	O
[	O
[	O
*	O
*	O
02	O
-	O
26	O
*	O
*	O
]	O
+	O
]	O
tr	B
.	O

normal	O
pa	O
systolic	O
pressure	O
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
normal	O
pulmonic	O
valve	O
leaflets	O
with	O
physiologic	O
pr	B
.	O

pericardium	O
:	O
trivial	O
/	O
physiologic	O
pericardial	B
effusion	I
.	O

general	O
comments	O
:	O
left	O
pleural	B
effusion	I
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
lvef>55%	O
)	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	B
regurgitation	I
.	O

the	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	O
mitral	B
regurgitation	I
.	O

the	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

the	O
estimated	O
pulmonary	O
artery	O
systolic	O
pressure	O
is	O
normal	O
.	O

there	O
is	O
a	O
trivial	O
/	O
physiologic	O
pericardial	B
effusion	I
.	O

274571	O
||||	O
21215	O
||||	O
25725	O
||||	O
radiology	O
_	O
report	O
||||	O
2014	O
-	O
02	O
-	O
05	O
16	O
:	O
16	O
:	O
00	O
.	O
0	O
||||	O
q424	O
ct	O
abd	O
w&w	O
/	O
o	O
c	O
||||	O
||||	O
clip	O
#	O
427	O
-	O
1170	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2014	O
-	O
02	O
-	O
05	O
*	O
*	O
]	O
4	O
:	O
16	O
pm	O

ct	O
abd	O
w&w	O
/	O
o	O
c	O
;	O
ct	O
pelvis	O
w&w	O
/	O
o	O
c	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
2244	O
*	O
*	O
]	O
reason	O
:	O
evaluate	O
for	O
nephrolithiasis	B
,	O
hydronephrosis	B
,	O
urinary	O
tract	O
admitting	O
diagnosis	O
:	O
alcohol	B
withdrawal	I

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

40	O
year	O
old	O
man	O
with	O
uti	B
/	O
flank	B
pain	I
reason	O
for	O
this	O
examination	O
:	O
evaluate	O
for	O
nephrolithiasis	B
,	O
hydronephrosis	B
,	O
urinary	B
tract	I
anomoly	I
no	O
contraindications	O
for	O
iv	O
contrast	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
40	O
-	O
year	O
-	O
old	O
male	O
with	O
uti	B
and	O
flank	B
pain	I
.	O

comparison	O
:	O
abdominal	O
ultrasound	O
from	O
two	O
days	O
prior	O
.	O

technique	O
:	O
multidetector	O
ct	O
scanning	O
of	O
the	O
abdomen	O
and	O
pelvis	O
was	O
performed	O
before	O
and	O
after	O
the	O
administration	O
of	O
intravenous	O
contrast	O
.	O

coronal	O
and	O
sagittal	O
reformations	O
were	O
obtained	O
.	O

ct	O
of	O
the	O
abdomen	O
:	O
the	O
lung	O
bases	O
are	O
clear	O
apart	O
from	O
dependent	O
atelectasis	B
.	O

the	O
visualized	O
heart	O
and	O
pericardium	O
appear	O
unremarkable	O
.	O

the	O
liver	O
is	O
diffusely	B
low	I
in	I
attenuation	I
consistent	O
with	O
fatty	O
infiltration	O
.	O

no	O
focal	O
lesions	B
are	O
identified	O
.	O

the	O
gallbladder	O
is	O
collapsed	O
.	O

the	O
adrenal	O
glands	O
,	O
pancreas	O
,	O
loops	O
of	O
bowel	O
,	O
and	O
kidneys	O
appear	O
normal	O
.	O

the	O
spleen	B
is	I
enlarged	I
measuring	O
18	O
cm	O
.	O

there	O
are	O
nonspecific	O
borderline	O
lymph	O
nodes	O
in	O
the	O
celiac	O
region	O
measuring	O
up	O
to	O
12	O
mm	O
in	O
short	O
axis	O
.	O

there	O
is	O
no	O
ascites	B
,	O
free	B
intraperitoneal	I
air	I
,	O
or	O
drainable	B
fluid	I
collections	I
.	O

small	O
retroperitoneal	O
lymph	O
nodes	O
are	O
seen	O
,	O
which	O
do	O
not	O
meet	O
criteria	O
for	O
pathologic	O
enlargement	O
.	O

the	O
abdominal	O
aorta	O
is	O
of	O
normal	O
caliber	O
throughout	O
.	O

ct	O
of	O
the	O
pelvis	O
:	O
the	O
ureters	O
appear	O
unremarkable	O
throughout	O
their	O
course	O
.	O

the	O
bladder	O
,	O
prostate	O
,	O
seminal	O
vesicles	O
,	O
and	O
rectum	O
appear	O
unremarkable	O
.	O

there	O
is	O
no	O
evidence	O
of	O
nephrolithiasis	B
.	O

there	O
is	O
no	O
hydronephrosis	B
.	O

small	O
bilateral	O
fat	O
containing	O
inguinal	O
hernias	O
are	O
seen	O
.	O

there	O
is	O
no	O
free	B
fluid	I
in	O
the	O
pelvis	O
.	O

no	O
pathologic	O
pelvic	O
or	O
inguinal	B
lymphadenopathy	I
is	O
seen	O
.	O

osseous	O
structures	O
:	O
there	O
is	O
degenerative	B
change	I
of	O
the	O
spine	O
without	O
concerning	O
lytic	O
or	O
sclerotic	B
lesions	I
.	O

healing	O
fractures	O
in	O
the	O
eighth	O
and	O
ninth	O
ribs	O
on	O
the	O
left	O
and	O
healed	O
fractures	O
of	O
the	O
tenth	O
right	O
rib	O
are	O
seen	O
.	O

impression	O
:	O

1	O
.	O
no	O
evidence	O
of	O
hydronephrosis	B
or	O
nephrolithiasis	B
.	O

normal	O
renal	O
enhancement	O
without	O
ct	O
evidence	O
of	O
pyelonephritis	B
.	O

2	O
.	O
diffusely	B
low	I
attenuation	I
liver	O
consistent	O
with	O
fatty	B
infiltration	I
.	O

3	O
.	O
splenomegaly	B
.	O

4	O
.	O
nonspecific	O
borderline	O
lymph	O
nodes	O
along	O
the	O
celiac	O
axis	O
.	O

92548	O
||||	O
21219	O
||||	O
21904	O
||||	O
ecg	O
_	O
report	O
||||	O
2013	O
-	O
08	O
-	O
14	O
09	O
:	O
04	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

atrial	B
fibrillation	I
.	O

compared	O
to	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2013	O
-	O
08	O
-	O
13	O
*	O
*	O
]	O
atrial	B
fibrillation	I
has	O
replaced	O
atrial	B
flutter	I
.	O

otherwise	O
,	O
no	O
important	O
change	O
.	O

244548	O
||||	O
21273	O
||||	O
19155	O
||||	O
radiology	O
_	O
report	O
||||	O
2019	O
-	O
07	O
-	O
04	O
10	O
:	O
30	O
:	O
00	O
.	O
0	O
||||	O
v99111	O
36569	O
picc	O
w	O
/	O
o	O
port	O
||||	O
||||	O
clip	O
#	O
406	O
-	O
2495	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2019	O
-	O
07	O
-	O
04	O
*	O
*	O
]	O
10	O
:	O
30	O
am	O

picc	O
line	O
placment	O
sch	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
2734	O
*	O
*	O
]	O
reason	O
:	O
please	O
place	O
picc	O
admitting	O
diagnosis	O
:	O
seizure	B
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
cpt	O
codes	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
36569	O
picc	O
w	O
/	O
o	O
[	O
*	O
*	O
state	O
/	O
zipcode	O
19	O
*	O
*	O
]	O
fluor	O
guid	O
plct	O
/	O
replct	O
/	O
remove	O
*	O
*	O
76937	O
us	O
guid	O
for	O
vas	O
.	O

access	O
c1751	O
cath	O
[	O
*	O
*	O
last	O
name	O
(	O
lf	O
)	O
20	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
first	O
name3	O
(	O
lf	O
)	O
21	O
*	O
*	O
]	O
/	O
cent	O
/	O
mid	O
(	O
not	O
d	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

56	O
year	O
old	O
man	O
with	O
frontotemporal	B
dementia	I
,	O
s	O
/	O
p	O
seizure	B
with	O
resolved	O
pna	B
and	O
c	B
.	I

diff	I

reason	O
for	O
this	O
examination	O
:	O

please	O
place	O
picc	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
56	O
-	O
year	O
-	O
old	O
man	O
with	O
frontotemporal	B
dementia	I
,	O
status	O
post	O
seizure	B
,	O
pneumonia	B
,	O
and	O
c	B
.	I
difficile	I
,	O
need	O
for	O
antibiotics	O
.	O

procedure	O
/	O
findings	O
:	O
the	O
procedure	O
was	O
performed	O
by	O
drs	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
870	O
*	O
*	O
]	O
and	O
[	O
*	O
*	O
doctor	O
last	O
name	O
1015	O
*	O
*	O
]	O
,	O
the	O
attending	O
radiologist	O
,	O
who	O
was	O
present	O
and	O
supervising	O
throughout	O
.	O

as	O
no	O
suitable	O
superficial	O
vein	O
was	O
present	O
,	O
the	O
deep	O
venous	O
system	O
of	O
the	O
right	O
upper	O
extremity	O
was	O
examined	O
with	O
ultrasound	O
.	O

the	O
right	O
brachial	O
vein	O
was	O
found	O
to	O
be	O
patent	O
and	O
compressible	O
.	O

the	O
area	O
was	O
prepped	O
and	O
draped	O
in	O
the	O
usual	O
sterile	O
fashion	O
.	O

local	O
anesthesia	O
with	O
2	O
cc	O
of	O
1%	O
lidocaine	O
was	O
administered	O
subcutaneously	O
.	O

using	O
realtime	O
ultrasound	O
guidance	O
,	O
a	O
21	O
-	O
gauge	O
needle	O
was	O
advanced	O
into	O
the	O
right	O
brachial	O
vein	O
.	O

a	O
hard	O
copy	O
ultrasound	O
image	O
before	O
and	O
after	O
establishing	O
puncture	O
was	O
obtained	O
.	O

a	O
0	O
.	O
018	O
-	O
inch	O
guide	O
wire	O
was	O
then	O
advanced	O
into	O
the	O
needle	O
and	O
into	O
the	O
superior	O
vena	O
cava	O
under	O
fluoroscopic	O
guidance	O
.	O

the	O
needle	O
was	O
then	O
removed	O
and	O
exchanged	O
for	O
a	O
4	O
[	O
*	O
*	O
ethnicity	O
23	O
*	O
*	O
]	O
introducer	O
sheath	O
.	O

based	O
upon	O
the	O
markers	O
on	O
the	O
wire	O
,	O
the	O
single	O
lumen	O
picc	O
was	O
trimmed	O
to	O
length	O
of	O
40	O
cm	O
.	O

the	O
picc	O
was	O
then	O
advanced	O
through	O
the	O
sheath	O
over	O
the	O
wire	O
.	O

the	O
wire	O
and	O
the	O
peel	O
-	O
away	O
sheath	O
were	O
removed	O
.	O

a	O
final	O
fluoroscopic	O
image	O
demonstrates	O
the	O
tip	O
of	O
the	O
catheter	O
in	O
the	O
superior	O
vena	O
cava	O
.	O

the	O
lumen	O
of	O
the	O
catheter	O
was	O
then	O
flushed	O
,	O
aspirated	O
,	O
capped	O
,	O
and	O
heplocked	O
.	O

the	O
catheter	O
was	O
fixed	O
in	O
place	O
using	O
a	O
statlock	O
device	O
,	O
and	O
a	O
sterile	O
dressing	O
applied	O
.	O

there	O
were	O
no	O
immediate	O
postprocedural	B
complications	I
.	O

the	O
line	O
is	O
ready	O
for	O
use	O
.	O

impression	O
:	O
successful	O
placement	O
of	O
a	O
40	O
cm	O
long	O
single	O
lumen	O
picc	O
via	O
the	O
right	O
brachial	O
vein	O
terminating	O
in	O
the	O
svc	O
using	O
fluoroscopic	O
and	O
ultrasound	O
guidance	O
.	O

the	O
line	O
is	O
ready	O
for	O
use	O
.	O

272404	O
||||	O
21280	O
||||	O
4754	O
||||	O
radiology	O
_	O
report	O
||||	O
2012	O
-	O
05	O
-	O
07	O
12	O
:	O
31	O
:	O
00	O
.	O
0	O
||||	O
v413	O
43761	O
reposition	O
gastric	O
tube	O
into	O
duodenum	O
||||	O
||||	O
clip	O
#	O
313	O
-	O
3429	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2012	O
-	O
05	O
-	O
07	O
*	O
*	O
]	O
12	O
:	O
31	O
pm	O

perc	O
g	O
/	O
g	O
-	O
j	O
tube	O
plmt	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
2831	O
*	O
*	O
]	O
reason	O
:	O
please	O
place	O
g	O
-	O
j	O
tube	O
for	O
long	O
-	O
term	O
feeding	O
,	O
aspiration	O
contrast	O
:	O
conray	O
amt	O
:	O
60	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
cpt	O
codes	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
43761	O
reposition	O
gastric	O
tube	O
into	O
d	O
74355	O
perc	O
plcmt	O
entroclysis	O
tube	O
*	O
*	O
c1769	O
guid	O
wires	O
incl	O
inf	O
c1769	O
guid	O
wires	O
incl	O
inf	O
*	O
*	O
c1769	O
guid	O
wires	O
incl	O
inf	O
c1892	O
int	O
/	O
shth	O
,	O
ep	O
,	O
fxd	O
curve	O
/	O
[	O
*	O
*	O
doctor	O
last	O
name	O
2832	O
*	O
*	O
]	O
awy	O
*	O
*	O
c1894	O
int	O
.	O
shth	O
not	O
/	O
guid	O
,	O
ep	O
,	O
nonlaser	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O
*	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

44	O
year	O
old	O
man	O
with	O
icu	O
neuropathy	B
,	O
needs	O
g	O
-	O
j	O
tube	O
for	O
feeds	O
reason	O
for	O
this	O
examination	O
:	O
please	O
place	O
g	O
-	O
j	O
tube	O
for	O
long	O
-	O
term	O
feeding	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

history	O
:	O
44	O
year	O
old	O
man	O
with	O
g	O
tube	O
and	O
needs	O
conversion	O
to	O
g	O
-	O
j	O
tube	O
for	O
long	O
-	O
term	O
feeding	O
.	O

radiologists	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
2833	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
and	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
2834	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
273	O
*	O
*	O
]	O
performed	O
the	O
procedure	O
.	O

dr	O
.	O
[	O
*	O
*	O
doctor	O
last	O
name	O
273	O
*	O
*	O
]	O
is	O
present	O
and	O
supervising	O
the	O
procedure	O
throughout	O
.	O

procedure	O
:	O
patient	O
has	O
a	O
previous	O
surgically	O
placed	O
18	O
-	O
[	O
*	O
*	O
ethnicity	O
23	O
*	O
*	O
]	O
g	O
tube	O
.	O

a	O
[	O
*	O
*	O
doctor	O
last	O
name	O
273	O
*	O
*	O
]	O
wire	O
is	O
advanced	O
through	O
the	O
g	O
tube	O
and	O
the	O
g	O
tube	O
is	O
removed	O
.	O

a	O
7	O
-	O
[	O
*	O
*	O
ethnicity	O
23	O
*	O
*	O
]	O
sheath	O
is	O
placed	O
.	O

an	O
h	O
-	O
1	O
and	O
then	O
c2	O
catheter	O
were	O
used	O
to	O
engage	O
the	O
pylorus	O
.	O

using	O
a	O
glide	O
wire	O
and	O
the	O
c2	O
catheter	O
,	O
the	O
wire	O
and	O
catheter	O
were	O
advanced	O
into	O
the	O
proximal	O
jejunum	O
.	O

contrast	O
was	O
injected	O
,	O
which	O
demonstrated	O
that	O
the	O
angle	O
between	O
the	O
pylorus	O
and	O
duodenum	O
is	O
very	O
acute	O
.	O

attempts	O
were	O
made	O
to	O
pass	O
an	O
amplatz	O
wire	O
into	O
the	O
duodenum	O
,	O
however	O
,	O
due	O
to	O
the	O
acute	O
angle	O
with	O
the	O
pylorus	O
,	O
this	O
was	O
not	O
possible	O
,	O
and	O
the	O
amplatz	O
was	O
exchanged	O
for	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
273	O
*	O
*	O
]	O
wire	O
.	O

over	O
the	O
[	O
*	O
*	O
doctor	O
last	O
name	O
273	O
*	O
*	O
]	O
wire	O
,	O
an	O
attempt	O
was	O
made	O
to	O
pass	O
an	O
18	O
fr	O
.	O

g	O
-	O
j	O
tube	O
,	O
however	O
,	O
the	O
catheter	O
would	O
not	O
pass	O
without	O
looping	O
the	O
wire	O
in	O
the	O
stomach	O
.	O

the	O
rosn	O
wire	O
was	O
replced	O
into	O
the	O
jejunum	O
,	O
and	O
an	O
attempt	O
to	O
place	O
a	O
16fr	O
.	O

g	O
-	O
j	O
tube	O
was	O
made	O
.	O

again	O
,	O
the	O
wire	O
would	O
not	O
support	O
the	O
catheter	O
,	O
and	O
access	O
to	O
the	O
duodenum	O
was	O
lost	O
.	O

several	O
attempts	O
were	O
then	O
made	O
to	O
re	O
-	O
engage	O
the	O
pylorus	O
,	O
but	O
these	O
were	O
unsuccessful	O
.	O

given	O
that	O
60	O
minutes	O
of	O
fluoro	O
time	O
has	O
been	O
sued	O
,	O
a	O
decision	O
to	O
replace	O
an	O
18	O
-	O
[	O
*	O
*	O
ethnicity	O
23	O
*	O
*	O
]	O
foley	O
catheter	O
was	O
made	O
,	O
and	O
the	O
foley	O
was	O
replaced	O
over	O
a	O
wire	O
into	O
the	O
stomach	O
,	O
and	O
balloon	O
inflated	O
with	O
5cc	O
of	O
saline	O
.	O

the	O
foley	O
catheter	O
was	O
secured	O
to	O
the	O
skin	O
.	O

the	O
patient	O
tolerated	O
the	O
procedure	O
without	O
immediate	O
post	O
procedure	O
complication	O
.	O

impression	O
:	O
unsuccessful	O
attempt	O
at	O
placement	O
of	O
g	O
-	O
j	O
tube	O
due	O
to	O
the	O
acute	O
angle	O
between	O
the	O
pylorus	O
and	O
the	O
duodenum	O
and	O
the	O
large	O
size	O
of	O
catheter	O
(	O
18fr	O
)	O
required	O
for	O
the	O
existing	O
entry	O
site	O
.	O

it	O
is	O
recommend	O
to	O
pursue	O
endoscopic	O
placement	O
of	O
g	O
-	O
j	O
tube	O
.	O

this	O
was	O
discussedw	O
ith	O
the	O
house	O
staff	O
.	O

(	O
over	O
)	O

date	O
:	O
[	O
*	O
*	O
2012	O
-	O
05	O
-	O
07	O
*	O
*	O
]	O
12	O
:	O
31	O
pm	O

perc	O
g	O
/	O
g	O
-	O
j	O
tube	O
plmt	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
2831	O
*	O
*	O
]	O
reason	O
:	O
please	O
place	O
g	O
-	O
j	O
tube	O
for	O
long	O
-	O
term	O
feeding	O
,	O
aspiration	O
contrast	O
:	O
conray	O
amt	O
:	O
60	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

(	O
cont	O
)	O

109632	O
||||	O
21286	O
||||	O
10971	O
||||	O
echo	O
_	O
report	O
||||	O
2019	O
-	O
04	O
-	O
03	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
coronary	B
artery	I
disease	I
.	O

acute	O
inferior	B
st	I
elevation	I
post	O
cabg	O
,	O
evaluate	O
lv	B
function	I
height	O
:	O
(	O
in	O
)	O
70	O

weight	O
(	O
lb	O
)	O
:	O
180	O

bsa	O
(	O
m2	O
)	O
:	O
2	O
.	O
00	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
108	O
/	O
53	O

hr	O
(	O
bpm	O
)	O
:	O
94	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2019	O
-	O
04	O
-	O
03	O
*	O
*	O
]	O
at	O
20	O
:	O
28	O

test	O
:	O
portable	O
tee	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

patient	O
was	O
intubated	O
and	O
monitored	O
by	O
the	O
csru	O
nurse	O
.	O

60	O
mg	O
of	O
iv	O
propofol	O
was	O
given	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
a	O
catheter	O
or	O
pacing	O
wire	O
is	O
seen	O
in	O
the	O
ra	O
and	O
extending	O
into	O
the	O
rv	O
.	O

no	O
asd	B
by	O
2d	O
or	O
color	O
doppler	O
.	O

left	O
ventricle	O
:	O
mild	O
regional	O
lv	B
systolic	I
dysfunction	I
.	O

lv	O
wall	O
motion	O
:	O
regional	O
lv	B
wall	I
motion	I
abnormalities	I
include	O
:	O
mid	O
anteroseptal	O
-	O
hypo	B
;	O
mid	O
inferoseptal	O
-	O
hypo	B
;	O
mid	O
inferior	O
-	O
hypo	B
;	O
septal	O
apex	O
-	O
hypo	B
;	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
.	O

normal	O
rv	O
systolic	O
function	O
.	O

aorta	O
:	O
simple	O
atheroma	B
in	O
aortic	O
arch	O
.	O

there	O
are	O
complex	O
(	O
>4mm	O
)	O
atheroma	B
in	O
the	O
descending	O
thoracic	O
aorta	O
.	O

aortic	O
valve	O
:	O
mildly	O
thickened	B
aortic	I
valve	I
leaflets	I
(	O
3	O
)	O
.	O

no	O
ar	B
.	O

mitral	O
valve	O
:	O
mildly	O
thickened	O
mitral	O
valve	O
leaflets	O
.	O

trivial	O
mr	B
.	O

tricuspid	O
valve	O
:	O
normal	O
tricuspid	O
valve	O
leaflets	O
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
normal	O
pulmonic	O
valve	O
leaflets	O
.	O

physiologic	O
(	O
normal	O
)	O
pr	B
.	O

pericardium	O
:	O
no	O
pericardial	B
effusion	I
.	O

general	O
comments	O
:	O
a	O
tee	O
was	O
performed	O
in	O
the	O
location	O
listed	O
above	O
.	O

i	O
certify	O
i	O
was	O
present	O
in	O
compliance	O
with	O
hcfa	O
regulations	O
.	O

the	O
patient	O
was	O
monitored	O
by	O
a	O
nurse	O
[	O
*	O
*	O
first	O
name	O
(	O
titles	O
)	O
2	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
3	O
*	O
*	O
]	O
throughout	O
the	O
procedure	O
.	O

the	O
patient	O
was	O
sedated	O
for	O
the	O
tee	O
.	O

medications	O
and	O
dosages	O
are	O
listed	O
above	O
(	O
see	O
test	O
information	O
section	O
)	O
.	O

no	O
tee	O
related	O
complications	B
.	O

conclusions	O
:	O

no	O
atrial	B
septal	I
defect	I
is	O
seen	O
by	O
2d	O
or	O
color	O
doppler	O
.	O

there	O
is	O
mild	O
regional	O
left	B
ventricular	I
systolic	I
dysfunction	I
with	O
very	O
mild	O
septal	O
and	O
inferior	O
hypokinesis	B
and	O
preserved	O
left	O
ventricular	O
function	O
with	O
an	O
ejection	O
fraction	O
of	O
50	O
-	O
55%	O
.	O

right	O
ventricular	O
systolic	O
function	O
is	O
normal	O
.	O

there	O
are	O
simple	O
atheroma	B
in	O
the	O
aortic	O
arch	O
.	O

there	O
are	O
complex	O
(	O
>4mm	O
)	O
non	O
-	O
mobile	O
atheroma	B
in	O
the	O
descending	O
thoracic	O
aorta	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
.	O

no	O
aortic	B
regurgitation	I
is	O
seen	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

trivial	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

impression	O
:	O
mild	O
regional	O
left	B
ventricular	I
systolic	I
dysfunction	I
with	O
mild	O
hypokinesis	B
of	O
the	O
septum	O
and	O
inferior	O
walls	O
.	O

aortic	O
atherosclerotic	B
plaque	I
.	O

20227	O
||||	O
21305	O
||||	O
2771	O
||||	O
discharge	O
_	O
summary	O
||||	O
2016	O
-	O
12	O
-	O
21	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
12	O
-	O
12	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
12	O
-	O
20	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1965	O
-	O
03	O
-	O
28	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O

history	O
of	O
present	O
illness	O
:	O
the	O
patient	O
is	O
a	O
51	O
year	O
old	O
alcoholic	O
man	O
with	O
a	O
history	O
of	O
alcoholic	B
pancreatitis	I
,	O
who	O
recently	O
presented	O
to	O
[	O
*	O
*	O
hospital	O
2339	O
*	O
*	O
]	O
hospital	O
on	O
[	O
*	O
*	O
11	O
-	O
27	O
*	O
*	O
]	O
with	O
abdominal	B
pain	I
,	O
increased	B
abdominal	I
girth	I
and	O
jaundice	B
.	O

the	O
patient	O
was	O
found	O
to	O
have	O
an	O
obstructive	O
mass	O
in	O
the	O
duodenum	O
,	O
left	O
inguinal	B
lymphadenopathy	I
,	O
ascites	B
,	O
pancreatitis	B
and	O
a	O
bilirubin	O
of	O
14	O
.	O
4	O
.	O

the	O
patient	O
underwent	O
an	O
endoscopic	O
retrogram	O
cholangiopancreatography	O
on	O
[	O
*	O
*	O
12	O
-	O
05	O
*	O
*	O
]	O
with	O
failure	O
to	O
cannulate	O
ampulla	O
resulting	O
in	O
respiratory	B
failure	I
during	O
procedure	O
and	O
intubation	O
.	O

the	O
patient	O
was	O
found	O
to	O
have	O
bilateral	B
infiltrates	I
and	O
pulmonary	B
effusions	I
,	O
thought	O
to	O
have	O
adult	B
respiratory	I
distress	I
syndrome	I
,	O
required	O
minimal	O
ventilatory	O
settings	O
,	O
though	O
.	O

the	O
patient	O
was	O
started	O
on	O
levofloxacin	O
,	O

flagyl	O
,	O
zosyn	O
for	O
concern	O
of	O
hospital	B
acquired	I
pneumonia	I
.	O

the	O
patient	O
was	O
transferred	O
to	O
[	O
*	O
*	O
hospital	O
377	O
*	O
*	O
]	O
for	O
percutaneous	O
attempt	O
at	O
biliary	O
drain	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
diabetes	B
mellitus	I
type	I
2	I
.	O

2	O
.	O
alcoholism	B
.	O

3	O
.	O
alcoholic	B
pancreatitis	I
.	O

recently	O
diagnosed	O
with	O
obstructive	B
jaundice	I
and	O
duodenal	O
mass	B
.	O

allergies	O
:	O
no	O
known	O
drug	O
allergies	O
.	O

medications	O
:	O
no	O
medications	O
at	O
home	O
.	O

medications	O
on	O
transfer	O
:	O

1	O
.	O
zosyn	O
3	O
.	O
375	O
four	O
times	O
a	O
day	O
.	O

2	O
.	O
diprivan	O
20	O
mics	O
per	O
kg	O
per	O
minute	O
.	O

3	O
.	O
regular	O
insulin	O
sliding	O
scale	O
.	O

4	O
.	O
levofloxacin	O
500	O
q	O
.	O
day	O
.	O

5	O
.	O
flagyl	O
500	O
mg	O
three	O
times	O
a	O
day	O
.	O

6	O
.	O
versed	O
gtts	O
.	O

7	O
.	O
ipratropium	O
.	O

8	O
.	O
albuterol	O
.	O

social	O
history	O
:	O
homeless	O
;	O
two	O
pack	O
a	O
day	O
smoker	O
.	O

denies	O
alcohol	O
consumption	O
in	O
the	O
past	O
two	O
months	O
.	O

family	O
history	O
:	O
noncontributory	O
.	O

physical	O
examination	O
:	O
in	O
evaluation	O
on	O
arrival	O
,	O
he	O
was	O
found	O
to	O
have	O
a	O
temperature	O
spike	O
of	O
104	O
.	O
5	O
f	O
.	O
;	O
temperature	O
on	O
the	O

medical	O
intensive	O
care	O
unit	O
was	O
100	O
.	O
0	O
f	O
.	O
;	O
88	O
pulse	O
;	O
111	O
/	O
65	O
blood	O
pressure	O
;	O
map	O
82	O
;	O
respiratory	O
rate	O
20	O
;	O
97%	O
on	O
ventilation	O
.	O

in	O
no	O
acute	B
distress	I
,	O
intubated	O
and	O
sedated	O
.	O

pupils	O
equally	O
round	O
and	O
reactive	O
to	O
light	O
and	O
accommodation	O
.	O

communications	O
through	O
use	O
of	O
hands	O
.	O

lung	O
sounds	O
are	O
coarse	O
bilaterally	O
,	O
diffuse	O
expiratory	O
and	O
inspiratory	B
wheeze	I
.	O

regular	O
rate	O
and	O
rhythm	O
,	O
no	O
murmurs	B
,	O
rubs	B
or	O
gallops	B
.	O

abdomen	O
soft	O
,	O
mildly	O
distended	O
,	O
positive	O
biliary	O
drain	O
in	O
right	O
upper	O
quadrant	O
;	O
no	O
erythema	B
.	O

positive	O
for	O
ascites	B
and	O
shifting	O
dullness	O
,	O
left	O
inguinal	B
mass	I
with	O
post	O
surgical	O
scar	B
exudates	O
.	O

chronic	O
venous	B
stasis	I
changes	O
in	O
lower	O
legs	O
bilaterally	O
.	O

plus	O
two	O
dorsalis	O
pedis	O
and	O
posterior	O
tibial	O
.	O

two	O
plus	O
pitting	B
edema	I
.	O

cranial	O
nerves	O
difficult	O
to	O
assess	O
secondary	O
to	O
sedation	O
.	O

laboratory	O
:	O
white	O
blood	O
cell	O
count	O
on	O
admission	O
13	O
.	O
3	O
,	O
hematocrit	O
41	O
,	O
bilirubin	O
3	O
.	O
1	O
,	O
albumin	O
2	O
.	O
6	O
,	O
ast	O
75	O
.	O

hospital	O
course	O
:	O
the	O
patient	O
was	O
admitted	O
to	O
the	O
medical	O

intensive	O
care	O
unit	O
for	O
work	O
-	O
up	O
of	O
obstructive	B
jaundice	I
and	O
history	O
of	O
alcoholic	B
pancreatitis	I
.	O

endoscopic	O
retrogram	O
cholangiopancreatography	O
was	O
consulted	O
with	O
the	O
recommendation	O
of	O
ptc	O
.	O

sections	O
of	O
the	O
duodenum	O
were	O
obtained	O
that	O
showed	O
mucosal	O
eroding	O
ulcerations	O
with	O
active	O
inflammation	B
;	O
biopsy	O
was	O
obtained	O
later	O
which	O
showed	O
chronic	B
inflammatory	I
change	I
and	O
fibrosis	B
;	O
no	O
evidence	O
of	O
malignancy	B
.	O

common	O
bile	O
duct	O
brushings	O
negative	O
for	O
malignancy	B
as	O
well	O
.	O

ca	O
-	O
19	O
was	O
found	O
to	O
be	O
77	O
;	O
cea	O
6	O
.	O
9	O
.	O

abdominal	O
ct	O
scan	O
with	O
intravenous	O
contrast	O
was	O
obtained	O
showing	O
bilateral	B
pleural	I
effusions	I
,	O
right	O
greater	O
than	O
left	O
,	O
ascites	B
with	O
hepatobiliary	O
dilatation	B
,	O
presumed	O
pancreatitis	B
,	O
no	O
pancreas	B
masses	I
seen	O
although	O
small	O
probably	O
cystic	B
area	I
in	O
the	O
head	O
of	O
the	O
pancreas	O
seen	O
.	O

there	O
are	O
additional	O
left	O
inguinal	B
lymphadenopathy	I
.	O

interventional	O
radiology	O
placed	O
bilateral	O
biliary	O
drains	O
,	O
internal	O
exiting	O
with	O
decompression	O
of	O
biliary	O
ductal	O
system	O
.	O

per	O
ir	O
,	O
long	O
area	O
of	O
stricture	O
of	O
the	O
common	O
bile	O
duct	O
,	O
mild	O
dilatation	B
of	O
the	O
right	O
and	O
left	O
intrahepatic	O
ducts	O
,	O
and	O
a	O
biopsy	O
was	O
obtained	O
of	O
the	O
lower	O
common	O
bile	O
duct	O
which	O
again	O
was	O
negative	O
for	O
malignancy	B
,	O
positive	O
for	O
chronic	B
inflammation	I
changes	O
.	O

the	O
patient's	O
bilirubin	O
continued	O
to	O
be	O
trending	O
down	O
and	O
right	O
internal	O
hepatic	O
drain	O
was	O
internalized	O
on	O
[	O
*	O
*	O
2016	O
-	O
12	O
-	O
19	O
*	O
*	O
]	O
.	O

the	O
patient	O
began	O
tolerating	O
sips	O
of	O
clear	O
and	O
p	O
.	O
o	O
.	O
intake	O
with	O
normal	O
bowel	O
movements	O
.	O

liver	O
enzymes	O
remained	O
flat	O
.	O

concern	O
for	O
portal	B
vein	I
thrombus	I
as	O
seen	O
on	O
ct	O
scan	O
.	O

repeat	O
right	O
upper	O
quadrant	O
ultrasound	O
revealed	O
normal	O
flow	O
,	O
no	O
evidence	O
of	O
complete	B
obstruction	I
,	O
although	O
presence	O
of	O
thrombus	B
could	O
not	O
be	O
eliminated	O
via	O
this	O
modality	O
.	O

ascites	B
were	O
sent	O
for	O
analysis	O
and	O
cytology	O
was	O
pending	O
at	O
time	O
of	O
dictation	O
.	O

2	O
.	O
oncology	O
:	O
preliminary	O
results	O
from	O
lymph	O
node	O
obtained	O
from	O
outside	O
hospital	O
was	O
negative	O
for	O
malignancy	B
.	O

lymph	O
node	O
showed	O
reactive	B
vascular	I
transformation	I
.	O

surgery	O
was	O
consulted	O
and	O
repeat	O
biopsy	O
was	O
obtained	O
;	O
preliminary	O
results	O
show	O
that	O
it	O
is	O
positive	O
for	O
lca	O
,	O
cd20	O
strong	O
positive	O
as	O
well	O
as	O
100%	O
myotic	O
index	O
,	O
is	O
an	O
indication	O
of	O
a	O
high	B
grade	I
b	I
cell	I
lymphoma	I
histologically	O
,	O
although	O
clinically	O
,	O
the	O
patient	O
does	O
not	O
appear	O
to	O
be	O
succumbing	O
to	O
a	O
high	B
grade	I
lymphoma	I
process	O
.	O

the	O
patient	O
,	O
at	O
this	O
time	O
,	O
declined	O
further	O
staging	O
work	O
-	O
up	O
and	O
would	O
recommend	O
pet	O
ct	O
scan	O
of	O
the	O
chest	O
to	O
delineate	O
the	O
presence	O
or	O
absence	O
of	O
mediastinal	O
nodes	O
.	O

ct	O
scan	O
of	O
the	O
abdomen	O
done	O
for	O
obstructive	B
jaundice	I
was	O
negative	O
for	O
intraperitoneal	O
nodes	O
.	O

3	O
.	O
respiratory	B
failure	I
:	O
the	O
patient	O
was	O
transferred	O
after	O
intubation	O
from	O
the	O
endoscopic	O
retrogram	O

cholangiopancreatography	O
.	O

he	O
was	O
subsequently	O
weaned	O
from	O
the	O
ventilator	O
and	O
extubated	O
on	O
hospital	O
day	O
three	O
,	O
requiring	O
nebulizers	O
and	O
respiratory	O
toilet	O
therapy	O
.	O

subsequently	O
he	O
was	O
breathing	O
98%	O
on	O
room	O
air	O
without	O
sequelae	O
.	O

he	O
has	O
small	O
bilateral	B
effusions	I
which	O
were	O
tapped	O
.	O

cytology	O
and	O
chemistries	O
are	O
pending	O
at	O
this	O
time	O
of	O
dictation	O
.	O

currently	O
he	O
is	O
without	O
evidence	O
of	O
pneumonia	B
.	O

he	O
was	O
continued	O
on	O
course	O
of	O
levofloxacin	O
.	O

4	O
.	O
infectious	O
disease	O
:	O
sputum	O
,	O
bile	O
gram	O
stain	O
negative	O
,	O
blood	O
cultures	O
negative	O
to	O
date	O
.	O

outside	O
hospital	O
reported	O
positive	O
ventilator	B
related	I
pneumonia	I
,	O
continued	O
on	O
broad	O
spectrum	O
antibiotics	O
and	O
defeversced	O
on	O
hospital	O
day	O
five	O
without	O
temperature	B
spikes	I
.	O

unasyn	O
and	O
bactrim	O
were	O
discontinued	O
.	O

the	O
patient	O
remained	O
on	O
vancomycin	O
and	O
zosyn	O
to	O
protect	O
for	O
sbp	B
.	O

currently	O
afebrile	B
without	O
leukocytosis	B
.	O

hiv	O
serology	O
is	O
negative	O
.	O

hepatology	O
viral	O
cultures	O
pending	O
at	O
time	O
of	O
dictation	O
.	O

5	O
.	O
dermatologic	O
:	O
the	O
patient	O
was	O
found	O
to	O
have	O
likely	O

condyloma	B
on	O
penis	O
with	O
areas	O
around	O
genitalia	O
consistent	O
with	O
herpes	B
simplex	I
one	I
and	O
two	O
,	O
dfa	O
sent	O
.	O

pending	O
at	O
time	O
of	O
dictation	O
.	O

the	O
patient	O
continued	O
on	O
famvir	O
300	O
three	O
times	O
a	O
day	O
to	O
be	O
discontinued	O
on	O
[	O
*	O
*	O
12	O
-	O
24	O
*	O
*	O
]	O
.	O

6	O
.	O
diabetes	B
mellitus	I
:	O
the	O
patient	O
switched	O
over	O
to	O
an	O
[	O
*	O
*	O
ethnicity	O
538	O
*	O
*	O
]	O
diabetic	O
association	O
diet	O
,	O
tolerating	O
p	O
.	O
o	O
.	O
well	O
,	O
coverage	O
with	O
regular	O
insulin	O
sliding	O
scale	O
with	O
good	O
control	O
of	O
blood	O
sugar	O
.	O

7	O
.	O
prophylaxis	O
:	O
the	O
patient	O
was	O
continued	O
on	O
subcutaneous	O
heparin	O
and	O
continued	O
ambulation	O
per	O
recommendations	O
of	O

physical	O
therapy	O
.	O

disposition	O
:	O
the	O
patient	O
very	O
uncooperative	O
to	O
nursing	O
staff	O
and	O
recommendations	O
of	O
further	O
work	O
-	O
up	O
for	O
positive	O
lymph	O
node	O
biopsy	O
.	O

declining	O
studies	O
for	O
further	O
evaluation	O
and	O
management	O
.	O

per	O
request	O
,	O
would	O
like	O
to	O
return	O
to	O
[	O
*	O
*	O
hospital	O
2339	O
*	O
*	O
]	O
hospital	O
for	O
continuation	O
of	O
care	O
and	O
possible	O
outpatient	O
management	O
of	O
oncologic	O
issues	O
.	O

would	O
recommend	O
staging	O
ct	O
scan	O
,	O
pet	O
preferably	O
.	O

discharge	O
medications	O
:	O

1	O
.	O
famvir	O
500	O
p	O
.	O
o	O
.	O
three	O
times	O
a	O
day	O
to	O
be	O
continued	O
until	O

[	O
*	O
*	O
2016	O
-	O
12	O
-	O
24	O
*	O
*	O
]	O
.	O

2	O
.	O
lactulose	O
30	O
ml	O
p	O
.	O
o	O
.	O
three	O
times	O
a	O
day	O
.	O

hold	O
for	O
stooling	O
.	O

3	O
.	O
zosyn	O
4	O
.	O
5	O
intravenous	O
q	O
.	O
eight	O
.	O

4	O
.	O
vancomycin	O
1	O
.	O
5	O
grams	O
intravenous	O
q	O
.	O

12	O
.	O

5	O
.	O
regular	O
insulin	O
sliding	O
scale	O
.	O

6	O
.	O
tylenol	O
p	O
.	O
r	O
.	O
n	O
.	O

7	O
.	O
albuterol	O
and	O
ipratropium	O
nebulizers	O
q	O
.	O
four	O
two	O
puffs	O
.	O

8	O
.	O
heparin	O
5000	O
units	O
q	O
.	O
eight	O
subcutaneously	O
.	O

discharge	O
instructions	O
:	O

1	O
.	O
follow	O
-	O
up	O
acute	O
transfer	O
to	O
[	O
*	O
*	O
hospital	O
2339	O
*	O
*	O
]	O
hospital	O
in	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
2339	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
state	O
*	O
*	O
]	O
.	O

condition	O
at	O
discharge	O
:	O
the	O
patient	O
is	O
transferred	O
in	O
fair	O
condition	O
.	O

summary	O
:	O

1	O
.	O
ampullary	B
mass	I
-	O
noted	O
on	O
ercp	O
as	O
well	O
as	O
on	O
abdominal	O
ct	O
.	O

ddx	O
includes	O
adenocarcinoma	B
and	O
lymphoma	B
(	O
less	O
likely	O
)	O
.	O

reccommend	O
outpatient	O
follow	O
up	O
after	O
treatment	O
forlymphoma	B
.	O

2	O
.	O
obstructive	B
jaundice	I
-	O
from	O
#1	O
.	O
only	O
intervention	O
here	O
at	O
[	O
*	O
*	O
hospital1	O
189	O
*	O
*	O
]	O
was	O
internalization	O
of	O
the	O
external	O
biliary	O
stent	O
.	O

patient	O
did	O
not	O
have	O
an	O
ercp	O
at	O
[	O
*	O
*	O
hospital1	O
189	O
*	O
*	O
]	O
.	O

3	O
.	O
lymphoma	B
-	O
noted	O
on	O
left	O
inguinal	O
node	O
biopsy	O
.	O

needs	O
treatment	O
in	O
near	O
future	O
.	O

needs	O
staging	O
.	O

considdr	O
pet	O
vs	O
torso	O
ct	O
.	O

4	O
.	O
id	O
-	O
had	O
been	O
on	O
bactrim	O
for	O
xanthomonas	B
maltophilia	I
in	O
his	O
sputum	O
though	O
no	O
overt	O
evidence	O
of	O
pneumonia	B
.	O

bacrtim	O
stopped	O
[	O
*	O
*	O
12	O
-	O
20	O
*	O
*	O
]	O
.	O

presumably	O
on	O
zosyn	O
for	O
biliary	O
coverage	O
.	O

would	O
discontinue	O
soon	O
.	O

has	O
been	O
afebrile	B
for	O
several	O
days	O
.	O

ddx	O
for	O
source	O
of	O
fevers	B
are	O
sbp	B
(	O
no	O
evidence	O
)	O
,	O
ascending	B
cholangitis	I
,	O
lung	O
,	O
decubitus	B
,	O
b	O
symptoms	O
from	O
lymphoma	B
.	O

all	O
blood	O
cultures	O
here	O
are	O
negative	O
to	O
date	O
.	O

had	O
been	O
on	O
vancomycin	O
as	O
well	O
stopped	O
[	O
*	O
*	O
12	O
-	O
20	O
*	O
*	O
]	O
.	O

5	O
.	O
hypercalcemia	B
-	O
presumed	O
hyperparathyroidism	B
with	O
pth	O
level	O
of	O
78	O
in	O
setting	O
of	O
mild	O
hypercalcemia	B

6	O
.	O
portal	B
vein	I
thrombosis	I
-	O
partial	O
.	O

noted	O
on	O
ct	O
.	O

maintained	O
on	O
lovenox	O
.	O

7	O
.	O
ascites	B
-	O
unclear	O
etiology	O
.	O

ddx	O
includes	O
portal	B
hypertension	I
,	O
related	O
to	O
portal	B
vein	I
thrombosis	I
,	O
malignancy	B
,	O
pancreatic	B
ascites	I
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
1116	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
984	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2016	O
-	O
12	O
-	O
20	O
*	O
*	O
]	O
12	O
:	O
47	O

t	O
:	O
[	O
*	O
*	O
2016	O
-	O
12	O
-	O
20	O
*	O
*	O
]	O
13	O
:	O
12	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
2340	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
1116	O
*	O
*	O
]	O
on	O
:	O
wed	O
[	O
*	O
*	O
2016	O
-	O
12	O
-	O
21	O
*	O
*	O
]	O
3	O
:	O
28	O
pm	O

(	O
end	O
of	O
report	O
)	O

34056	O
||||	O
21349	O
||||	O
17761	O
||||	O
ecg	O
_	O
report	O
||||	O
2013	O
-	O
09	O
-	O
10	O
12	O
:	O
09	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
rhythm	I

left	I
atrial	I
abnormality	I

-	O
first	B
degree	I
a	I
-	I
v	I
block	I

left	I
bundle	I
branch	I
block	I

since	O
previous	O
tracing	O
,	O
left	B
bundle	I
branch	I
block	I
new	O

12450	O
||||	O
21413	O
||||	O
15592	O
||||	O
discharge	O
_	O
summary	O
||||	O
2015	O
-	O
04	O
-	O
24	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
04	O
-	O
20	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
04	O
-	O
24	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1931	O
-	O
01	O
-	O
13	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
medicine	O

allergies	O
:	O

ace	O
inhibitors	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
474	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

weakness	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

none	O

history	O
of	O
present	O
illness	O
:	O

84	O
y	O
.	O
o	O
.	O
man	O
with	O
h	O
/	O
o	O
cad	B
,	O
afib	B
,	O
esrd	B
on	O
hd	O
,	O
pvd	B
,	O
severe	O
mitral	B
regurg	I
,	O
poor	O
historian	O
,	O
who	O
presented	O
last	O
night	O
to	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
via	O
ems	O
for	O
increased	O
weakness	B
.	O

patient	O
says	O
he	O
has	O
been	O
weak	B
for	O
some	O
time	O
,	O
and	O
on	O
day	O
of	O
presentation	O
had	O
two	O
episdes	O
where	O
he	O
was	O
unable	B
to	I
rise	I
from	O
a	O
sitting	O
position	O
.	O

the	O
first	O
time	O
he	O
was	O
unable	B
to	I
rise	I
from	O
a	O
toilet	O
.	O

his	O
wife	O
called	O
ems	O
but	O
pt	O
refused	O
transport	O
.	O

later	O
in	O
the	O
day	O
,	O
patient	O
was	O
unable	B
to	I
rise	I
from	O
a	O
chair	O
and	O
agreed	O
to	O
be	O
taken	O
to	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
.	O

the	O
paramedics	O
noted	O
a	O
sbp	O
in	O
the	O
70's	O
which	O
responded	O
to	O
ivf	O
.	O

in	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
,	O
blood	O
and	O
urine	O
cultures	O
were	O
sent	O
and	O
the	O
patient	O
received	O
vanco	O
,	O
levo	O
,	O
and	O
flagyl	O
,	O
asa	O
325	O
and	O
tylenol	O
x	O
1	O
.	O
his	O
rectal	O
temp	O
was	O
noted	O
to	O
be	O
102	O
.	O
6	O
and	O
he	O
was	O
again	O
hypotensive	B
to	O
the	O
70's	O
.	O

he	O
was	O
given	O
ivf	O
,	O
vanco	O
,	O
levo	O
,	O
and	O
flagyl	O
and	O
his	O
blood	B
pressure	I
improved	O
and	O
have	O
stable	O
since	O
that	O
time	O
.	O

patient	O
says	O
he	O
last	O
felt	O
well	O
about	O
a	O
week	O
ago	O
.	O

denies	O
any	O
specific	O
symptoms	B
of	O
illness	B
-	O
no	O
cough	B
or	O
cold	B
symptoms	I
,	O
no	O
abd	B
pain	I
,	O
diarrhea	B
,	O
constipation	B
,	O
vomiting	B
,	O
dysuria	B
.	O

says	O
his	O
appetite	O
has	O
been	O
normal	O
.	O

however	O
,	O
as	O
noted	O
patient	O
is	O
a	O
poor	O
historian	O
.	O

past	O
medical	O
history	O
:	O

1	O
)	O
chf	B
:	O
ischemic	B
cardiomyopathy	I
w	O
/	O
severe	O
lv	B
systolic	I
dysfunction	I
with	O
ef	O
of	O
30%	O

2	O
)	O
cad	B

3	O
)	O
severe	O
mitral	B
regurgitation	I

4	O
)	O
atrial	B
fibrillation	I
,	O
s	O
/	O
p	O
icd	O
-	O
not	O
anticoagulated	O
,	O
on	O
amio	O
5	O
)	O
peripheral	B
vascular	I
disease	I
,	O
s	O
/	O
p	O
bypass	O
leg	O
surgery	O
6	O
)	O
esrd	B
on	O
hd	O
with	O
r	O
tunneled	O
line	O

7	O
)	O
anemia	B
on	O
procrit	O
and	O
iron	O
supplementation	O
8	O
)	O
?	O

cva	B
[	O
*	O
*	O
33	O
*	O
*	O
]	O
years	O
ago	O
with	O
left	B
facial	I
numbness	I
9	O
)	O
hypothyroidism	B

10	O
)	O
s	O
/	O
p	O
right	O
above	O
the	O
knee	O
popliteal	O
bypass	O
graft	O
in	O
[	O
*	O
*	O
2003	O
*	O
*	O
]	O
and	O

a	O
left	O
femoral	O
popliteal	O
artery	O
bypass	O
graft	O
with	O
revision	O
that	O

included	O
the	O
left	O
femoral	O
to	O
anterior	O
tibial	O
artery	O
jump	O
graft	O
in	O
[	O
*	O
*	O
2010	O
*	O
*	O
]	O

11	O
)	O
brbpr	B
:	O
hospitalized	O
[	O
*	O
*	O
04	O
-	O
01	O
*	O
*	O
]	O
,	O
egd	O
showed	O
severe	O
gastritis	B
and	O
colonoscopy	O
showed	O
numerous	B
diverticuli	I
and	O
adenomatous	B
polyps	I
,	O
tagged	O
rbc	O
scan	O
negative	O

12	O
)	O
cdiff	B
[	O
*	O
*	O
2015	O
-	O
03	O
-	O
29	O
*	O
*	O
]	O

13	O
)	O
l	O
foot	O
hematoma	B
requiring	O
i	O
and	O
d	O
hospitalization	O

social	O
history	O
:	O

smoked	O
1	O
ppd	O
x	O
50	O
yrs	O
,	O
quit	O
1998	O
.	O

reported	O
heavy	O
etoh	O
use	O
in	O
past	O
,	O
none	O
currently	O
.	O
currently	O
at	O
[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
.	O

lives	O
with	O
his	O
wife	O
in	O
[	O
*	O
*	O
name2	O
(	O
ni	O
)	O
674	O
*	O
*	O
]	O
.	O

2	O
children	O
living	O
in	O
[	O
*	O
*	O
state	O
1627	O
*	O
*	O
]	O
.	O
retired	O
maintenance	O
worker	O
at	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
.	O

family	O
history	O
:	O

nc	O

physical	O
exam	O
:	O

vs	O
:	O
97	O
.	O
9	O
125	O
/	O
59	O
82	O
rr	O
:	O
11	O
98%	O
on	O
2l	O

gen	O
:	O
elderly	O
man	O
lying	O
in	O
bed	O
,	O
dozing	O
,	O
in	O
no	O
apparent	B
distress	I
heent	O
:	O
perrla	O
,	O
neck	O
supple	O

cardiac	O
:	O
irregular	B
,	O
[	O
*	O
*	O
03	O
-	O
03	O
*	O
*	O
]	O
murmur	B

pulm	O
:	O
scattered	O
wheezes	B
in	O
all	O
lungs	O
fields	O

abd	O
:	O
soft	O
,	O
nt	O
,	O
nd	O
,	O
+	O
bs	O

ext	O
:	O
+	O
2	O
edema	B
,	O
+	O
2	O
dp	O
pulses	O

neuro	O
:	O
alert	O
,	O
oriented	O
,	O
variably	O
cooperative	O
with	O
exam	O
,	O
cn	O
[	O
*	O
*	O
03	O
-	O
09	O
*	O
*	O
]	O
intact	O
,	O
strength	O
3	O
-	O
4	O
/	O
5	O
in	O
bl	O
upper	O
and	O
r	O
lower	O
extremity	O
,	O
(	O
inconsistant	O
)	O
lle	O
seems	O
to	O
be	O
1	O
-	O
2	O
/	O
5	O
,	O
cerbellar	O
exam	O
wnl	O
,	O
reflexes	O
+	O
3	O
in	O
rle	O
,	O
and	O
+	O
2	O
elsewhere	O
.	O

sensation	B
diminished	O
in	O
lower	O
extremities	O
to	O
shins	O
bl	O
.	O

pertinent	O
results	O
:	O

ct	O
abd	O
/	O
pelvis	O
:	O
1	O
.	O
ultrasound	O
and	O
ct	O
findings	O
are	O
consistent	O
with	O
adenomyomatosis	O
of	O
the	O
gallbladder	O
.	O

there	O
is	O
also	O
a	O
gallstone	B
present	O
.	O

2	O
.	O
mass	B
lesion	I
within	O
the	O
lower	O
lobe	O
of	O
the	O
left	O
lung	O
,	O
measuring	O
up	O
to	O
2	O
.	O
7	O
cm	O
in	O
diameter	O
.	O

correlation	O
with	O
outside	O
imaging	O
studies	O
would	O
be	O
helpful	O
.	O

3	O
.	O
small	O
bilateral	B
pleural	I
effusions	I
.	O

4	O
.	O
massive	O
splenomegaly	B
,	O
with	O
a	O
wedge	O
shaped	O
peripheral	B
hypodensity	I
concerning	O
for	O
infarct	B
.	O

5	O
.	O
atherosclerotic	B
disease	I
of	O
the	O
abdominal	O
aorta	O
with	O
aortobifemoral	O
bypass	O
.	O

6	O
.	O
tiny	O
hypodensities	B
of	O
the	O
liver	O
and	O
kidneys	O
,	O
too	O
small	O
to	O
characterize	O
.	O

7	O
.	O
sigmoid	B
diverticulosis	I
,	O
without	O
evidence	O
of	O
diverticulitis	B
.	O

ruq	O
us	O
:	O
1	O
.	O
collapsed	B
gallbladder	I
with	O
calcifications	B
of	O
the	O
wall	O
,	O
which	O
is	O
thickened	B
.	O

there	O
is	O
no	O
ultrasound	O
evidence	O
of	O
acute	B
cholecystitis	I
.	O

2	O
.	O
hemangioma	B
of	O
the	O
left	O
lobe	O
of	O
the	O
liver	O
.	O

3	O
.	O
no	O
intra	O
-	O
or	O
extrahepatic	O
biliary	B
ductal	I
dilatation	I
.	O

cxr	O
:	O
no	O
evidence	O
of	O
acute	O
cardiopulmonary	B
process	I
.	O

brief	O
hospital	O
course	O
:	O

84	O
y	O
.	O
o	O
.	O
man	O
with	O
h	O
/	O
o	O
cad	B
,	O
afib	B
,	O
esrd	B
on	O
hd	O
,	O
pvd	B
,	O
severe	O
mitral	B
regurg	I
,	O
poor	O
historian	O
,	O
who	O
presented	O
to	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
*	O
*	O
]	O
via	O
ems	O
with	O
increased	O
weakness	B
and	O
hypotension	B
.	O

#weakness	O
:	O
neuro	O
exam	O
essentially	O
normal	O
although	O
strength	O
is	O
difficult	O
to	O
assess	O
[	O
*	O
*	O
02	O
-	O
27	O
*	O
*	O
]	O
variable	O
patient	O
effort	O
.	O

ddx	O
includes	O
deconditioning	B
,	O
infection	B
,	O
inadequately	O
repleted	O
hypothyroidism	B
,	O
hypoadrenalism	B
.	O

per	O
patient's	O
wife	O
he	O
has	O
declined	O
recently	O
and	O
he	O
has	O
not	O
had	O
a	O
good	O
quality	O
of	O
life	O
.	O

in	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
154	O
*	O
*	O
]	O
he	O
continued	O
to	O
spike	O
fevers	B
and	O
although	O
bp	O
was	O
stable	O
,	O
his	O
mental	B
status	I
was	O
poor	O
.	O

the	O
family	O
decided	O
that	O
he	O
would	O
not	O
have	O
wanted	O
such	O
aggressive	O
measures	O
given	O
his	O
poor	O
state	O
of	O
functioning	O
and	O
he	O
was	O
made	O
cmo	B
.	O

the	O
patient	O
was	O
put	O
on	O
morphine	O
gtt	O
and	O
died	O
on	O
[	O
*	O
*	O
2015	O
-	O
04	O
-	O
24	O
*	O
*	O
]	O
.	O

medications	O
on	O
admission	O
:	O

hydralazine	O
50	O
mg	O
q6h	O

amiodarone	O
200	O
mg	O
daily	O

toprol	O
100	O
mg	O
daily	O

neurontin	O
100	O
mg	O
bid	O

imdur	O
30	O
mg	O
daily	O

renagel	O
400	O
tid	O

protonix	O
40	O
qd	O

levoxyl	O
137	O
qd	O

valsartan	O
80	O
mg	O
daily	O

mvi	O

lasix	O

allopurinol	O
100	O
qd	O

glyburide	O
1	O
.	O
25	O
qd	O

discharge	O
medications	O
:	O

none	O

discharge	O
disposition	O
:	O

expired	O

discharge	O
diagnosis	O
:	O

expired	O

discharge	O
condition	O
:	O

expired	O

discharge	O
instructions	O
:	O

none	O

followup	O
instructions	O
:	O

none	O

mark	O
[	O
*	O
*	O
name8	O
(	O
md	O
)	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
480	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
254	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
1628	O
*	O
*	O
]	O
[	O
*	O
*	O
name8	O
(	O
md	O
)	O
1629	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1630	O
*	O
*	O
]	O
[	O
*	O
*	O
2015	O
-	O
05	O
-	O
03	O
*	O
*	O
]	O
@	O
1639	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2015	O
-	O
07	O
-	O
17	O
*	O
*	O
]	O
4	O
:	O
38	O
pm	O

(	O
end	O
of	O
report	O
)	O

29484	O
||||	O
21633	O
||||	O
5725	O
||||	O
discharge	O
_	O
summary	O
||||	O
2011	O
-	O
12	O
-	O
07	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
12	O
-	O
01	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2011	O
-	O
12	O
-	O
07	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1950	O
-	O
11	O
-	O
09	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
csu	O

history	O
of	O
present	O
illness	O
:	O
this	O
is	O
a	O
61	O
-	O
year	O
-	O
old	O
gentleman	O
with	O
a	O
history	O
of	O
shortness	B
of	I
breath	I
which	O
has	O
increased	O
over	O
the	O
past	O
several	O
days	O
prior	O
to	O
his	O
admission	O
.	O

he	O
has	O
known	O
history	O
of	O
coronary	B
artery	I
disease	I
and	O
a	O
prior	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
.	O

he	O
is	O
also	O
noted	O
to	O
have	O
congestive	B
heart	I
failure	I
on	O
his	O
initial	O
evaluation	O
at	O
[	O
*	O
*	O
hospital	O
684	O
*	O
*	O
]	O
and	O
elevated	O
troponin	B
levels	O
.	O

the	O
patient	O
was	O
started	O
on	O
a	O
heparin	O
drip	O
at	O
[	O
*	O
*	O
hospital	O
686	O
*	O
*	O
]	O
.	O

a	O
cardiac	O
catheterization	O
was	O
performed	O
prior	O
to	O
admission	O
on	O
[	O
*	O
*	O
2011	O
-	O
11	O
-	O
30	O
*	O
*	O
]	O
which	O
showed	O
an	O
occluded	B
left	O
anterior	O
descending	O
proximal	O
to	O
his	O
prior	O
left	O
anterior	O
descending	O
stent	O
,	O
a	O
90	O
percent	O
obtuse	O
marginal	O
lesion	B
,	O
and	O
an	O
80	O
percent	O
proximal	O
posterior	O
descending	O
artery	O
lesion	B
.	O

ventriculography	O
was	O
not	O
performed	O
as	O
the	O
patient	O
had	O
depressed	B
left	I
ventricular	I
function	I
.	O

the	O
patient	O
was	O
transferred	O
to	O
[	O
*	O
*	O
hospital	O
473	O
*	O
*	O
]	O
for	O

coronary	O
artery	O
bypass	O
grafting	O
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
insulin	B
-	I
dependent	I
diabetes	I
mellitus	I
.	O

2	O
.	O
coronary	B
artery	I
disease	I
;	O
status	O
post	O
left	O
anterior	O
descending	O
stent	O
.	O

3	O
.	O
hypertension	B
.	O

4	O
.	O
peripheral	B
vascular	I
disease	I
.	O

5	O
.	O
congestive	B
heart	I
failure	I
.	O

past	O
surgical	O
history	O
:	O
cholecystectomy	O
and	O
bilateral	O
toe	O
amputations	O
.	O

allergies	O
:	O
he	O
has	O
no	O
known	O
drug	O
allergies	O
.	O

medications	O
on	O
admission	O
:	O
lisinopril	O
20	O
mg	O
by	O
mouth	O
once	O
daily	O
,	O
lopressor	O
50	O
mg	O
by	O
mouth	O
twice	O
daily	O
,	O
zocor	O
20	O
mg	O
by	O
mouth	O
once	O
daily	O
,	O
aspirin	O
325	O
mg	O
by	O
mouth	O
once	O
daily	O
,	O
and	O
insulin	O
(	O
70	O
/	O
30	O
)	O
35	O
units	O
twice	O
daily	O
.	O

social	O
history	O
:	O
he	O
has	O
a	O
20	O
-	O
pack	O
-	O
year	O
history	O
of	O
smoking	O
but	O
quit	O
in	O
[	O
*	O
*	O
1982	O
*	O
*	O
]	O
.	O

he	O
has	O
rare	O
use	O
of	O
alcohol	O
.	O

physical	O
examination	O
on	O
admission	O
:	O
his	O
blood	O
pressure	O
was	O
130	O
/	O
72	O
,	O
his	O
heart	O
rate	O
was	O
72	O
,	O
his	O
respiratory	O
rate	O
was	O
20	O
,	O
and	O
he	O
was	O
saturating	O
97	O
percent	O
on	O
2	O
liters	O
.	O

he	O
was	O
in	O
no	O
apparent	B
distress	I
.	O

he	O
had	O
a	O
systolic	B
ejection	I
murmur	I
.	O

he	O
had	O
decreased	B
breath	I
sounds	I
at	O
the	O
bases	O
,	O
but	O
no	O
rales	B
or	O
rhonchi	B
.	O

the	O
abdomen	O
was	O
obese	B
.	O

there	O
were	O
positive	O
bowel	O
sounds	O
and	O
was	O
soft	O
and	O
nondistended	O
.	O

his	O
extremities	O
had	O
no	O
clubbing	B
,	O
cyanosis	B
or	O
edema	B
.	O

he	O
had	O
brawny	O
induration	B
and	O
erythema	B
on	O
his	O
right	O
lower	O
extremity	O
greater	O
than	O
on	O
his	O
left	O
lower	O
extremity	O
.	O

the	O
right	O
third	O
toe	O
amputation	O
site	O
with	O
some	O
dry	B
eschar	I
.	O

he	O
had	O
no	O
varicosities	B
noted	O
.	O

he	O
had	O
no	O
hematoma	B
present	O
in	O
his	O
right	O
groin	O
which	O
was	O
dressed	O
post	O
catheterization	O
.	O

he	O
had	O
no	O
carotid	B
bruits	I
.	O

he	O
had	O
2	O
plus	O
bilateral	O
carotid	O
,	O
radial	O
,	O
and	O
femoral	O
pulses	O
.	O

he	O
had	O
a	O
1	O
plus	O
dorsalis	O
pedis	O
pulse	O
on	O
the	O
left	O
and	O
a	O
2	O
plus	O
posterior	O
tibial	O
pulse	O
on	O
the	O
right	O
.	O

no	O
palpable	B
dorsalis	I
pedis	I
pulse	I
on	O
the	O
right	O
.	O

he	O
had	O
a	O
2	O
plus	O
posterior	O
tibial	O
pulse	O
on	O
the	O
right	O
.	O

pertinent	O
laboratory	O
data	O
on	O
admission	O
:	O
preoperative	O
laboratories	O
revealed	O
white	O
blood	O
cell	O
count	O
was	O
6	O
.	O
3	O
,	O
hematocrit	O
was	O
31	O
.	O
1	O
,	O
and	O
platelet	O
count	O
was	O
159	O
,	O
000	O
.	O

pt	O
was	O
16	O
.	O
5	O
,	O
ptt	O
was	O
37	O
.	O
4	O
,	O
and	O
inr	O
was	O
1	O
.	O
7	O
.	O

he	O
had	O
hematuria	B
present	O
in	O
his	O
urine	O
,	O
but	O
otherwise	O
had	O
a	O
negative	O
urinalysis	O
.	O

sodium	O
was	O
118	O
,	O
potassium	O
was	O
3	O
.	O
2	O
,	O
chloride	O
was	O
89	O
,	O
bicarbonate	O
was	O
23	O
,	O
anion	O
gap	O
was	O
9	O
,	O
blood	O
urea	O
nitrogen	O
was	O
16	O
,	O
creatinine	O
was	O
1	O
,	O
and	O
blood	O
glucose	O
was	O
705	O
.	O

calcium	O
was	O
7	O
.	O
5	O
,	O
alkaline	O
phosphatase	O
was	O
33	O
.	O
6	O
,	O
magnesium	O
was	O
1	O
.	O
8	O
.	O

hemoglobin	O
a1c	O
was	O
7	O
.	O
4	O
percent	O
.	O

radiology	O
:	O
a	O
preoperative	O
chest	O
x	O
-	O
ray	O
showed	O
cardiomegaly	B
and	O
small	O
bilateral	B
pleural	I
effusions	I
.	O

a	O
preoperative	O
electrocardiogram	O
showed	O
a	O
sinus	O
rhythm	O
at	O
66	O
with	O
first	B
-	I
degree	I
atrioventricular	I
block	I
and	O
a	O
question	O
of	O
left	B
ventricular	I
hypertrophy	I
.	O

please	O
refer	O
to	O
the	O
ekg	O
report	O
dated	O
[	O
*	O
*	O
2011	O
-	O
12	O
-	O
01	O
*	O
*	O
]	O
.	O

summary	O
of	O
hospital	O
course	O
:	O
the	O
patient	O
was	O
referred	O
to	O
dr	O
.	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
32	O
*	O
*	O
]	O
.	O

on	O
[	O
*	O
*	O
12	O
-	O
02	O
*	O
*	O
]	O
,	O
he	O
underwent	O
coronary	O
artery	O
bypass	O
grafting	O
times	O
three	O
with	O
a	O
left	O
internal	O
mammary	O
artery	O
to	O
the	O
left	O
anterior	O
descending	O
,	O
a	O
vein	O
graft	O
to	O
the	O
posterior	O
descending	O
artery	O
,	O
sequence	O
to	O
the	O
obtuse	O
marginal	O
.	O

he	O
was	O
transferred	O
to	O
the	O
cardiothoracic	O
intensive	O
care	O
unit	O
in	O
stable	O
condition	O
on	O
a	O
neo	O
-	O
synephrine	O
drip	O
at	O
0	O
.	O
3	O
mcg	O
/	O
kg	O
per	O
minute	O
and	O
a	O
titrated	O
propofol	O
drip	O
.	O

on	O
postoperative	O
day	O
one	O
,	O
he	O
was	O
a	O
paced	O
for	O
bradycardia	B
overnight	O
.	O

he	O
began	O
lasix	O
diuresis	O
.	O

he	O
was	O
hemodynamically	O
stable	O
.	O

his	O
blood	O
pressure	O
was	O
108	O
/	O
47	O
.	O

he	O
was	O
on	O
an	O
insulin	O
drip	O
at	O
3	O
units	O
per	O
hour	O
and	O
begun	O
on	O
aspirin	O
therapy	O
.	O

postoperative	O
laboratories	O
were	O
as	O
follows	O
.	O

white	O
blood	O
cell	O
count	O
was	O
10	O
.	O
5	O
,	O
hematocrit	O
was	O
26	O
.	O
6	O
,	O
and	O
platelet	O
count	O
was	O
158	O
,	O
000	O
.	O

potassium	O
was	O
3	O
.	O
9	O
,	O
blood	O
urea	O
nitrogen	O
was	O
17	O
,	O
creatinine	O
was	O
0	O
.	O
8	O
,	O
with	O
a	O
blood	O
sugar	O
of	O
75	O
.	O

he	O
remained	O
in	O
the	O
cardiothoracic	O
intensive	O
care	O
unit	O
.	O

he	O
was	O
receiving	O
morphine	O
and	O
percocet	O
for	O
pain	B
.	O

he	O
was	O
extubated	O
successfully	O
.	O

he	O
had	O
some	O
stridor	B
overnight	O
,	O
for	O
which	O
he	O
received	O
a	O
cool	O
nebulizer	O
.	O

lasix	O
diuresis	O
was	O
begun	O
.	O

on	O
postoperative	O
day	O
two	O
,	O
his	O
pacer	O
was	O
turned	O
off	O
.	O

lopressor	O
beta	O
blockade	O
was	O
given	O
.	O

his	O
white	B
blood	I
cell	I
count	I
rose	I
slightly	O
to	O
12	O
.	O
6	O
.	O

his	O
creatinine	O
was	O
stable	O
at	O
1	O
.	O
he	O
was	O
off	O
all	O
drips	O
.	O

his	O
examination	O
was	O
unremarkable	O
.	O

the	O
incisions	B
were	O
clean	O
,	O
dry	O
,	O
and	O
intact	O
.	O

the	O
chest	O
tubes	O
were	O
discontinued	O
.	O

he	O
was	O
evaluated	O
by	O
case	O
management	O
.	O

on	O
postoperative	O
day	O
two	O
,	O
he	O
again	O
had	O
some	O
stridor	B
overnight	O
and	O
was	O
given	O
some	O
steroids	O
in	O
addition	O
to	O
the	O
cool	O
nebulizers	O
.	O

his	O
foley	O
was	O
discontinued	O
.	O

on	O
[	O
*	O
*	O
12	O
-	O
05	O
*	O
*	O
]	O
,	O
he	O
was	O
transferred	O
out	O
to	O
the	O
floor	O
to	O
begin	O
working	O
with	O
physical	O
therapy	O
and	O
the	O
nurses	O
to	O
increase	O
his	O
activity	O
level	O
.	O

he	O
was	O
encouraged	O
to	O
continue	O
to	O
ambulate	O
and	O
to	O
use	O
his	O
incentive	O
spirometer	O
.	O

he	O
was	O
also	O
seen	O
by	O
the	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
48	O
*	O
*	O
]	O
service	O
in	O
consultation	O
for	O
management	O
of	O
his	O
blood	O
sugars	O
,	O
and	O
these	O
recommendations	O
were	O
appreciated	O
by	O
the	O

cardiac	O
surgery	O
team	O
.	O

he	O
also	O
had	O
a	O
full	O
evaluation	O
by	O

physical	O
therapy	O
,	O
and	O
he	O
was	O
doing	O
extremely	O
well	O
with	O
his	O
postoperative	O
ambulation	O
.	O

his	O
lopressor	O
was	O
increased	O
to	O
25	O
mg	O
twice	O
daily	O
on	O
postoperative	O
day	O
four	O
.	O

he	O
was	O
also	O
started	O
again	O
on	O
his	O
statin	O
therapy	O
and	O
restarted	O
on	O
plavix	O
.	O

his	O
examination	O
was	O
unremarkable	O
.	O

he	O
cleared	O
a	O
level	O
v	O
on	O
postoperative	O
day	O
five	O
and	O
was	O
deemed	O
safe	O
to	O
be	O
discharged	O
home	O
with	O
vna	O
services	O
.	O

discharge	O
laboratories	O
were	O
as	O
follows	O
.	O

white	O
blood	O
cell	O
count	O
was	O
11	O
.	O
3	O
,	O
hematocrit	O
was	O
28	O
.	O
2	O
,	O
and	O
platelet	O
count	O
was	O
234	O
,	O
000	O
.	O

sodium	O
was	O
136	O
,	O
potassium	O
was	O
4	O
,	O
chloride	O
was	O
108	O
,	O
bicarbonate	O
was	O
27	O
,	O
blood	O
urea	O
nitrogen	O
was	O
34	O
,	O
creatinine	O
was	O
1	O
,	O
and	O
blood	O
glucose	O
was	O
94	O
.	O

he	O
was	O
alert	O
and	O
oriented	O
with	O
a	O
nonfocal	O
examination	O
.	O

the	O
lungs	O
were	O
clear	O
bilaterally	O
.	O

his	O
heart	O
was	O
regular	O
in	O
rate	O
and	O
rhythm	O
.	O

his	O
incisions	O
were	O
clean	O
,	O
dry	O
,	O
and	O
intact	O
.	O

he	O
had	O
positive	O
bowel	O
sounds	O
.	O

he	O
had	O
1	O
plus	O
peripheral	B
edema	I
in	O
his	O
legs	O
.	O

discharge	O
disposition	O
:	O
he	O
was	O
discharged	O
to	O
home	O
with	O
vna	O
services	O
on	O
[	O
*	O
*	O
2011	O
-	O
12	O
-	O
07	O
*	O
*	O
]	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
status	O
post	O
coronary	O
artery	O
bypass	O
grafting	O
times	O
three	O
.	O

2	O
.	O
status	O
post	O
left	O
anterior	O
descending	O
stent	O
.	O

3	O
.	O
insulin	B
-	I
dependent	I
diabetes	I
mellitus	I
.	O

4	O
.	O
hypertension	B
.	O

5	O
.	O
peripheral	B
vascular	I
disease	I
.	O

6	O
.	O
congestive	B
heart	I
failure	I
.	O

medications	O
on	O
discharge	O
:	O

1	O
.	O
potassium	O
chloride	O
20	O
meq	O
by	O
mouth	O
twice	O
daily	O
(	O
times	O
seven	O
days	O
)	O
.	O

2	O
.	O
colace	O
100	O
mg	O
by	O
mouth	O
twice	O
daily	O
(	O
times	O
one	O
month	O
)	O
.	O

3	O
.	O
protonix	O
40	O
mg	O
by	O
mouth	O
once	O
daily	O
.	O

4	O
.	O
enteric	O
coated	O
aspirin	O
81	O
mg	O
by	O
mouth	O
once	O
daily	O
.	O

5	O
.	O
lasix	O
40	O
mg	O
by	O
mouth	O
twice	O
daily	O
(	O
times	O
seven	O
days	O
)	O
.	O

6	O
.	O
insulin	O
(	O
70	O
/	O
30	O
)	O
20	O
units	O
subcutaneously	O
twice	O
daily	O
.	O

7	O
.	O
percocet	O
5	O
/	O
325	O
one	O
to	O
two	O
tablets	O
by	O
mouth	O
q	O
.	O
4	O
.	O
h	O
.	O
as	O
needed	O
(	O
for	O
pain	B
)	O
.	O

8	O
.	O
plavix	O
75	O
mg	O
by	O
mouth	O
once	O
daily	O
.	O

9	O
.	O
vitamin	O
c	O
500	O
mg	O
by	O
mouth	O
twice	O
daily	O
.	O

10	O
.	O

ferrous	O
sulfate	O
325	O
-	O
mg	O
tablets	O
by	O
mouth	O
once	O
daily	O
.	O

11	O
.	O

zocor	O
20	O
mg	O
by	O
mouth	O
once	O
daily	O
.	O

12	O
.	O

lisinopril	O
20	O
mg	O
by	O
mouth	O
once	O
daily	O
.	O

13	O
.	O

metoprolol	O
25	O
mg	O
by	O
mouth	O
twice	O
daily	O
.	O

discharge	O
instructions	O
:	O

1	O
.	O
the	O
patient	O
was	O
instructed	O
to	O
make	O
an	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
32	O
*	O
*	O
]	O
(	O
his	O
surgeon	O
)	O
for	O
postoperative	O
followup	O
in	O
the	O
office	O
in	O
six	O
weeks	O
.	O

2	O
.	O
the	O
patient	O
was	O
also	O
instructed	O
to	O
follow	O
up	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
2774	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
in	O
one	O
to	O
two	O
weeks	O
and	O
to	O
follow	O
up	O
with	O
his	O
cardiologist	O
(	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
171	O
*	O
*	O
]	O
)	O
in	O
one	O
to	O
two	O
weeks	O
postoperatively	O
.	O

discharge	O
status	O
:	O
the	O
patient	O
was	O
discharged	O
to	O
home	O
on	O

[	O
*	O
*	O
2011	O
-	O
12	O
-	O
07	O
*	O
*	O
]	O
.	O

condition	O
on	O
discharge	O
:	O
stable	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
33	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
state	O
/	O
zipcode	O
34	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
252	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2012	O
-	O
01	O
-	O
16	O
*	O
*	O
]	O
12	O
:	O
07	O
:	O
29	O

t	O
:	O
[	O
*	O
*	O
2012	O
-	O
01	O
-	O
16	O
*	O
*	O
]	O
20	O
:	O
02	O
:	O
02	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
2775	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
first	O
name9	O
(	O
namepattern2	O
)	O
37	O
*	O
*	O
]	O
[	O
*	O
*	O
2012	O
-	O
01	O
-	O
31	O
*	O
*	O
]	O
3	O
:	O
16	O
pm	O
(	O
end	O
of	O
report	O
)	O

105660	O
||||	O
21647	O
||||	O
14167	O
||||	O
echo	O
_	O
report	O
||||	O
2013	O
-	O
01	O
-	O
23	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
left	B
ventricular	I
function	I
.	O

height	O
:	O
(	O
in	O
)	O
67	O

weight	O
(	O
lb	O
)	O
:	O
160	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
84	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
120	O
/	O
72	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2013	O
-	O
01	O
-	O
23	O
*	O
*	O
]	O
at	O
15	O
:	O
36	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

this	O
study	O
was	O
compared	O
to	O
the	O
report	O
of	O
the	O
prior	O
study	O
(	O
images	O
not	O
available	O
)	O
of	O
[	O
*	O
*	O
2012	O
-	O
10	O
-	O
29	O
*	O
*	O
]	O
.	O

left	O
atrium	O
:	O
moderate	O
la	B
enlargement	I
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
mildly	O
dilated	B
ra	I
.	O

left	O
ventricle	O
:	O
mild	O
symmetric	O
lvh	B
.	O

normal	O
lv	O
cavity	O
size	O
.	O

overall	O
normal	O
lvef	O
(	O
>55%	O
)	O
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

aorta	O
:	O
normal	O
aortic	O
root	O
diameter	O
.	O

mildly	O
dilated	B
ascending	I
aorta	I
.	O

aortic	O
valve	O
:	O
normal	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
.	O

no	O
as	B
.	O

no	O
ar	B
.	O

no	O
as	B
.	O

mitral	O
valve	O
:	O
mildly	O
thickened	O
mitral	O
valve	O
leaflets	O
.	O

mild	O
thickening	B
of	O
mitral	O
valve	O
chordae	O
.	O

mild	O
(	O
1	O
+	O
)	O
mr	B
.	O

[	O
due	O
to	O
acoustic	O
shadowing	O
,	O
the	O
severity	O
of	O
mr	B
may	O
be	O
significantly	O
underestimated	O
.	O
]	O

tricuspid	O
valve	O
:	O
normal	O
tricuspid	O
valve	O
leaflets	O
.	O

mild	O
[	O
1	O
+	O
]	O
tr	B
.	O

moderate	O
pa	O
systolic	B
hypertension	I
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
normal	O
pulmonic	O
valve	O
leaflets	O
with	O
physiologic	O
pr	B
.	O

pericardium	O
:	O
small	O
pericardial	B
effusion	I
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
moderately	O
dilated	O
.	O

there	O
is	O
mild	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
lvef>55%	O
)	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
ascending	O
aorta	O
is	O
mildly	O
dilated	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	B
regurgitation	I
.	O

there	O
is	O
no	O
aortic	B
valve	I
stenosis	I
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

mild	O
(	O
1	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

[	O
due	O
to	O
acoustic	O
shadowing	O
,	O
the	O
severity	O
of	O
mitral	B
regurgitation	I
may	O
be	O
significantly	O
underestimated	O
.	O
]	O

there	O
is	O
moderate	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

there	O
is	O
a	O
small	O
pericardial	B
effusion	I
.	O

diastolic	B
dysfunction	I
cannot	O
be	O
excluded	O
.	O

compared	O
with	O
the	O
report	O
of	O
the	O
prior	O
study	O
(	O
tape	O
unavailable	O
for	O
review	O
)	O
of	O
[	O
*	O
*	O
2012	O
-	O
10	O
-	O
29	O
*	O
*	O
]	O
,	O
tricuspid	O
and	O
mitral	B
regurgitation	I
are	O
now	O
less	O
prominent	O
.	O

estimated	O
pulmonary	B
artery	I
systolic	I
pressure	I
is	O
unchanged	O
.	O

107599	O
||||	O
21662	O
||||	O
3643	O
||||	O
echo	O
_	O
report	O
||||	O
2015	O
-	O
02	O
-	O
11	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
chronic	B
lung	I
disease	I
.	O

pulmonary	B
embolus	I
.	O

height	O
:	O
(	O
in	O
)	O
73	O

weight	O
(	O
lb	O
)	O
:	O
130	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
79	O
m2	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2015	O
-	O
02	O
-	O
11	O
*	O
*	O
]	O
at	O
13	O
:	O
19	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
focused	O
pulse	O
and	O
color	O
flow	O

contrast	O
:	O
saline	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
ventricle	O
:	O
the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
lvef>55%	O
)	O
.	O

right	O
ventricle	O
:	O
the	O
right	O
ventricular	O
cavity	O
is	O
markedly	O
dilated	O
.	O

there	O
is	O
severe	O
global	O
right	O
ventricular	O
free	O
wall	O
hypokinesis	B
.	O

there	O
is	O
abnormal	B
septal	I
motion	I
/	O
position	O
consistent	O
with	O
right	O
ventricular	O
pressure	O
/	O
volume	O
overload	O
.	O

tricuspid	O
valve	O
:	O
mild	O
tricuspid	O
[	O
1	O
+	O
]	O
regurgitation	O
is	O
seen	O
.	O

there	O
is	O
severe	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

pericardium	O
:	O
there	O
is	O
a	O
small	O
pericardial	B
effusion	I
.	O

general	O
comments	O
:	O
contrast	O
study	O
was	O
performed	O
with	O
one	O
iv	O
injection	O
of	O
8	O
ccs	O
of	O
agitated	O
normal	O
saline	O
at	O
rest	O
.	O

conclusions	O
:	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
lvef>55%	O
)	O
.	O

the	O
right	O
ventricular	O
cavity	O
is	O
massively	O
dilated	O
.	O

there	O
is	O
severe	O
global	O
right	O
ventricular	O
free	O
wall	O
hypokinesis	B
.	O

there	O
is	O
abnormal	B
septal	I
motion	I
/	O
position	O
consistent	O
with	O
right	O
ventricular	O
pressure	O
/	O
volume	O
overload	O
.	O

there	O
is	O
severe	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

there	O
is	O
a	O
small	O
pericardial	B
effusion	I
.	O

echodense	O
region	O
seen	O
in	O
the	O
main	O
pulmonary	O
artery	O
and	O
proximal	O
left	O
pulmonary	O
artery	O
suggestive	O
of	O
thrombus	O
.	O

compared	O
to	O
the	O
prior	O
study	O
of	O
[	O
*	O
*	O
2015	O
-	O
02	O
-	O
10	O
*	O
*	O
]	O
,	O
findings	O
are	O
similar	O
(	O
estimated	O
pulmonary	O
artery	O
systolic	O
pressure	O
is	O
now	O
slightly	O
lower	O
)	O
.	O

the	O
proximal	O
pulmonary	O
artery	O
was	O
better	O
visualized	O
in	O
the	O
current	O
study	O
.	O

the	O
interatrial	O
septum	O
is	O
bowed	O
toward	O
the	O
left	O
atrium	O
.	O

contrast	O
study	O
revealed	O
a	O
shunt	B
(	O
passage	O
of	O
bubbles	O
right	O
to	O
left	O
)	O
consistent	O
with	O
the	O
presence	O
of	O
a	O
stretched	O
patent	B
foramen	I
ovale	I
or	O
atrial	B
septal	I
defect	I
.	O

25001	O
||||	O
21745	O
||||	O
15732	O
||||	O
discharge	O
_	O
summary	O
||||	O
2013	O
-	O
03	O
-	O
28	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
03	O
-	O
20	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
03	O
-	O
28	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1927	O
-	O
10	O
-	O
08	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
general	O
surgery	O
/	O
purple	O

chief	O
complaint	O
:	O
small	B
bowel	I
obstruction	I
.	O

history	O
of	O
present	O
illness	O
:	O
this	O
is	O
an	O
85	O
-	O
year	O
-	O
old	O
female	O
who	O
presented	O
to	O
the	O
[	O
*	O
*	O
hospital1	O
18	O
*	O
*	O
]	O
with	O
nausea	B
,	O
vomiting	B
and	O
chest	O
and	O
back	B
pain	I
for	O
one	O
day	O
.	O

she	O
had	O
no	O
abdominal	B
pain	I
,	O
no	O
diarrhea	B
,	O
no	O
constipation	B
.	O

her	O
last	O
bowel	O
movement	O
was	O
prior	O
to	O
admission	O
.	O

she	O
does	O
not	O
remember	O
passing	O
any	O
flatus	O
.	O

she	O
denies	O
any	O
fevers	B
,	O
but	O
reports	O
that	O
she	O
has	O
had	O
chills	B
and	O
sweats	B
,	O
and	O
also	O
denies	O
any	O
abdominal	B
pain	I
.	O

these	O
symptoms	B
all	O
started	O
on	O
the	O
day	O
prior	O
to	O
admission	O
.	O

her	O
pain	B
is	O
actually	O
now	O
relieved	O
,	O
but	O
her	O
nausea	B
remains	O
.	O

her	O
last	O
meal	O
was	O
this	O
morning	O
,	O
and	O
she	O
vomited	B
about	O
3	O
:	O
00	O
pm	O
,	O
prior	O
to	O
coming	O
to	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
5	O
*	O
*	O
]	O
.	O

prior	O
medical	O
history	O
:	O

1	O
.	O
gastroesophageal	B
reflux	I
and	O
hiatal	B
hernia	I
.	O

an	O
egd	O
and	O
colonoscopy	O
in	O
[	O
*	O
*	O
2010	O
*	O
*	O
]	O
were	O
normal	O
.	O

2	O
.	O
iron	B
deficiency	I
anemia	I
.	O

3	O
.	O
recurrent	B
utis	I
.	O

4	O
.	O
paroxysmal	B
atrial	I
fibrillation	I
.	O

prior	O
surgical	O
history	O
:	O
appendectomy	O
.	O

allergies	O
:	O
zantac	O
.	O

medications	O
at	O
home	O
:	O

1	O
.	O
prevacid	O
.	O

2	O
.	O
metamucil	O
.	O

social	O
history	O
:	O
she	O
does	O
not	O
smoke	O
.	O

she	O
does	O
not	O
drink	O
.	O

physical	O
exam	O
:	O
she	O
is	O
afebrile	O
with	O
pulse	O
71	O
,	O
blood	O
pressure	O
145	O
/	O
71	O
,	O
respiratory	O
rate	O
24	O
,	O
o2	O
sat	O
92%	O
on	O
room	O
air	O
.	O

general	O
:	O
in	O
no	O
acute	O
distress	O
,	O
alert	O
and	O
oriented	O
x	O
3	O
.	O

head	O
and	O
neck	O
:	O
anicteric	O
.	O

no	O
cervical	B
lymphadenopathy	I
.	O

heart	O
:	O
regular	O
rate	O
and	O
rhythm	O
.	O

lungs	O
:	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

abdomen	O
:	O
obese	B
.	O

soft	O
abdomen	O
with	O
hypoactive	B
bowel	I
sounds	I
,	O
nondistended	O
.	O

she	O
does	O
have	O
some	O
tenderness	O
in	O
the	O
right	O
side	O
of	O
the	O
abdomen	O
,	O
and	O
some	O
tenderness	O
associated	O
with	O
her	O
prior	O
appendectomy	O
scar	O
.	O

rectal	O
exam	O
:	O
guaiac	O
negative	O
with	O
no	O
masses	B
and	O
no	O
stool	O
in	O
the	O
rectal	O
vault	O
.	O

lower	O
extremities	O
:	O
warm	O
,	O
well	O
-	O
perfused	O
.	O

laboratory	O
values	O
on	O
admission	O
:	O
white	O
count	O
7	O
.	O
8	O
,	O
hematocrit	O
34	O
.	O
1	O
,	O
platelets	O
234	O
.	O

coags	O
within	O
normal	O
limits	O
.	O

ck	O
-	O
mb	O
and	O
cardiac	O
enzymes	O
were	O
negative	O
.	O

she	O
had	O
a	O
sodium	O
of	O
149	O
,	O
potassium	O
3	O
.	O
1	O
,	O
chloride	O
119	O
,	O
bicarb	O
22	O
,	O
bun	O
15	O
,	O
creatinine	O

0	O
.	O
3	O
,	O
lactate	O
1	O
.	O
4	O
.	O

chest	O
x	O
-	O
ray	O
:	O
showed	O
a	O
right	O
-	O
sided	O
pleural	B
effusion	I
with	O
a	O
large	O
hiatal	B
hernia	I
with	O
no	O
obvious	O
free	B
air	I
.	O

abdominal	O
x	O
-	O
ray	O
:	O
although	O
it	O
did	O
not	O
show	O
any	O
dilated	B
loops	I
,	O
it	O
did	O
show	O
significant	O
paucity	B
of	I
air	I
distally	O
.	O

cat	O
scan	O
abdomen	O
:	O
showed	O
a	O
diagnosis	O
of	O
a	O
small	B
bowel	I
obstruction	I
,	O
dilated	B
loops	I
of	O
small	O
bowel	O
,	O
the	O
proximal	O
jejunum	O
in	O
the	O
left	O
upper	O
quadrant	O
with	O
an	O
associated	O
transition	O
point	O
.	O

hospital	O
course	O
:	O
because	O
of	O
the	O
findings	O
of	O
a	O
small	B
bowel	I
obstruction	I
,	O
ms	O
.	O
[	O
*	O
*	O
lastname	O
3205	O
*	O
*	O
]	O
was	O
admitted	O
to	O
the	O
general	O
surgery	O
purple	O
service	O
under	O
the	O
care	O
of	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
704	O
*	O
*	O
]	O
.	O

she	O
was	O
made	O
npo	O
,	O
given	O
iv	O
fluids	O
,	O
and	O
had	O
an	O
ng	O
tube	O
,	O
and	O
foley	O
catheter	O
placed	O
.	O

the	O
rest	O
of	O
her	O
hospital	O
course	O
can	O
be	O
discussed	O
in	O
an	O
organ	O
system	O
based	O
fashion	O
.	O

the	O
major	O
problems	O
were	O
cardiovascular	O
,	O
pulmonary	O
,	O
and	O
gastrointestinal	O
.	O

1	O
)	O
cardiovascular	O
:	O
on	O
hospital	O
day	O
#2	O
,	O
ms	O
.	O
[	O
*	O
*	O
lastname	O
3205	O
*	O
*	O
]	O
had	O
an	O
episode	O
of	O
rapid	B
atrial	I
fibrillation	I
.	O

intravenous	O
lopressor	O
was	O
not	O
able	O
to	O
convert	O
her	O
,	O
and	O
neither	O
was	O
diltiazem	O
.	O

however	O
,	O
the	O
afib	B
did	O
respond	O
to	O
amiodarone	O
.	O

she	O
was	O
placed	O
on	O
an	O
amiodarone	O
drip	O
which	O
she	O
tolerated	O
well	O
,	O
and	O
cardiology	O
was	O
consulted	O
,	O
and	O
they	O
followed	O
her	O
for	O
the	O
rest	O
of	O
her	O
admission	O
.	O

gradually	O
,	O
the	O
amiodarone	O
was	O
converted	O
over	O
to	O
po	O
,	O
and	O
she	O
was	O
sent	O
home	O
on	O
po	O
amiodarone	O
.	O

follow	O
-	O
up	O
pulmonary	O
function	O
tests	O
were	O
scheduled	O
as	O
an	O
outpatient	O
as	O
a	O
baseline	O
to	O
check	O
for	O
pulmonary	B
sequelae	I
to	O
chronic	O
amiodarone	O
dosing	O
.	O

on	O
hospital	O
day	O
#4	O
,	O
ms	O
.	O
[	O
*	O
*	O
lastname	O
3205	O
*	O
*	O
]	O
was	O
transferred	O
to	O
the	O
icu	O
for	O
decreased	B
respiratory	I
status	I
.	O

a	O
stat	O
echocardiogram	O
was	O
obtained	O
which	O
revealed	O
2	O
+	O
aortic	B
insufficiency	I
.	O

because	O
of	O
this	O
new	O
onset	O
of	O
atrial	B
fibrillation	I
,	O
she	O
was	O
anticoagulated	O
with	O
coumadin	O
.	O

this	O
was	O
started	O
on	O
[	O
*	O
*	O
03	O
-	O
27	O
*	O
*	O
]	O
,	O
prior	O
to	O
her	O
discharge	O
.	O

2	O
)	O
respiratory	O
:	O
as	O
mentioned	O
above	O
,	O
ms	O
.	O
[	O
*	O
*	O
lastname	O
3205	O
*	O
*	O
]	O
had	O
an	O
episode	O
of	O
poor	O
sats	O
and	O
just	O
general	O
respiratory	B
instability	I
.	O

she	O
was	O
transferred	O
to	O
the	O
icu	O
for	O
closer	O
care	O
.	O

at	O
this	O
time	O
,	O
a	O
right	O
ij	O
central	O
line	O
was	O
attempted	O
,	O
but	O
the	O
patient	O
could	O
not	O
tolerate	O
it	O
,	O
and	O
a	O
left	O
subclavian	O
line	O
was	O
attempted	O
.	O

however	O
,	O
as	O
a	O
complication	B
to	O
this	O
line	O
,	O
the	O
patient	O
developed	O
a	O
left	B
pneumothorax	I
.	O

a	O
pigtail	O
catheter	O
was	O
placed	O
with	O
good	O
result	O
,	O
and	O
the	O
pneumothorax	B
was	O
relieved	O
.	O

that	O
occurred	O
on	O
[	O
*	O
*	O
03	O
-	O
24	O
*	O
*	O
]	O
.	O

on	O
[	O
*	O
*	O
03	O
-	O
26	O
*	O
*	O
]	O
,	O
the	O
chest	O
tube	O
was	O
placed	O
to	O
water	O
-	O
seal	O
and	O
was	O
subsequently	O
discontinued	O
without	O
any	O
difficulties	O
.	O

3	O
)	O
gi	O
:	O
ms	O
.	O
[	O
*	O
*	O
lastname	O
3205	O
*	O
*	O
]	O
presented	O
with	O
a	O
small	B
bowel	I
obstruction	I
with	O
a	O
transition	O
point	O
.	O

this	O
was	O
managed	O
conservatively	O
with	O
ng	O
tube	O
decompression	O
and	O
intravenous	O
fluids	O
.	O

she	O
eventually	O
opened	O
up	O
,	O
and	O
on	O
hospital	O
day	O
#3	O
she	O
passed	B
flatus	I
.	O

during	O
all	O
the	O
excitement	O
with	O
her	O
being	O
transferred	O
to	O
the	O
unit	O
and	O
having	O
the	O
pneumothorax	B
,	O
po	O
food	O
was	O
not	O
started	O
until	O
[	O
*	O
*	O
03	O
-	O
26	O
*	O
*	O
]	O
.	O

this	O
was	O
started	O
with	O
sips	O
and	O
was	O
slowly	O
advanced	O
to	O
a	O
low	O
-	O
residual	O
diet	O
without	O
nausea	B
,	O
vomiting	B
or	O
abdominal	B
pain	I
.	O

therefore	O
,	O
on	O
[	O
*	O
*	O
2013	O
-	O
03	O
-	O
28	O
*	O
*	O
]	O
,	O
hospital	O
day	O
#9	O
,	O
ms	O
.	O
[	O
*	O
*	O
lastname	O
3205	O
*	O
*	O
]	O
was	O
discharged	O
to	O
home	O
in	O
good	O
condition	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
small	B
bowel	I
obstruction	I
.	O

2	O
.	O
paroxysmal	B
atrial	I
fibrillation	I
.	O

3	O
.	O
rapid	B
atrial	I
fibrillation	I
.	O

4	O
.	O
aortic	B
insufficiency	I
.	O

5	O
.	O
pleural	B
effusion	I
.	O

6	O
.	O
pneumothorax	B
.	O

7	O
.	O
gastroesophageal	B
reflux	I
.	O

8	O
.	O
hiatal	B
hernia	I
.	O

9	O
.	O
iron	B
deficiency	I
anemia	I
.	O

10	O
.	O
colonic	B
polyps	I
.	O

follow	O
-	O
up	O
:	O

1	O
.	O
she	O
will	O
be	O
followed	O
by	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
658	O
*	O
*	O
]	O
,	O
her	O
primary	O
cardiologist	O
,	O
who	O
has	O
agreed	O
to	O
follow	O
her	O
coumadin	O
levels	O
.	O

she	O
is	O
going	O
to	O
get	O
her	O
inr	O
checked	O
on	O
tuesday	O
,	O
[	O
*	O
*	O
04	O
-	O
02	O
*	O
*	O
]	O
,	O
at	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
6299	O
*	O
*	O
]	O
after	O
receiving	O
5	O
days	O
of	O
low	O
dose	O
coumadin	O
,	O
and	O
on	O
the	O
18	O
she	O
has	O
a	O
follow	O
-	O
up	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
658	O
*	O
*	O
]	O
.	O

2	O
.	O
she	O
is	O
also	O
recommended	O
to	O
contact	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
6300	O
*	O
*	O
]	O
office	O
to	O
follow	O
-	O
up	O
in	O
about	O
2	O
weeks	O
.	O

3	O
.	O
she	O
is	O
also	O
scheduled	O
for	O
a	O
pulmonary	O
function	O
tests	O
in	O
the	O
next	O
2	O
weeks	O
,	O
and	O
she	O
can	O
schedule	O
an	O
outpatient	O
appointment	O
with	O
the	O
nutrition	O
team	O
to	O
discuss	O
her	O
low	O
-	O
residue	O
diet	O
as	O
needed	O
.	O

discharge	O
medications	O
:	O

1	O
.	O
amiodarone	O
200	O
mg	O
po	O
qd	O
.	O

2	O
.	O
hydralazine	O
25	O
mg	O
po	O
q	O
6	O
.	O

3	O
.	O
albuterol	O
inhaler	O
1	O
-	O
2	O
puffs	O
q	O
6	O
h	O
prn	O
shortness	B
of	I
breath	I
or	O
wheezing	B
.	O

4	O
.	O
protonix	O
1	O
tablet	O
po	O
qd	O
,	O
or	O

5	O
.	O
if	O
she	O
wants	O
she	O
can	O
also	O
take	O
prevacid	O
1	O
tablet	O
po	O
qd	O
.	O

6	O
.	O
coumadin	O
-	O
-	O
her	O
dosing	O
schedule	O
as	O
discussed	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
658	O
*	O
*	O
]	O
is	O
as	O
follows	O
:	O
on	O
thursday	O
,	O
[	O
*	O
*	O
03	O
-	O
28	O
*	O
*	O
]	O
she	O
is	O
to	O
take	O
5	O
mg	O
,	O

friday	O
she	O
is	O
to	O
take	O
5	O
mg	O
,	O
saturday	O
2	O
.	O
5	O
mg	O
,	O
sunday	O
2	O
.	O
5	O
mg	O
,	O

monday	O
2	O
.	O
5	O
mg	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
3064	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
6301	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2013	O
-	O
04	O
-	O
02	O
*	O
*	O
]	O
09	O
:	O
33	O

t	O
:	O
[	O
*	O
*	O
2013	O
-	O
04	O
-	O
02	O
*	O
*	O
]	O
09	O
:	O
40	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
6302	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
doctor	O
first	O
name	O
55	O
*	O
*	O
]	O
[	O
*	O
*	O
2013	O
-	O
04	O
-	O
11	O
*	O
*	O
]	O
12	O
:	O
36	O
am	O
(	O
end	O
of	O
report	O
)	O

3461	O
||||	O
21833	O
||||	O
25152	O
||||	O
discharge	O
_	O
summary	O
||||	O
2016	O
-	O
01	O
-	O
04	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2016	O
-	O
01	O
-	O
04	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1978	O
-	O
07	O
-	O
01	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
medicine	O

allergies	O
:	O

tegretol	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
619	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

transferred	O
from	O
osh	O
for	O
group	B
a	I
strep	I
bacteremia	I
and	O
sirs	B

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

cvl	O
placement	O
[	O
*	O
*	O
01	O
-	O
01	O
*	O
*	O
]	O

picc	O
line	O
placement	O

history	O
of	O
present	O
illness	O
:	O

37	O
yo	O
female	O
w	O
/	O
pmhx	O
significant	O
for	O
tuberous	B
sclerosis	I
and	O
seizure	B
disorder	I
who	O
was	O
transferred	O
to	O
[	O
*	O
*	O
hospital1	O
2	O
*	O
*	O
]	O
for	O
group	B
a	I
strep	I
bacteremia	I
and	O
possible	O
pneumonia	B
,	O
concern	O
for	O
impending	O
ards	B
.	O

the	O
patient	O
reports	O
that	O
she	O
was	O
feeling	O
in	O
her	O
ush	O
up	O
until	O
sunday	O
(	O
[	O
*	O
*	O
12	O
-	O
27	O
*	O
*	O
]	O
)	O
when	O
she	O
experienced	O
fever	B
,	O
abdominal	B
pain	I
,	O
nausea	B
and	O
emesis	B
.	O

the	O
pt	O
continued	O
to	O
feel	O
poorly	O
and	O
went	O
to	O
the	O
[	O
*	O
*	O
doctor	O
first	O
name	O
3	O
*	O
*	O
]	O
on	O
monday	O
(	O
[	O
*	O
*	O
12	O
-	O
28	O
*	O
*	O
]	O
)	O
,	O
where	O
she	O
was	O
found	O
to	O
be	O
febrile	B
up	O
to	O
104	O
rr	O
24	O
and	O
tachycardic	B
hr	O
137	O
.	O

wbc	O
with	O
10	O
k	O
wbc	O
and	O
11	O
%	O
bands	O
.	O

she	O
had	O
an	O
abnormal	O
ua	O
c	O
5	O
wbc	O
.	O

cxr	O
was	O
nl	O
.	O

the	O
pt	O
was	O
admitted	O
for	O
iv	O
antibiotics	O
/	O
and	O
hydration	O
to	O
treat	O
possible	O
pneumonia	B
/	O
uti	B
.	O
she	O
was	O
given	O
ceftriaxone	O
and	O
levofloxacin	O
.	O

patient	O
remained	O
persistently	B
febrile	I
and	O
on	O
[	O
*	O
*	O
12	O
-	O
29	O
*	O
*	O
]	O
her	O
respiratory	B
status	I
worsened	O
.	O

she	O
was	O
subsequently	O
transferred	O
to	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
221	O
*	O
*	O
]	O
for	O
monitoring	O
.	O

never	O
intubated	O
.	O

blood	O
cultures	O
from	O
[	O
*	O
*	O
12	O
-	O
28	O
*	O
*	O
]	O
turned	O
positive	O
for	O
group	B
a	I
strep	I
,	O
and	O
the	O
patient	O
was	O
started	O
on	O
ceftriaxone	O
/	O
clinda	O
/	O
and	O
pcn	O
g	O
.	O

urine	O
culture	O
with	O
gropu	B
b	I
streptococcus	I
.	O

non	O
contrast	O
abdominal	O
ct	O
revealed	O
markedly	O
enlarged	B
r	I
kidney	I
w	O
/	O
numerous	O
adipose	B
tissue	I
densities	I
,	O
no	O
air	B
fluid	I
levels	I
/	O
gas	B
present	I
,	O
enlarged	B
spleen	I
.	O

id	O
consult	O
was	O
obtained	O
,	O
and	O
the	O
etiology	O
of	O
strep	B
a	I
was	O
undetermined	O
.	O

it	O
was	O
recommended	O
that	O
she	O
be	O
started	O
on	O
iv	O
ig	O
and	O
possibly	O
apc	O
,	O
and	O
an	O
mri	O
be	O
obtained	O
to	O
further	O
characterize	O
renal	B
lesion	I
.	O

on	O
arrival	O
the	O
patient	O
denies	O
any	O
difficulty	B
breathing	I
.	O

reports	O
some	O
flank	O
pain	O
on	O
the	O
right	O
.	O

no	O
n	B
/	O
v	B
,	O
no	O
chest	B
pain	I
.	O
+	O
feeling	B
lh	I
.	O

recent	O
loose	B
stools	I
,	O
denies	O
blood	B
in	I
stool	I
.	O

denies	O
hx	O
of	O
pharyngitis	B
or	O
skin	B
infection	I
,	O
dysuria	B
,	O
no	O
muscle	B
aches	I
or	O
joint	B
pains	I
,	O
had	O
a	O
non	B
productive	I
cough	I
,	O
no	O
headache	B
,	O
n	B
/	O
v	B
.	O

no	O
recent	B
trauma	I
,	O
wounds	O
,	O
areas	O
of	O
skin	B
breakdown	I

past	O
medical	O
history	O
:	O

1	O
.	O
tuberous	B
sclerosis	I
with	O
involvement	O
of	O
left	O
kidney	O
resulting	O
in	O
l	O
nephrectomy	O
due	O
to	O
hemorrhage	B
at	O
age	O
7	O
.	O

2	O
.	O
seizure	B
disorder	I

3	O
.	O
gyne	O
history	O
-	O
g1p1	O
,	O
lmp	O
[	O
*	O
*	O
2015	O
-	O
12	O
-	O
21	O
*	O
*	O
]	O
.	O

social	O
history	O
:	O

soc	O
hx	O
:	O
married	O
,	O
lives	O
with	O
husband	O
and	O
6	O
year	O
-	O
old	O
child	O
.	O

works	O
as	O
a	O
secretary	O
,	O
no	O
tobacco	O
,	O
rare	O
etoh	O
,	O
no	O
illicits	O

family	O
history	O
:	O

non	O
contributory	O
.	O

physical	O
exam	O
:	O

vitals	O
:	O
100	O
.	O
4	O
/	O
137	O
/	O
84	O
/	O
rr	O
35	O
/	O
hr	O
98	O

gen	O
:	O
awake	O
,	O
alert	O
,	O
sitting	O
upright	O
,	O
mildly	O
distressed	B

heent	O
:	O
anicteric	O
,	O
eomi	O
,	O
dry	B
mucosa	I
,	O
no	O
pharyngeal	B
exudate	I

neck	O
:	O
no	O
jvd	B
,	O
no	O
lad	B

cv	O
:	O
tachy	B
,	O
no	O
murmurs	B
,	O
no	O
rubs	B

lungs	O
:	O
rhonci	B
b	O
/	O
l	O
,	O
decreased	B
bs	I
at	O
bases	O
,	O
l>r	O

abd	O
:	O
soft	O
,	O
mild	O
distended	O
,	O
mild	O
tenderness	O
in	O
ruq	O
,	O
no	O
rebound	B
,	O
no	O
organomegaly	B
.	O

no	O
flank	B
tenderness	I

ext	O
:	O
warm	O
,	O
dry	O
.	O

distal	O
pulses	O
full	O
and	O
equal	O
b	O
/	O
l	O
.	O

no	O
obvious	O
rashes	B
,	O
areas	O
of	O
skin	B
breakdown	I
.	O

no	O
lle	B
.	O

neuro	O
:	O
a	O
/	O
o	O
x3	O
,	O
no	O
focal	B
deficits	I
,	O
reflexes	O
brisk	O
and	O
symmetric	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
09	O
:	O
58pm	O
wbc	O
-	O
6	O
.	O
2	O
rbc	O
-	O
3	O
.	O
48	O
*	O
hgb	O
-	O
9	O
.	O
9	O
*	O
hct	O
-	O
28	O
.	O
6	O
*	O
mcv	O
-	O
82	O
mch	O
-	O
28	O
.	O
6	O
mchc	O
-	O
34	O
.	O
8	O
rdw	O
-	O
15	O
.	O
2	O

[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
09	O
:	O
58pm	O
glucose	O
-	O
113	O
*	O
urea	O
n	O
-	O
13	O
creat	O
-	O
1	O
.	O
2	O
*	O
sodium	O
-	O
135	O
potassium	O
-	O
4	O
.	O
1	O
chloride	O
-	O
107	O
total	O
co2	O
-	O
18	O
*	O
anion	O
gap	O
-	O
14	O

[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
11	O
:	O
52pm	O
urine	O
rbc	O
-	O
0	O
-	O
2	O
wbc	O
-	O
<1	O
bacteria	O
-	O
none	O
yeast	O
-	O
none	O
epi	O
-	O
0	O
-	O
2	O

[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
11	O
:	O
52pm	O
urine	O
ucg	O
-	O
negative	O

[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
09	O
:	O
58pm	O
pt	O
-	O
11	O
.	O
9	O
ptt	O
-	O
25	O
.	O
8	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
0	O

[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
09	O
:	O
58pm	O
ret	O
aut	O
-	O
0	O
.	O
7	O
*	O

[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
09	O
:	O
58pm	O
pt	O
-	O
11	O
.	O
9	O
ptt	O
-	O
25	O
.	O
8	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
0	O

[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
09	O
:	O
58pm	O
plt	O
smr	O
-	O
normal	O
plt	O
count	O
-	O
180	O

[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
09	O
:	O
58pm	O
hypochrom	O
-	O
normal	O
anisocyt	O
-	O
1	O
+	O
poikilocy	O
-	O
1	O
+	O
macrocyt	O
-	O
occasional	O
microcyt	O
-	O
1	O
+	O
polychrom	O
-	O
occasional	O
burr	O
-	O
1	O
+	O
[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
09	O
:	O
58pm	O
neuts	O
-	O
81	O
.	O
4	O
*	O
bands	O
-	O
0	O
lymphs	O
-	O
15	O
.	O
6	O
*	O
monos	O
-	O
2	O
.	O
0	O
eos	O
-	O
0	O
.	O
4	O
basos	O
-	O
0	O
.	O
6	O

[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
09	O
:	O
58pm	O
wbc	O
-	O
6	O
.	O
2	O
rbc	O
-	O
3	O
.	O
48	O
*	O
hgb	O
-	O
9	O
.	O
9	O
*	O
hct	O
-	O
28	O
.	O
6	O
*	O
mcv	O
-	O
82	O
mch	O
-	O
28	O
.	O
6	O
mchc	O
-	O
34	O
.	O
8	O
rdw	O
-	O
15	O
.	O
2	O

[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
09	O
:	O
58pm	O
albumin	O
-	O
2	O
.	O
5	O
*	O
calcium	O
-	O
7	O
.	O
7	O
*	O
phosphate	O
-	O
2	O
.	O
1	O
*	O
magnesium	O
-	O
1	O
.	O
5	O
*	O
uric	O
acid	O
-	O
5	O
.	O
2	O

[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
09	O
:	O
58pm	O
lipase	O
-	O
18	O

[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
09	O
:	O
58pm	O
alt	O
(	O
sgpt	O
)	O
-	O
87	O
*	O
ast	O
(	O
sgot	O
)	O
-	O
45	O
*	O
ld	O
(	O
ldh	O
)	O
-	O
341	O
*	O
ck	O
(	O
cpk	O
)	O
-	O
71	O
alk	O
phos	O
-	O
114	O
amylase	O
-	O
38	O
tot	O
bili	O
-	O
0	O
.	O
5	O

[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
09	O
:	O
58pm	O
glucose	O
-	O
113	O
*	O
urea	O
n	O
-	O
13	O
creat	O
-	O
1	O
.	O
2	O
*	O
sodium	O
-	O
135	O
potassium	O
-	O
4	O
.	O
1	O
chloride	O
-	O
107	O
total	O
co2	O
-	O
18	O
*	O
anion	O
gap	O
-	O
14	O

[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
11	O
:	O
52pm	O
urine	O
rbc	O
-	O
0	O
-	O
2	O
wbc	O
-	O
<1	O
bacteria	O
-	O
none	O
yeast	O
-	O
none	O
epi	O
-	O
0	O
-	O
2	O

[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
11	O
:	O
52pm	O
urine	O
blood	O
-	O
mod	O
nitrite	O
-	O
neg	O
protein	O
-	O
100	O
glucose	O
-	O
neg	O
ketone	O
-	O
neg	O
bilirubin	O
-	O
neg	O
urobilngn	O
-	O
neg	O
ph	O
-	O
5	O
.	O
0	O
leuk	O
-	O
neg	O

[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
11	O
:	O
52pm	O
urine	O
color	O
-	O
straw	O
appear	O
-	O
clear	O
sp	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
83	O
*	O
*	O
]	O
-	O
1	O
.	O
014	O

[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
11	O
:	O
52pm	O
urine	O
ucg	O
-	O
negative	O

[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
11	O
:	O
52pm	O
urine	O
hours	O
-	O
random	O
creat	O
-	O
56	O
sodium	O
-	O
91	O

[	O
*	O
*	O
2015	O
-	O
12	O
-	O
30	O
*	O
*	O
]	O
11	O
:	O
52pm	O
urine	O
hours	O
-	O
random	O

cxr	O
:	O

bilateral	O
pulmonary	B
infiltrates	I
consistent	O
with	O
pneumonia	B
.	O

interval	O
improvement	O
on	O
the	O
right	O
.	O

persistent	O
left	B
effusion	I
.	O

us	O
kidneys	O
:	O

1	O
.	O
grossly	O
deformed	B
and	O
enlarged	B
right	I
kidney	I
due	O
to	O
the	O
presence	O
of	O
multiple	O
amls	O
.	O

the	O
largest	O
is	O
at	O
the	O
upper	O
pole	O
measuring	O
over	O
11	O
cm	O
but	O
showing	O
no	O
signs	O
of	O
hemorrhage	B
.	O

in	O
the	O
middle	O
third	O
of	O
the	O
right	O
kidney	O
,	O
there	O
is	O
an	O
indeterminate	O
lesion	B
measuring	O
4	O
.	O
3	O
cm	O
.	O

this	O
may	O
be	O
a	O
somewhat	O
lipid	O
poor	O
aml	B
but	O
further	O
evaluation	O
is	O
recommended	O
with	O
mri	O
to	O
exclude	O
possible	O
renal	B
cell	I

carcinoma	I
,	O
since	O
we	O
have	O
no	O
other	O
studies	O
for	O
comparison	O
.	O

small	O
bilateral	O
effusions	B
and	O
status	O
post	O
left	O
nephrectomy	O
.	O

echo	O
:	O

the	O
left	O
atrium	O
is	O
mildly	O
dilated	O
.	O

the	O
interatrial	O
septum	O
is	O
aneurysmal	O
,	O
and	O
there	O
is	O
right	O
-	O
to	O
-	O
left	O
flow	O
of	O
saline	O
contrast	O
,	O
indicating	O
a	O
patent	B
foramen	I
ovale	I
.	O

left	O
ventricular	O
wall	O
thickness	O
,	O
cavity	O
size	O
,	O
and	O
systolic	O
function	O
are	O
normal	O
(	O
lvef>55%	O
)	O
.	O

regional	O
left	O
ventricular	O
wall	O
motion	O
is	O
normal	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	B
regurgitation	I
.	O

no	O
masses	B
or	O
vegetations	O
are	O
seen	O
on	O
the	O
aortic	O
valve	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
structurally	O
normal	O
.	O

there	O
is	O
no	O
mitral	B
valve	I
prolapse	I
.	O

no	O
mass	B
or	O
vegetation	O
is	O
seen	O
on	O
the	O
mitral	O
valve	O
.	O

mild	O
(	O
1	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

the	O
estimated	O
pulmonary	O
artery	O
systolic	O
pressure	O
is	O
normal	O
.	O

there	O
is	O
a	O
trivial	O
/	O
physiologic	O
pericardial	B
effusion	I
.	O

impression	O
:	O
no	O
evidence	O
of	O
endocarditis	B
.	O

normal	O
global	O
and	O
regional	O

biventricular	O
systolic	O
function	O
.	O

patent	B
foramen	I
ovale	I
.	O

brief	O
hospital	O
course	O
:	O

assessment	O
/	O
plan	O
:	O

36	O
yo	O
f	O
with	O
tuberous	B
sclerosis	I
presents	O
with	O
group	B
a	I
strep	I
bacteremia	I
,	O
sepsis	B
now	O
resolved	O
.	O

#	O
bacteremia	B
:	O
unclear	O
the	O
source	O
of	O
her	O
strep	B
a	I
group	I
bacteremia	I
,	O
echo	O
without	O
vegatations	B
.	O

pt	O
will	O
need	O
to	O
continue	O
pen	O
g	O
.	O

has	O
picc	O
line	O
placed	O
.	O
will	O
continue	O
pcn	O
4	O
mu	O
iv	O
q4h	O
for	O
coverage	O
for	O
14	O
days	O
total	O
.	O

#	O
hypoxia	B
:	O
patient	O
hypoxic	B
on	O
admission	O
,	O
requiring	O
nrb	O
to	O
maintain	O
o2	O
sats	O
.	O

likely	O
due	O
to	O
paneumonia	B
or	O
early	O
ards	B
.	O
was	O
put	O
on	O
albuterol	O
/	O
atrovent	O
nebs	O
.	O
was	O
weaned	O
off	O
o2	O
.	O
was	O
satting	O
well	O
on	O
ra	O
at	O
discharge	O

#	O
renal	O
ct	O
scan	O
findings	O
:	O
pt	O
w	O
/	O
fatty	B
infiltrate	I
on	O
ct	O
scan	O
(	O
w	O
/	O
out	O
contrast	O
)	O
from	O
osh	O
.	O

reviewed	O
w	O
/	O
our	O
radiologists	O
,	O
who	O
believed	O
the	O
fatty	B
infiltrate	I
likely	O
represents	O
angiomyolipoma	B
,	O
c	O
/	O
w	O
her	O
h	O
/	O
o	O
tuberous	B
sclerosis	I
.	O

could	O
get	O
mri	O
for	O
further	O
imaging	O
as	O
outpatient	O

#	O
h	O
/	O
o	O
seizure	B
d	I
/	I
o	I
:	O
continued	O
home	O
lamotrigine	O

#	O
proph	O
:	O
pneumoboots	O
,	O
sc	O
heparin	O

#	O
f	O
/	O
e	O
/	O
n	O
:	O
adat	O
,	O
moniter	O
and	O
replete	O
lytes	O
prn	O

medications	O
on	O
admission	O
:	O

ceftriaxone	O
1	O
gram	O
iv	O
bid	O

clindamycin	O
900	O
mg	O
iv	O
q8	O

pcn	O
4	O
million	O
units	O
q	O
4h	O

tylenol	O
650	O
mg	O
q	O
6h	O

duo	O
-	O
nebs	O

lamictal	O
400	O
mg	O
daily	O

oxygen	O
4l	O
nc	O

discharge	O
medications	O
:	O

1	O
.	O
heparin	O
lock	O
flush	O
(	O
porcine	O
)	O
100	O
unit	O
/	O
ml	O
syringe	O
sig	O
:	O
one	O
(	O
1	O
)	O
ml	O
intravenous	O
daily	O
(	O
daily	O
)	O
as	O
needed	O
.	O

disp	O
:	O
*	O
30	O
ml	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

2	O
.	O
heparin	O
lock	O
flush	O
(	O
porcine	O
)	O
100	O
unit	O
/	O
ml	O
syringe	O
sig	O
:	O
two	O
(	O
2	O
)	O
ml	O
intravenous	O
daily	O
(	O
daily	O
)	O
as	O
needed	O
.	O

disp	O
:	O
*	O
30	O
ml	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

3	O
.	O
penicillin	O
g	O
potassium	O
20	O
,	O
000	O
,	O
000	O
unit	O
recon	O
soln	O
sig	O
:	O
one	O
(	O
1	O
)	O
4	O
million	O
units	O
injection	O
q4h	O
(	O
every	O
4	O
hours	O
)	O
for	O
8	O
days	O
.	O

disp	O
:	O
*	O
48	O
doses	O
*	O
refills	O
:	O
*	O
0	O
*	O

4	O
.	O
acetaminophen	O
325	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
q4	O
-	O
6h	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
for	O
fever	B
.	O

5	O
.	O
lamotrigine	O
100	O
mg	O
tablet	O
sig	O
:	O
four	O
(	O
4	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

discharge	O
disposition	O
:	O

home	O
with	O
service	O

discharge	O
diagnosis	O
:	O

group	B
a	I
streptococcus	I
bacteremia	I

secondary	O

tuberous	B
sclerosis	I

seizure	I
disorder	I

discharge	O
condition	O
:	O

stable	O

discharge	O
instructions	O
:	O

please	O
take	O
all	O
mediations	O
as	O
prescribed	O
.	O

please	O
take	O
the	O
antibiotic	O
through	O
the	O
picc	O
line	O
for	O
the	O
next	O
8	O
days	O
.	O

if	O
you	O
have	O
fever	B
,	O
cough	B
,	O
chest	B
pain	I
,	O
rigors	B
,	O
nausea	B
,	O
vomitting	B
,	O
pain	O
in	O
abdomen	O
please	O
call	O
your	O
primary	O
care	O
physcian	O
or	O
fo	O
to	O
the	O
emergency	O
room	O

followup	O
instructions	O
:	O

provider	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
237	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
3612	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
first	O
name3	O
(	O
lf	O
)	O
*	O
*	O
]	O
phone	O
:	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
3613	O
*	O
*	O
]	O
date	O
/	O
time	O
:	O
[	O
*	O
*	O
2016	O
-	O
03	O
-	O
08	O
*	O
*	O
]	O
11	O
:	O
00	O

provider	O
:	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
3614	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
phone	O
:	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
3615	O
*	O
*	O
]	O
date	O
/	O
time	O
:	O
[	O
*	O
*	O
2016	O
-	O
12	O
-	O
08	O
*	O
*	O
]	O
9	O
:	O
45	O

please	O
make	O
a	O
follow	O
up	O
appointment	O
with	O
your	O
primary	O
care	O
physician	O
dr	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
3616	O
*	O
*	O
]	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
3617	O
*	O
*	O
]	O
)	O
within	O
2	O
weeks	O
of	O
discharge	O

patient	O
needs	O
a	O
follow	O
up	O
abdomian	O
mri	O
within	O
1	O
month	O
to	O
evaluate	O
her	O
renal	B
lesions	I
(	O
suspected	O
angiomyolipoma	B
)	O

patinet	O
was	O
guaiac	O
positive	O
in	O
the	O
hospital	O
but	O
the	O
hematocrit	O
was	O
stable	O
.	O

she	O
will	O
need	O
colonoscopy	O
as	O
an	O
outpatient	O

patinet	O
will	O
also	O
need	O
endocarditis	B
prophylaxis	O
befoe	O
undergoing	O
any	O
minor	O
or	O
major	O
surgical	O
procedure	O
as	O
patinet	O
has	O
patent	B
foramen	I
ovale	I
.	O

please	O
check	O
iron	O
studies	O
.	O

[	O
*	O
*	O
name6	O
(	O
md	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
633	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
634	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
name6	O
(	O
md	O
)	O
647	O
*	O
*	O
]	O
[	O
*	O
*	O
name8	O
(	O
md	O
)	O
648	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
649	O
*	O
*	O
]	O
[	O
*	O
*	O
2016	O
-	O
01	O
-	O
05	O
*	O
*	O
]	O
@	O
1606	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
bell	O
on	O
:	O
tue	O
[	O
*	O
*	O
2016	O
-	O
02	O
-	O
02	O
*	O
*	O
]	O
10	O
:	O
35	O
am	O

(	O
end	O
of	O
report	O
)	O

106697	O
||||	O
21967	O
||||	O
496	O
||||	O
echo	O
_	O
report	O
||||	O
2014	O
-	O
09	O
-	O
22	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
left	B
ventricular	I
function	I
.	O

episodes	O
of	O
bradycrdia	B
.	O

height	O
:	O
(	O
in	O
)	O
72	O

weight	O
(	O
lb	O
)	O
:	O
278	O

bsa	O
(	O
m2	O
)	O
:	O
2	O
.	O
45	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
120	O
/	O
53	O

hr	O
(	O
bpm	O
)	O
:	O
93	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2014	O
-	O
09	O
-	O
22	O
*	O
*	O
]	O
at	O
12	O
:	O
51	O

test	O
:	O
portable	O
tte	O
(	O
focused	O
views	O
)	O

doppler	O
:	O
focused	O
pulse	O
and	O
color	O
flow	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
the	O
left	O
atrium	O
is	O
mildly	O
dilated	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
a	O
catheter	O
or	O
pacing	O
wire	O
is	O
seen	O
in	O
the	O
right	O
atrium	O
and	O
/	O
or	O
right	O
ventricle	O
.	O

left	O
ventricle	O
:	O
there	O
is	O
mild	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
lvef>55%	O
)	O
.	O

right	O
ventricle	O
:	O
the	O
right	O
ventricular	O
cavity	O
is	O
dilated	O
.	O

aorta	O
:	O
the	O
aortic	O
root	O
is	O
mildly	O
dilated	O
.	O

aortic	O
valve	O
:	O
the	O
aortic	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

mitral	O
valve	O
:	O
the	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	O
mitral	B
regurgitation	I
.	O

tricuspid	O
valve	O
:	O
the	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

mild	O
tricuspid	O
[	O
1	O
+	O
]	O
regurgitation	O
is	O
seen	O
.	O

the	O
pulmonary	O
artery	O
systolic	O
pressure	O
could	O
not	O
be	O
determined	O
.	O

pulmonic	O
valve	O
/	O
pulmonary	O
artery	O
:	O
the	O
pulmonic	O
valve	O
is	O
not	O
well	O
seen	O
.	O

pericardium	O
:	O
there	O
is	O
a	O
small	O
pericardial	B
effusion	I
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
mildly	O
dilated	O
.	O

there	O
is	O
mild	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
lvef>55%	O
)	O
.	O

the	O
right	O
ventricular	O
cavity	O
is	O
dilated	O
.	O

right	O
ventricular	O
free	O
wall	O
motion	O
appears	O
grossly	O
preserved	O
.	O

the	O
aortic	O
root	O
is	O
mildly	O
dilated	O
.	O

the	O
aortic	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

the	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	O
mitral	B
regurgitation	I
.	O

the	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

the	O
pulmonary	O
artery	O
systolic	O
pressure	O
could	O
not	O
be	O
determined	O
.	O

there	O
is	O
a	O
small	O
pericardial	B
effusion	I
.	O

compared	O
with	O
the	O
prior	O
study	O
of	O
[	O
*	O
*	O
2014	O
-	O
09	O
-	O
21	O
*	O
*	O
]	O
,	O
there	O
is	O
probably	O
no	O
significant	O
change	O
.	O

report	O
modified	O
on	O
[	O
*	O
*	O
2014	O
-	O
09	O
-	O
23	O
*	O
*	O
]	O
to	O
note	O
that	O
a	O
right	O
heart	O
catheter	O
/	O
wire	O
was	O
observed	O
without	O
any	O
definite	O
associated	O
mass	O
.	O

62555	O
||||	O
21971	O
||||	O
18129	O
||||	O
ecg	O
_	O
report	O
||||	O
2014	O
-	O
02	O
-	O
09	O
12	O
:	O
29	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
rhythm	I
.	O

p	B
-	I
r	I
interval	I
prolongation	I
.	O

q	B
-	I
t	I
interval	I
prolongation	I
.	O

probable	O
left	B
ventricular	I
hypertrophy	I
.	O

no	O
previous	O
tracing	O
available	O
for	O
comparison	O
.	O

tracing	O
#1	O

75494	O
||||	O
22225	O
||||	O
3797	O
||||	O
ecg	O
_	O
report	O
||||	O
2012	O
-	O
09	O
-	O
01	O
06	O
:	O
57	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

atrial	B
fibrillation	I

lateral	O
st	B
changes	I
are	I
nonspecific	I

repolarization	I
changes	O
may	O
be	O
partly	O
due	O
to	O
rhythm	O

since	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2012	O
-	O
09	O
-	O
01	O
*	O
*	O
]	O
:	O
paced	B
rhythm	I
is	O
not	O
seen	O

40122	O
||||	O
22230	O
||||	O
17644	O
||||	O
ecg	O
_	O
report	O
||||	O
2018	O
-	O
01	O
-	O
25	O
17	O
:	O
22	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
rhythm	I
.	O

left	B
axis	I
deviation	I
.	O

left	B
ventricular	I
hypertrophy	I
.	O

diffuse	O
non	B
-	I
specific	I
st	I
-	I
t	I
wave	I
changes	I
.	O

compared	O
to	O
the	O
previous	O
tracing	O
left	B
ventricular	I
hypertrophy	I
and	O
diffuse	O
st	B
-	I
t	I
wave	I
changes	I
are	O
new	O
.	O

tracing	O
#1	O

260776	O
||||	O
22264	O
||||	O
2798	O
||||	O
radiology	O
_	O
report	O
||||	O
2014	O
-	O
11	O
-	O
07	O
16	O
:	O
45	O
:	O
00	O
.	O
0	O
||||	O
a18	O
portable	O
abdomen	O
||||	O
||||	O
clip	O
#	O
327	O
-	O
1447	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2014	O
-	O
11	O
-	O
07	O
*	O
*	O
]	O
4	O
:	O
45	O
pm	O

portable	O
abdomen	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
2643	O
*	O
*	O
]	O
reason	O
:	O
pt	O
c	O
/	O
o	O
abd	B
distention	I
and	O
nausea	B
with	O
ng	O
tube	O
in	O
place	O
admitting	O
diagnosis	O
:	O
liver	B
failure	I

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

68	O
year	O
old	O
woman	O
with	O
s	O
/	O
p	O
liver	O
transplant	O

reason	O
for	O
this	O
examination	O
:	O

pt	O
c	O
/	O
o	O
abd	B
distention	I
and	O
nausea	B
with	O
ng	O
tube	O
in	O
place	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
68	O
year	O
old	O
woman	O
status	O
post	O
liver	O
transplant	O
.	O

now	O
complains	O
of	O
abdominal	B
distention	I
and	O
nausea	B
.	O

kub	O
:	O
comparison	O
is	O
made	O
to	O
prior	O
radiograph	O
dated	O
[	O
*	O
*	O
2014	O
-	O
11	O
-	O
05	O
*	O
*	O
]	O
as	O
well	O
as	O
the	O
ct	O
scan	O
of	O
the	O
abdomen	O
and	O
pelvis	O
dated	O
[	O
*	O
*	O
2014	O
-	O
11	O
-	O
06	O
*	O
*	O
]	O
.	O

the	O
study	O
is	O
technically	O
limited	O
by	O
positioning	O
and	O
motion	O
artifact	O
.	O

an	O
ng	O
tube	O
tip	O
is	O
in	O
the	O
stomach	O
.	O

there	O
are	O
mildly	O
prominent	O
loops	O
of	O
small	O
bowel	O
in	O
the	O
mid	O
-	O
abdomen	O
,	O
a	O
nonspecific	O
finding	O
.	O

there	O
is	O
gas	O
in	O
the	O
colon	O
to	O
the	O
level	O
of	O
the	O
sigmoid	O
.	O

retained	B
barium	I
is	O
seen	O
in	O
the	O
colon	O
.	O

two	O
drains	O
overlie	O
the	O
right	O
upper	O
quadrant	O
.	O

impression	O
:	O
limited	O
study	O
;	O
nonspecific	O
bowel	O
gas	O
pattern	O
;	O
early	O
or	O
partial	B
small	I
bowel	I
obstruction	I
cannot	O
be	O
excluded	O
.	O

continued	O
radiographic	O
evaluation	O
is	O
recommended	O
to	O
assess	O
for	O
interval	O
change	O
.	O

151087	O
||||	O
22566	O
||||	O
25489	O
||||	O
radiology	O
_	O
report	O
||||	O
2018	O
-	O
11	O
-	O
12	O
11	O
:	O
09	O
:	O
00	O
.	O
0	O
||||	O
c11	O
chest	O
(	O
pa	O
&	O
lat	O
)	O
||||	O
||||	O
clip	O
#	O
419	O
-	O
9906	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2018	O
-	O
11	O
-	O
12	O
*	O
*	O
]	O
11	O
:	O
09	O
am	O

chest	O
(	O
pa	O
&	O
lat	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
5039	O
*	O
*	O
]	O
reason	O
:	O
evaluate	O
for	O
pneumonia	B
or	O
cardiapulm	B
changes	I
admitting	O
diagnosis	O
:	O
seizure	B

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

77	O
year	O
old	O
man	O
with	O
questionable	O
rul	B
pneumonia	I
on	O
portable	O
reason	O
for	O
this	O
examination	O
:	O
evaluate	O
for	O
pneumonia	B
or	O
cardiapulm	B
changes	I
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

history	O
:	O
prior	O
study	O
raising	O
the	O
question	O
of	O
infiltrate	B
.	O

findings	O
:	O
two	O
views	O
of	O
the	O
chest	O
viewed	O
in	O
conjunction	O
with	O
the	O
single	O
portable	O
view	O
done	O
one	O
day	O
earlier	O
.	O

there	O
remains	O
diffuse	O
increased	O
interstitial	B
markings	I
likely	O
due	O
to	O
pulmonary	B
overload	I
,	O
given	O
the	O
cardiomegaly	B
.	O

note	O
is	O
made	O
of	O
gastric	B
distention	I
with	O
associated	O
left	O
basilar	O
atelectasis	B
.	O

no	O
definite	O
focal	O
infiltrate	B
is	O
appreciated	O
.	O

the	O
patient	O
is	O
status	O
post	O
multiple	O
vertebroplasties	O
.	O

healed	B
fracture	I
of	O
the	O
right	O
humeral	O
neck	O
.	O

impression	O
:	O
mild	O
diffuse	O
increase	O
in	O
interstitial	B
markings	I
,	O
unchanged	O
compared	O
to	O
studies	O
dating	O
back	O
to	O
2005	O
.	O

no	O
definite	O
focal	O
infiltrate	B
.	O

65777	O
||||	O
22682	O
||||	O
6073	O
||||	O
ecg	O
_	O
report	O
||||	O
2013	O
-	O
05	O
-	O
19	O
15	O
:	O
21	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

possible	O
atrial	B
flutter	I
with	O
variable	B
block	I

no	O
previous	O
tracing	O

20612	O
||||	O
22739	O
||||	O
15278	O
||||	O
discharge	O
_	O
summary	O
||||	O
2012	O
-	O
09	O
-	O
07	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
09	O
-	O
04	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2012	O
-	O
09	O
-	O
07	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1981	O
-	O
11	O
-	O
03	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
acove	O

history	O
of	O
present	O
illness	O
:	O
this	O
is	O
a	O
30	O
-	O
year	O
-	O
old	O
[	O
*	O
*	O
ethnicity	O
3711	O
*	O
*	O
]	O
male	O
,	O
who	O
presents	O
with	O
a	O
3	O
.	O
5	O
week	O
history	O
of	O
increasing	B
thirst	I
and	O
urination	O
.	O

he	O
noticed	O
he	O
was	O
drinking	O
up	O
to	O
3	O
gallons	O
per	O
day	O
in	O
the	O
last	O
several	O
days	O
and	O
also	O
urinating	B
multiple	I
times	I
up	O
to	O
5	O
-	O
6x	O
/	O
hour	O
at	O
night	O
.	O

he	O
has	O
lost	B
37	I
pounds	I
in	O
the	O
past	O
month	O
and	O
is	O
now	O
at	O
a	O
weight	O
of	O
187	O
from	O

224	O
.	O

on	O
the	O
night	O
prior	O
to	O
admission	O
,	O
at	O
approximately	O
2	O
a	O
.	O
m	O
.	O
,	O
he	O
began	O
vomiting	B
and	O
had	O
some	O
associated	O
abdominal	B
discomfort	I
.	O

he	O
was	O
able	O
to	O
tolerate	O
these	O
symptoms	B
and	O
went	O
to	O
work	O
that	O
morning	O
,	O
but	O
then	O
decided	O
to	O
seek	O
medical	O
attention	O
for	O
his	O
symptoms	B
which	O
then	O
included	O
dizziness	B
as	O
well	O
.	O

patient's	O
primary	O
care	O
physician	O
noted	O
the	O
patient	O
to	O
be	O
tachycardic	B
,	O
hypertensive	B
,	O
who	O
found	O
his	O
fingerstick	O
blood	O
sugar	O
to	O
be	O
critically	O
high	O
and	O
urinalysis	O
showed	O
the	O
presence	O
of	O
ketones	O
.	O

he	O
was	O
referred	O
to	O
the	O
emergency	O
department	O
for	O
evaluation	O
and	O
treatment	O
of	O
new	O
onset	O
diabetes	B
.	O

past	O
medical	O
history	O
:	O
genital	B
herpes	I
in	O
[	O
*	O
*	O
2012	O
-	O
07	O
-	O
03	O
*	O
*	O
]	O
.	O

medications	O
:	O
ibuprofen	O
prn	O
.	O

allergies	O
:	O
no	O
known	O
drug	O
allergies	O
.	O

social	O
history	O
:	O
no	O
tobacco	O
or	O
alcohol	O
use	O
,	O
no	O
iv	O
drug	O
use	O
,	O
no	O
illicit	O
drug	O
use	O
.	O

patient	O
immigrated	O
from	O
[	O
*	O
*	O
country	O
1114	O
*	O
*	O
]	O
six	O
years	O
ago	O
,	O
currently	O
works	O
in	O
the	O
banking	O
industry	O
.	O

family	O
history	O
:	O
notable	O
for	O
a	O
father	O
who	O
has	O
hypertension	B
,	O
but	O
there	O
is	O
no	O
family	O
history	O
of	O
coronary	B
artery	I
disease	I
,	O
diabetes	B
mellitus	I
,	O
or	O
cancer	B
.	O

physical	O
exam	O
on	O
admission	O
:	O
vital	O
signs	O
:	O
temperature	O
98	O
.	O
4	O
,	O
heart	O
rate	O
108	O
,	O
blood	O
pressure	O
152	O
/	O
82	O
,	O
respiratory	O
rate	O
20	O
,	O
and	O
oxygen	O
saturation	O
97%	O
.	O

general	O
:	O
pleasant	O
,	O
conversational	O
,	O
well	O
built	O
[	O
*	O
*	O
ethnicity	O
537	O
*	O
*	O
]	O
[	O
*	O
*	O
ethnicity	O
538	O
*	O
*	O
]	O
male	O
.	O

heent	O
:	O
pupils	O
are	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

extraocular	O
muscles	O
are	O
intact	O
.	O

oropharynx	O
clear	O
,	O
moist	O
mucosal	O
membranes	O
.	O

neck	O
:	O
no	O
jugular	B
venous	I
distention	I
,	O
no	O
lymphadenopathy	B
,	O
supple	O
.	O

cardiovascular	O
:	O
regular	O
,	O
rate	O
,	O
and	O
rhythm	O
,	O
normal	O
s1	O
,	O
s2	O
,	O
1	O
/	O
6	O
systolic	B
murmur	I
at	O
the	O
left	O
sternal	O
border	O
.	O

lungs	O
are	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

no	O
wheezes	B
,	O
no	O
rales	B
.	O

abdomen	O
is	O
soft	O
,	O
nontender	O
,	O
nondistended	O
,	O
no	O
masses	B
,	O
active	O
bowel	O
sounds	O
.	O

extremities	O
:	O

no	O
clubbing	B
,	O
cyanosis	B
,	O
or	O
edema	B
.	O

dorsalis	O
pedis	O
pulse	O
is	O
1	O
+	O
bilaterally	O
.	O

neurologically	O
:	O
the	O
patient	O
is	O
awake	O
,	O
alert	O
,	O
and	O
oriented	O
times	O
three	O
.	O

cranial	O
nerves	O
ii	O
through	O
xii	O
intact	O
.	O

ekg	O
:	O
normal	O
sinus	O
rhythm	O
at	O
100	O
beats	O
per	O
minute	O
,	O
normal	O
intervals	O
,	O
normal	O
axis	O
,	O
peak	O
t	O
waves	O
v2	O
through	O
v6	O
.	O

laboratory	O
data	O
on	O
admission	O
:	O
white	O
count	O
11	O
.	O
4	O
,	O
hematocrit	O

55	O
.	O
4	O
,	O
platelet	O
count	O
337	O
.	O

white	O
count	O
differential	O
:	O

neutrophils	O
88%	O
,	O
lymphocytes	O
8	O
.	O
6%	O
,	O
monocytes	O
3	O
.	O
0%	O
.	O

electrolytes	O
on	O
admission	O
:	O
sodium	O
134	O
,	O
potassium	O
5	O
.	O
8	O
,	O
chloride	O
92	O
,	O
bicarb	O
21	O
,	O
bun	O
27	O
,	O
creatinine	O
2	O
.	O
1	O
,	O
glucose	O
1	O
,	O
292	O
.	O

calcium	O
12	O
.	O
6	O
,	O
phosphate	O
6	O
.	O
9	O
,	O
magnesium	O
3	O
.	O
2	O
.	O

assessment	O
and	O
plan	O
:	O
this	O
is	O
a	O
30	O
-	O
year	O
-	O
old	O
male	O
with	O
no	O
significant	O
past	O
medical	O
history	O
,	O
who	O
presents	O
with	O
new	O
onset	O
diabetes	B
in	O
diabetic	B
ketoacidosis	I
.	O

hospital	O
course	O
:	O
patient	O
was	O
admitted	O
to	O
the	O
intensive	O
care	O
unit	O
and	O
treated	O
with	O
an	O
insulin	O
drip	O
at	O
7	O
units	O
/	O
hour	O
for	O
nine	O
hours	O
until	O
his	O
fingersticks	O
blood	O
sugar	O
level	O
had	O
reached	O
121	O
and	O
the	O
anion	O
gap	O
noted	O
on	O
presentation	O
had	O
closed	O
to	O
6	O
.	O

on	O
[	O
*	O
*	O
09	O
-	O
05	O
*	O
*	O
]	O
,	O
he	O
was	O
changed	O
to	O
a	O
regimen	O
including	O
nph	O
18	O
units	O
q	O
.	O
a	O
.	O
m	O
.	O
,	O
9	O
units	O
q	O
.	O
p	O
.	O
m	O
.	O
per	O
the	O
recommendations	O
of	O
the	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
491	O
*	O
*	O
]	O
diabetes	B
team	O
,	O
humalog	O
sliding	O
scale	O
was	O
also	O
started	O
.	O

this	O
regimen	O
was	O
adjusted	O
throughout	O
the	O
remainder	O
of	O
his	O
hospital	O
stay	O
.	O

on	O
[	O
*	O
*	O
09	O
-	O
07	O
*	O
*	O
]	O
,	O
he	O
was	O
on	O
a	O
regimen	O
of	O
nph	O
22	O
units	O
q	O
.	O
a	O
.	O
m	O
.	O
and	O
12	O
units	O
q	O
.	O
p	O
.	O
m	O
.	O
with	O
an	O
adjusted	O

humalog	O
sliding	O
scale	O
as	O
per	O
the	O
recommendations	O
of	O
the	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
491	O
*	O
*	O
]	O
diabetes	B
team	O
.	O

the	O
patient	O
was	O
referred	O
to	O
the	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
491	O
*	O
*	O
]	O
diabetes	B
for	O
multiple	O
follow	O
-	O
up	O
appointments	O
including	O
nutrition	O
,	O
dietary	O
consultation	O
,	O
education	O
programs	O
about	O
diabetes	B
,	O
and	O
glucose	O
monitoring	O
,	O
and	O
a	O
follow	O
-	O
up	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
3712	O
*	O
*	O
]	O
at	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
491	O
*	O
*	O
]	O
diabetes	B
center	O
.	O

2	O
.	O
fluids	O
,	O
electrolytes	O
,	O
and	O
nutrition	O
:	O
careful	O
monitoring	O
of	O
the	O
patient's	O
electrolytes	O
was	O
done	O
throughout	O
the	O
administration	O
of	O
insulin	O
to	O
correct	O
his	O
sugars	O
with	O
particular	O
attention	O
to	O
potassium	O
and	O
phosphate	O
.	O

the	O
patient	O
was	O
begun	O
on	O
a	O
diabetic	B
appropriate	O
diet	O
,	O
and	O
appropriate	O
nutrition	O
consultation	O
and	O
teaching	O
occurred	O
during	O
his	O
hospital	O
stay	O
.	O

discharge	O
condition	O
:	O
good	O
.	O

blood	O
sugars	O
under	O
adequate	O
control	O
.	O

patient	O
has	O
no	O
symptoms	B
and	O
is	O
hemodynamically	O
stable	O
.	O

discharge	O
diagnoses	O
:	O

1	O
.	O
diabetic	B
ketoacidosis	I
.	O

2	O
.	O
type	B
1	I
diabetes	I
mellitus	I
,	O
new	O
onset	O
.	O

3	O
.	O
hypovolemia	B
.	O

discharge	O
medications	O
:	O
insulin	O
nph	O
22	O
units	O
q	O
.	O
a	O
.	O
m	O
.	O
with	O
breakfast	O
,	O
insulin	O
nph	O
12	O
units	O
subcutaneous	O
q	O
.	O
h	O
.	O
s	O
.	O

humalog	O
insulin	O
-	O
sliding	O
scale	O
as	O
prescribed	O
by	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
3712	O
*	O
*	O
]	O
.	O

blood	O
glucose	O
test	O
strips	O
,	O
lancets	O
,	O
controlled	O
solution	O
,	O
insulin	O
syringes	O
.	O

follow	O
-	O
up	O
plans	O
:	O
the	O
patient	O
was	O
recommended	O
to	O
attend	O
the	O
following	O
classes	O
available	O
at	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
491	O
*	O
*	O
]	O
diabetes	B
:	O
on	O
[	O
*	O
*	O
09	O
-	O
10	O
*	O
*	O
]	O
,	O
first	O
steps	O
at	O
8	O
:	O
30	O
a	O
.	O
m	O
.	O
,	O
[	O
*	O
*	O
09	O
-	O
13	O
*	O
*	O
]	O
,	O
nutrition	O

class	O
"doc	O
,	O
what	O
can	O
i	O
eat"	O
at	O
10	O
:	O
30	O
a	O
.	O
m	O
.	O
and	O
weights	O
and	O

balances	O
at	O
1	O
p	O
.	O
m	O
.	O
[	O
*	O
*	O
09	O
-	O
14	O
*	O
*	O
]	O
,	O
nutrition	O
consultation	O
with	O
[	O
*	O
*	O
first	O
name5	O
(	O
namepattern1	O
)	O
3713	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
3714	O
*	O
*	O
]	O
at	O
5	O
p	O
.	O
m	O
.	O

follow	O
-	O
up	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
3712	O
*	O
*	O
]	O
on	O
[	O
*	O
*	O
09	O
-	O
21	O
*	O
*	O
]	O
at	O
12	O
:	O
30	O
p	O
.	O
m	O
.	O

patient	O
was	O
advised	O
to	O
schedule	O
a	O
follow	O
-	O
up	O
appointment	O
with	O
his	O
primary	O
care	O
physician	O
,	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
3715	O
*	O
*	O
]	O
within	O
one	O
week	O
of	O
his	O
hospital	O
stay	O
.	O

mark	O
[	O
*	O
*	O
doctor	O
last	O
name	O
835	O
*	O
*	O
]	O
,	O
m	O
.	O

d	O
.	O
[	O
*	O
*	O
md	O
number	O
1074	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
2144	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2012	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O
21	O
:	O
24	O

t	O
:	O
[	O
*	O
*	O
2012	O
-	O
09	O
-	O
18	O
*	O
*	O
]	O
10	O
:	O
16	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
3716	O
*	O
*	O
]	O

cc	O
:	O
[	O
*	O
*	O
cc	O
contact	O
info	O
3717	O
*	O
*	O
]	O

4908	O
||||	O
22743	O
||||	O
20721	O
||||	O
discharge	O
_	O
summary	O
||||	O
2017	O
-	O
09	O
-	O
29	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
21	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
29	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1959	O
-	O
02	O
-	O
09	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O
neurosurgery	O

allergies	O
:	O

patient	O
recorded	O
as	O
having	O
no	O
known	O
allergies	O
to	O
drugs	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
1196	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

gram	B
negative	I
rods	I
in	O
csf	O
.	O

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

omaya	O
reseveroir	O
was	O
removed	O
and	O
an	O
external	O
ventricular	O
drain	O
was	O
placed	O
and	O
subsequently	O
removed	O
.	O

history	O
of	O
present	O
illness	O
:	O

mrs	O
.	O
[	O
*	O
*	O
lastname	O
543	O
*	O
*	O
]	O
is	O
a	O
58	O
yo	O
woman	O
with	O
metastatic	B
breast	I
ca	I
and	O
newly	O
dx'd	O
leptomeningeal	B
disease	I
involving	O
brain	O
and	O
spinal	O
cord	O
.	O

she	O
has	O
had	O
various	O
chemotherapeutic	O
regimens	O
as	O
listed	O
below	O
,	O
but	O
most	O
recently	O
has	O
been	O
receiving	O
temodar	O
po	O
and	O
depocyte	O
by	O
omaya	O
shunt	O
.	O

on	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O
,	O
she	O
was	O
admitted	O
for	O
nausea	B
and	O
vomitting	B
and	O
was	O
found	O
to	O
have	O
a	O
uti	B
.	O

after	O
48	O
hours	O
,	O
she	O
was	O
discharged	O
home	O
with	O
levaquin	O
.	O

her	O
husband	O
reports	O
that	O
she	O
had	O
an	O
outpatient	O
lumbar	O
puncture	O
as	O
well	O
as	O
a	O
tap	O
of	O
her	O
omaya	O
shunt	O
earlier	O
today	O
based	O
on	O
some	O
findings	O
from	O

her	O
mri	O
on	O
saturday	O
the	O
23rd	O
.	O

he	O
was	O
told	O
that	O
during	O
there	O
was	O
a	O
lesion	B
suspicious	O
for	O
puss	B
vs	O
.	O
tumor	B
vs	O
.	O
blood	B
.	O

today's	O
tap	O
per	O
pathology	O
,	O
showed	O
three	O
tubes	O
from	O
the	O
lp	O
that	O
were	O
clean	O
,	O
and	O
one	O
tube	O
from	O
the	O
omaya	O
shunt	O
that	O
had	O
3	O
+	O
gram	B
negative	I
rods	I
.	O

the	O
patient	O
was	O
called	O
at	O
home	O
and	O
told	O
that	O
she	O
would	O
be	O
admitted	O
based	O
on	O
these	O
findings	O
.	O

past	O
medical	O
history	O
:	O

metastatic	B
breast	I
ca	I
with	O
leptomeningeal	B
disease	I

hypothyroidism	I

social	O
history	O
:	O

she	O
has	O
a	O
bachelor's	O
degree	O
.	O

she	O
is	O
retired	O
.	O

she	O
used	O
to	O
work	O
as	O
an	O
insurance	O
[	O
*	O
*	O
doctor	O
last	O
name	O
589	O
*	O
*	O
]	O
.	O

she	O
is	O
married	O
.	O

she	O
lives	O
with	O
her	O
spouse	O
.	O

she	O
does	O
not	O
smoke	O
.	O

she	O
does	O
not	O
drink	O
.	O

she	O
denies	O
any	O
recreational	O
drug	O
abuse	O
.	O

family	O
history	O
:	O

mother	O
died	O
at	O
77	O
of	O
bowel	B
obstruction	I
.	O

she	O
had	O
a	O
difficult	O
surgery	O
,	O
and	O
bowel	B
obstruction	I
was	O
secondary	O
to	O
prior	O
surgeries	O
for	O
colon	B
cancer	I
.	O

her	O
father	O
died	O
at	O
77	O
with	O
coronary	B
problems	I
.	O
[	O
*	O
*	O
name	O
(	O
ni	O
)	O
*	O
*	O
]	O
sister	O
is	O
alive	O
at	O
47	O
in	O
good	O
health	O
.	O

she	O
has	O
one	O
brother	O
who	O
died	O
at	O
27	O
in	O
a	O
fire	O
,	O
and	O
she	O
has	O
three	O
other	O
brothers	O
,	O
59	O
,	O
57	O
,	O
15	O
,	O
in	O
good	O
health	O
.	O

she	O
has	O
two	O
daughters	O
,	O
30	O
and	O
26	O
,	O
in	O
good	O
health	O
and	O
a	O
son	O
,	O
32	O
,	O
in	O
good	O
health	O
.	O

physical	O
exam	O
:	O

vitals	O
:	O
tc=98	O
.	O
0	O
,	O
p	O
:	O
116	O
,	O
110	O
/	O
64	O
,	O
20	O

gen	O
:	O
appears	O
slightly	O
dry	B
.	O

thin	O
.	O

tired	B
.	O

older	O
than	O
her	O
stated	O
age	O
.	O

alert	O
,	O
attentive	O
with	O
exam	O

chest	O
:	O
cta	O
bilaterally	O

back	O
:	O
sacral	B
ulcer	I
without	O
dressing	O
.	O

no	O
puss	B
or	O
erythema	B
.	O

cv	O
:	O
regular	O
rate	O
and	O
rhythm	O
no	O
mg	B
/	O
r	B

abd	O
:	O
soft	O
,	O
nontender	O
,	O
nondistended	O
,	O
+	O
bs	O

extrem	O
:	O
warm	O
.	O

well	O
perfused	O
.	O

2	O
+	O
dp	O
bilaterally	O
.	O

neuro	O
:	O

mental	O
status	O
:	O

patient	O
is	O
a	O
+	O
o	O
times	O
3	O
.	O
she's	O
tired	B
but	O
attentive	O
,	O
flat	B
affect	I
,	O
speech	O
fluent	O
.	O

per	O
husbands	O
report	O
,	O
she	O
is	O
at	O
her	O
baseline	O
with	O
no	O
changes	B
in	I
personality	I
or	O
level	B
of	I
alertness	I
.	O

quiet	O
,	O
but	O
speaks	O
spontaneously	O
.	O

memory	O
intact	O
.	O

attention	O
good	O
.	O

names	O
low	O
frequency	O
objects	O
and	O
follows	O
commands	O
.	O

heent	O
:	O
head	O
-	O
left	O
frontal	O
region	O
has	O
omaya	O
reservoir	O
below	O
sub	O
-	O
cutaneously	O
.	O

no	O
erythema	B
,	O
no	O
edema	B
,	O
no	O
fluctuance	B
.	O

no	O
other	O
signs	O
of	O
infxn	B
at	O
site	O
.	O

eyes	O
-	O
pupils	O
reactive	O
bilaterally	O
5	O
to	O
4	O
l	O
and	O
[	O
*	O
*	O
05	O
-	O
29	O
*	O
*	O
]	O
right	O
.	O

eomi	O
.	O

vff	O
.	O

no	O
nystagmus	B
.	O

mouth	O
-	O
tongue	O
midline	O
,	O
palate	B
elevated	I
symmetrically	O
.	O

no	O
thrush	B

neck	O
-	O
soft	O
,	O
supple	O

cranial	O
nerves	O
:	O
ii	O
-	O
vii	O
,	O
ix	O
-	O
xii	O
intact	O
.	O

intact	O
hearing	O
bilaterally	O

motor	O
-	O
good	O
effort	O
on	O
exam	O
,	O
4	O
+	O
5	O
in	O
bilateral	O
ues	O

les	O
:	O
i	O
/	O
p	O
legflex	O
legext	O
df	O
pf	O

r	O
[	O
*	O
*	O
05	O
-	O
31	O
*	O
*	O
]	O
4	O
-	O
/	O
5	O
[	O
*	O
*	O
05	O
-	O
31	O
*	O
*	O
]	O
4	O
-	O
4	O

l	O
[	O
*	O
*	O
05	O
-	O
31	O
*	O
*	O
]	O
[	O
*	O
*	O
05	O
-	O
31	O
*	O
*	O
]	O
4	O
+	O
/	O
5	O
4	O
+	O
4	O
+	O

sensory	O
:	O
intact	O
in	O
all	O
four	O
extremities	O
to	O
lt	O
,	O
pp	O
,	O
cold	O
.	O

reflexes	O
:	O

[	O
*	O
*	O
hospital1	O
*	O
*	O
]	O
br	O
tri	O
pat	O
ach	O
toes	O

rt	O
:	O
1	O
1	O
1	O
0	O
0	O
mute	O

left	O
:	O
1	O
1	O
1	O
0	O
0	O
mute	O

cereberllar	O
:	O
normal	O
fnf	O
.	O

gait	O
small	O
steps	O
,	O
requires	O
assist	O
of	O
1	O
person	O
.	O

at	O
baseline	O
per	O
husband	O
.	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2017	O
-	O
09	O
-	O
21	O
*	O
*	O
]	O
01	O
:	O
06pm	O
cerebrospinal	O
fluid	O
(	O
csf	O
)	O
wbc	O
-	O
2	O
rbc	O
-	O
12	O
*	O
polys	O
-	O
32	O
lymphs	O
-	O
5	O
monos	O
-	O
0	O
atyps	O
-	O
1	O
macrophag	O
-	O
62	O

[	O
*	O
*	O
2017	O
-	O
09	O
-	O
21	O
*	O
*	O
]	O
01	O
:	O
06pm	O
cerebrospinal	O
fluid	O
(	O
csf	O
)	O
protein	O
-	O
1080	O
*	O
glucose	O
-	O
197	O
ld	O
(	O
ldh	O
)	O
-	O
144	O
misc	O
-	O
cea=26	O

[	O
*	O
*	O
2017	O
-	O
09	O
-	O
21	O
*	O
*	O
]	O
02	O
:	O
40pm	O
cerebrospinal	O
fluid	O
(	O
csf	O
)	O
wbc	O
-	O
0	O
rbc	O
-	O
130	O
*	O
polys	O
-	O
3	O
lymphs	O
-	O
39	O
monos	O
-	O
58	O

[	O
*	O
*	O
2017	O
-	O
09	O
-	O
21	O
*	O
*	O
]	O
02	O
:	O
40pm	O
cerebrospinal	O
fluid	O
(	O
csf	O
)	O
protein	O
-	O
101	O
*	O
glucose	O
-	O
134	O
ld	O
(	O
ldh	O
)	O
-	O
27	O

brief	O
hospital	O
course	O
:	O

the	O
patient	O
is	O
a	O
58	O
-	O
year	O
-	O
old	O
female	O
who	O
is	O
well	O
known	O
to	O
the	O
neuro	O
-	O
oncology	O
/	O
neurosurgery	O
service	O
at	O
the	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
[	O
*	O
*	O
hospital	O
*	O
*	O
]	O
medical	O
center	O
.	O

she	O
is	O
known	O
to	O
have	O
metastatic	B
breast	I
carcinoma	I
.	O

the	O
patient	O
suffers	O
from	O
meningeal	B
carcinomatosis	I
.	O

she	O
had	O
recently	O
had	O
a	O
csf	O
reservoir	O
/	O
access	O
device	O
placed	O
by	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
.	O

the	O
patient	O
now	O
returns	O
several	O
weeks	O
later	O
with	O
a	O
ventriculitis	B
.	O

the	O
patient	O
is	O
neurologically	O
in	O
good	O
condition	O
.	O

the	O
gram	O
stain	O
of	O
the	O
recent	O
csf	O
specimen	O
revealed	O
3	O
+	O
gram	O
negative	O
rods	O
.	O

the	O
patient	O
is	O
in	O
need	O
of	O
removal	O
of	O
the	O
previous	O
csf	O
access	O
device	O
and	O
placement	O
of	O
a	O
new	O
intraventricular	O
evd	O
for	O
infiltration	O
of	O
intrathecal	O
antibiotics	O
which	O
were	O
never	O
given	O
.	O

she	O
was	O
admitted	O
to	O
the	O
icu	O
for	O
close	O
neuro	O
observation	O
and	O
care	O
.	O
she	O
was	O
followed	O
by	O
id	O
and	O
treated	O
initially	O
with	O
vanco	O
and	O
ceftazdime	O
.	O

her	O
evd	O
was	O
kept	O
in	O
until	O
[	O
*	O
*	O
09	O
-	O
25	O
*	O
*	O
]	O
.	O

she	O
was	O
transferred	O
to	O
the	O
floor	O
on	O
[	O
*	O
*	O
09	O
-	O
26	O
*	O
*	O
]	O
.	O

lm	B
disease	I
-	O
pt	O
received	O
it	O
depocyte	O
and	O
6	O
/	O
7	O
days	O
of	O
tmz	O
.	O
-	O
mri	O
of	O
l	O
spine	O
shows	O
stable	O
disease	B

2	O
)	O
id	O
-	O
pt	O
now	O
in	O
step	O
down	O
unit	O
.	O

id	O
wants	O
a	O
full	O
14days	O
of	O
vanc	O
/	O
ceftaz	O
(	O
ceft	O
started	O
[	O
*	O
*	O
09	O
-	O
23	O
*	O
*	O
]	O
,	O
vanc	O
started	O
[	O
*	O
*	O
09	O
-	O
25	O
*	O
*	O
]	O
)	O
,	O
all	O
of	O
her	O

csf	O
cultures	O
have	O
been	O
negative	O
(	O
1st	O
set	O
done	O
before	O
abxs	O
)	O
.	O

on	O
discharge	O
id	O
recommened	O
14	O
days	O
of	O
levaquin	O

3	O
)	O
myopathy	B
-	O
in	O
proximal	O
thighs	O
,	O
probably	O
from	O
steroids	O
,	O
pt	O
was	O

on	O
decadron	O
taper	O
before	O
,	O
will	O
have	O
husband	O
cont	O
it	O
once	O
d	O
/	O
c'd	O
from	O
hospital	O

4	O
)	O
thrush	B
-	O
none	O
today	O
,	O
but	O
would	O
cont	O
nystatin	O
s&s	O
as	O
pt	O
on	O
decadron	O

5	O
)	O
gi	O
-	O
spoke	O
to	O
pa	O
on	O
nsg	O
service	O
and	O
nurse	O
who	O
will	O
see	O
if	O
pt	O
is	O
accurate	O
in	O
her	O
statment	O
of	O
no	O
bm	B
for	O
one	O
week	O
.	O

7	O
)	O
cerebral	B
edema	I
-	O
husband	O
should	O
cont	O
decadron	O
taper	O
as	O
brain	O
mri	O
stable	O
.	O

he	O
has	O
taper	O
schedule	O
given	O
to	O
him	O
.	O

8	O
)	O
nausea	B
-	O
cont	O
zydis	O
10	O
mg	O
qd	O
,	O
pt	O
not	O
had	O
any	O
nausea	B
since	O
being	O
put	O
on	O
zydis	O
.	O

her	O
exam	O
on	O
discharge	O
was	O
:	O

patient	O
is	O
tired	B
but	O
attentive	O
,	O
flat	B
affect	I
,	O
fluent	O
,	O
presodic	O
speech	O
.	O

a&ox3	O
.	O

registration	O
intact	O
.	O

able	O
to	O
count	O
20	O
-	O
-	O
>1	O
without	O

diff	O
,	O
serial	O
3's	O
got	O
to	O
21	O
and	O
then	O
stopped	O
.	O

intact	O
repetition	O
/	O
naming	O
/	O
[	O
*	O
*	O
03	O
-	O
31	O
*	O
*	O
]	O
-	O
step	O
command	O
.	O

no	O
r	B
/	I
l	I
disorientation	I
.	O

no	O
ideomotor	B
apraxia	I
.	O

recall	O
:	O
0	O
/	O
3	O
spont	O
,	O
[	O
*	O
*	O
02	O
-	O
28	O
*	O
*	O
]	O
with	O
lists	O

heent	O
:	O
head	O
-	O
nc	O
/	O
at	O
,	O
alopecic	B
from	I
radiation	I

eyes	O
-	O
perrl	O
.	O

eomi	O
.	O

vff	O
.	O

no	O
nystagmus	B
.	O

mouth	O
-	O
tongue	O
midline	O
,	O
palate	B
elevated	I
symmetrically	O
.	O

no	O
thrush	B

neck	O
-	O
soft	O
,	O
supple	O

cranial	O
nerves	O
:	O
ii	O
-	O
vii	O
,	O
ix	O
-	O
xii	O
intact	O
.	O

intact	O
hearing	O
bilaterally	O

motor	O
-	O
good	O
effort	O
on	O
exam	O
,	O
[	O
*	O
*	O
06	O
-	O
30	O
*	O
*	O
]	O
in	O
bilateral	O
ues	O

les	O
:	O
i	O
/	O
p	O
legflex	O
legext	O
df	O
pf	O

r	O
[	O
*	O
*	O
05	O
-	O
31	O
*	O
*	O
]	O
5	O
/	O
5	O
[	O
*	O
*	O
06	O
-	O
30	O
*	O
*	O
]	O
5	O
5	O

l	O
[	O
*	O
*	O
05	O
-	O
31	O
*	O
*	O
]	O
5	O
/	O
5	O
[	O
*	O
*	O
06	O
-	O
30	O
*	O
*	O
]	O
5	O
5	O

sensory	O
:	O
pt	O
stated	O
intact	O
lt	O
even	O
over	O
groin	O
area	O
,	O

cereberllar	O
:	O
normal	O
appendicular	O
coordination	O
.	O

didn't	O
test	O
gait	O

medications	O
on	O
admission	O
:	O

decadron	O
2	O
mg	O
q8h	O
po	O

dolasetron	O
mesylate	O
12	O
.	O
5	O
mg	O
q8h	O
:	O
prn	O
iv	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O
@	O
1900	O
insulin	O
-	O
sliding	O
scale	O
sliding	O
scale	O
0	O
unit	O
asdir	O
sc	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O

pantoprazole	O
40	O
mg	O
q24h	O
po	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O
@	O
1900	O

prochlorperazine	O
10	O
mg	O
q6h	O
:	O
prn	O
iv	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O
@	O
1900	O

prochlorperazine	O
maleate	O
10	O
mg	O
q6h	O
:	O
prn	O
po	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O
@	O
1900	O

senna	O
1	O
tab	O
bid	O
:	O
prn	O
po	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O
@	O
1900	O

docusate	O
sodium	O
100	O
mg	O
bid	O
po	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O
@	O
2000	O

clotrimazole	O
1	O
troc	O
qid	O
po	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O
@	O
2200	O

olanzapine	O
(	O
disintegrating	O
tablet	O
)	O
5	O
mg	O
qhs	O
po	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O
@	O
2200	O
levothyroxine	O
sodium	O
44	O
mcg	O
qsun	O
(	O
su	O
)	O
po	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
17	O
*	O
*	O
]	O
@	O
1300	O

pregabalin	O
50	O
mg	O
bid	O
oral	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
17	O
*	O
*	O
]	O
@	O
2000	O

pregabalin	O
150	O
mg	O
bid	O
oral	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
17	O
*	O
*	O
]	O
@	O
2000	O

levothyroxine	O
sodium	O
88	O
mcg	O
qmowefr	O
(	O
mo	O
,	O
we	O
,	O
fr	O
)	O
po	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
18	O
*	O
*	O
]	O
@	O
levothyroxine	O
sodium	O
88	O
mcg	O
qtuthsa	O
(	O
tu	O
,	O
th	O
,	O
sa	O
)	O
po	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
19	O
*	O
*	O
]	O

discharge	O
medications	O
:	O

1	O
.	O
hospital	O
bed	O

2	O
.	O
one	O
-	O
step	O
mattress	O

3	O
.	O
standard	O
wheelchair	O

4	O
.	O
levofloxacin	O
500	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
once	O
a	O
day	O
for	O
14	O
days	O
.	O

disp	O
:	O
*	O
14	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

decadron	O
2	O
mg	O
q8h	O
po	O

dolasetron	O
mesylate	O
12	O
.	O
5	O
mg	O
q8h	O
:	O
prn	O
iv	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O
@	O
1900	O
insulin	O
-	O
sliding	O
scale	O
sliding	O
scale	O
0	O
unit	O
asdir	O
sc	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O

pantoprazole	O
40	O
mg	O
q24h	O
po	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O
@	O
1900	O

prochlorperazine	O
10	O
mg	O
q6h	O
:	O
prn	O
iv	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O
@	O
1900	O

prochlorperazine	O
maleate	O
10	O
mg	O
q6h	O
:	O
prn	O
po	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O
@	O
1900	O

senna	O
1	O
tab	O
bid	O
:	O
prn	O
po	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O
@	O
1900	O

docusate	O
sodium	O
100	O
mg	O
bid	O
po	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O
@	O
2000	O

clotrimazole	O
1	O
troc	O
qid	O
po	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O
@	O
2200	O

olanzapine	O
(	O
disintegrating	O
tablet	O
)	O
5	O
mg	O
qhs	O
po	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
16	O
*	O
*	O
]	O
@	O
2200	O
levothyroxine	O
sodium	O
44	O
mcg	O
qsun	O
(	O
su	O
)	O
po	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
17	O
*	O
*	O
]	O
@	O
1300	O

pregabalin	O
50	O
mg	O
bid	O
oral	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
17	O
*	O
*	O
]	O
@	O
2000	O

pregabalin	O
150	O
mg	O
bid	O
oral	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
17	O
*	O
*	O
]	O
@	O
2000	O

levothyroxine	O
sodium	O
88	O
mcg	O
qmowefr	O
(	O
mo	O
,	O
we	O
,	O
fr	O
)	O
po	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
18	O
*	O
*	O
]	O
@	O
levothyroxine	O
sodium	O
88	O
mcg	O
qtuthsa	O
(	O
tu	O
,	O
th	O
,	O
sa	O
)	O
po	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
19	O
*	O
*	O
]	O

discharge	O
disposition	O
:	O

home	O
with	O
service	O

discharge	O
diagnosis	O
:	O

csf	O
infection	B
.	O

discharge	O
condition	O
:	O

stable	O
.	O

discharge	O
instructions	O
:	O

please	O
complete	O
the	O
prescribed	O
antibiotics	O
as	O
prescribed	O
.	O

please	O
call	O
or	O
return	O
for	O
headache	B
,	O
vision	B
changes	I
,	O
redness	B
,	O
swelling	B
or	O
drainage	B
from	I
wound	I
,	O
fever	B
,	O
chills	B
,	O
or	O
any	O
other	O
concern	O
.	O

you	O
also	O
have	O
a	O
decubitus	B
ulcer	I
that	O
should	O
be	O
cared	O
for	O
by	O
a	O
wound	O
nurse	O
.	O

we	O
are	O
providing	O
you	O
a	O
referral	O
for	O
that	O
service	O
.	O

followup	O
instructions	O
:	O

please	O
return	O
for	O
removal	O
of	O
sutures	O
[	O
*	O
*	O
10	O
-	O
07	O
*	O
*	O
]	O
.	O

2	O
weeks	O
after	O
completion	O
of	O
antibiotics	O
,	O
please	O
return	O
for	O
clinic	O
visit	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
and	O
mri	O
.	O

please	O
call	O
brain	B
tumor	I
clinic	O
to	O
set	O
up	O
an	O
appointment	O
time	O
.	O
(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
4379	O
*	O
*	O
]	O
.	O

you	O
will	O
have	O
an	O
appointment	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
4120	O
*	O
*	O
]	O
on	O
tuesday	O
morning	O
at	O
the	O
infusion	O
center	O
for	O
intrathecal	O
depocyte	O
.	O

her	O
assistant	O
will	O
call	O
you	O
with	O
the	O
appointment	O
time	O
.	O

[	O
*	O
*	O
name6	O
(	O
md	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
1197	O
*	O
*	O
]	O
md	O
[	O
*	O
*	O
md	O
number	O
1198	O
*	O
*	O
]	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
2241	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
2242	O
*	O
*	O
]	O
np	O
80	O
-	O
aky	O
[	O
*	O
*	O
2017	O
-	O
09	O
-	O
29	O
*	O
*	O
]	O
@	O
1106	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
:	O
mon	O
[	O
*	O
*	O
2017	O
-	O
10	O
-	O
16	O
*	O
*	O
]	O
3	O
:	O
39	O
pm	O

(	O
end	O
of	O
report	O
)	O

41469	O
||||	O
22818	O
||||	O
25678	O
||||	O
ecg	O
_	O
report	O
||||	O
2016	O
-	O
11	O
-	O
19	O
07	O
:	O
42	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

atrial	B
fibrillation	I
.	O

non	O
-	O
specific	O
t	B
wave	I
flattening	I
.	O

poor	B
r	I
wave	I
progression	I
.	O

compared	O
to	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2016	O
-	O
11	O
-	O
18	O
*	O
*	O
]	O
the	O
rate	O
is	O
faster	O
.	O

tracing	O
#2	O

26994	O
||||	O
22821	O
||||	O
14126	O
||||	O
discharge	O
_	O
summary	O
||||	O
2013	O
-	O
06	O
-	O
28	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
06	O
-	O
03	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2013	O
-	O
06	O
-	O
28	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1976	O
-	O
10	O
-	O
25	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
neurosurgery	O

allergies	O
:	O

penicillins	O
/	O
bactrim	O

attending	O
:	O
[	O
*	O
*	O
attending	O
info	O
1518	O
*	O
*	O
]	O

chief	O
complaint	O
:	O

sudden	O
onset	O
ha	B
and	O
neck	B
pain	I
radiating	O
to	O
l	O
sided	O
temporal	O
and	O
neck	B
pain	I
.	O

major	O
surgical	O
or	O
invasive	O
procedure	O
:	O

coil	O
embolization	O
of	O
a	O
ruptured	O
distal	O
right	O
pica	O
aneurysm	O

history	O
of	O
present	O
illness	O
:	O

36	O
yo	O
hiv	B
+	I
m	O
in	O
his	O
usual	O
state	O
of	O
health	O
until	O
the	O
am	O
of	O
5	O
/	O
13	O
when	O
he	O
developed	O
a	O
severe	O
l	O
-	O
sided	O
ha	B
with	O
radiation	O
to	O
his	O
neck	O
and	O
temporal	O
area	O
associated	O
with	O
photophobia	B
.	O

he	O
denies	O
however	O
,	O
n	B
/	O
v	B
,	O
cp	B
,	O
sob	B
or	O
anticedent	O
trauma	B
.	O

past	O
medical	O
history	O
:	O

1	O
.	O
enuresis	B
seen	O
by	O
sleep	O
clinic	O
.	O

2	O
.	O
alcohol	B
abuse	I
;	O
no	O
alcohol	O
for	O
12	O
years	O
.	O

3	O
.	O
human	B
immunodeficiency	I
virus	I
diagnosed	O
in	O
[	O
*	O
*	O
2003	O
*	O
*	O
]	O
.	O

history	O
of	O
pneumocystis	B
carinii	I
pneumonia	I
.	O

has	O
been	O
on	O
haart	O
,	O
now	O
off	O
since	O
[	O
*	O
*	O
2011	O
-	O
11	O
-	O
19	O
*	O
*	O
]	O
due	O
to	O
insurance	O
reasons	O
.	O

viral	O
load	O
last	O
undetectable	O
in	O
11	O
/	O
2003	O
.	O

social	O
history	O
:	O

patient	O
is	O
a	O
gay	O
male	O
,	O
runs	O
a	O
restaurant	O
,	O
is	O
a	O
current	O
2	O
ppd	O
smoker	O
for	O
many	O

years	O
.	O

prior	O
alcohol	O
and	O
cocaine	O
11	O
years	O
ago	O
.	O

family	O
history	O
:	O

lives	O
alone	O
.	O
+	O
for	O
cad	B
,	O
but	O
neg	O
for	O
prior	O
know	O
cvd	B
.	O

physical	O
exam	O
:	O

96	O
.	O
5	O
134	O
/	O
70	O
68	O
16	O
100%ra	O

nad	O

cta	O
-	O
b	O
/	O
rrr	O

ext	O
:	O
smooth	O
,	O
symmetric	O
,	O
purposeful	O
motion	O
of	O
all	O
4	O
ext	O
,	O
sensation	O
intact	O
no	O
edema	B

abd	O
nt	O
/	O
nd	O

neuro	O
:	O
aox3	O
,	O
neg	O
pronator	B
drift	I
.	O

cn	O
[	O
*	O
*	O
md	O
number	O
2468	O
*	O
*	O
]	O
intact	O
b	O
,	O
eomi	O
,	O
perrla	O

pertinent	O
results	O
:	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
03	O
*	O
*	O
]	O
06	O
:	O
00am	O
blood	O
wbc	O
-	O
9	O
.	O
0#	O
rbc	O
-	O
4	O
.	O
84	O
hgb	O
-	O
13	O
.	O
9	O
*	O
hct	O
-	O
39	O
.	O
5	O
*	O
mcv	O
-	O
82	O
mch	O
-	O
28	O
.	O
7	O
mchc	O
-	O
35	O
.	O
2	O
*	O
rdw	O
-	O
14	O
.	O
0	O
plt	O
ct	O
-	O
183	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
03	O
*	O
*	O
]	O
05	O
:	O
18pm	O
blood	O
wbc	O
-	O
7	O
.	O
3	O
rbc	O
-	O
4	O
.	O
10	O
*	O
hgb	O
-	O
12	O
.	O
0	O
*	O
hct	O
-	O
33	O
.	O
7	O
*	O
mcv	O
-	O
82	O
mch	O
-	O
29	O
.	O
1	O
mchc	O
-	O
35	O
.	O
4	O
*	O
rdw	O
-	O
14	O
.	O
1	O
plt	O
ct	O
-	O
172	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
04	O
*	O
*	O
]	O
03	O
:	O
15am	O
blood	O
wbc	O
-	O
9	O
.	O
6	O
rbc	O
-	O
4	O
.	O
15	O
*	O
hgb	O
-	O
11	O
.	O
8	O
*	O
hct	O
-	O
33	O
.	O
8	O
*	O
mcv	O
-	O
81	O
*	O
mch	O
-	O
28	O
.	O
4	O
mchc	O
-	O
34	O
.	O
9	O
rdw	O
-	O
14	O
.	O
2	O
plt	O
ct	O
-	O
175	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
14	O
*	O
*	O
]	O
03	O
:	O
30am	O
blood	O
wbc	O
-	O
3	O
.	O
9	O
*	O
rbc	O
-	O
4	O
.	O
02	O
*	O
hgb	O
-	O
11	O
.	O
7	O
*	O
hct	O
-	O
32	O
.	O
6	O
*	O
mcv	O
-	O
81	O
*	O
mch	O
-	O
29	O
.	O
0	O
mchc	O
-	O
35	O
.	O
8	O
*	O
rdw	O
-	O
14	O
.	O
5	O
plt	O
ct	O
-	O
206	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
26	O
*	O
*	O
]	O
03	O
:	O
12am	O
blood	O
wbc	O
-	O
5	O
.	O
5	O
rbc	O
-	O
3	O
.	O
55	O
*	O
hgb	O
-	O
10	O
.	O
3	O
*	O
hct	O
-	O
31	O
.	O
4	O
*	O
mcv	O
-	O
88	O
mch	O
-	O
29	O
.	O
0	O
mchc	O
-	O
32	O
.	O
9	O
rdw	O
-	O
15	O
.	O
7	O
*	O
plt	O
ct	O
-	O
439	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
27	O
*	O
*	O
]	O
06	O
:	O
25am	O
blood	O
wbc	O
-	O
5	O
.	O
3	O
rbc	O
-	O
3	O
.	O
64	O
*	O
hgb	O
-	O
10	O
.	O
1	O
*	O
hct	O
-	O
31	O
.	O
8	O
*	O
mcv	O
-	O
87	O
mch	O
-	O
27	O
.	O
9	O
mchc	O
-	O
31	O
.	O
9	O
rdw	O
-	O
15	O
.	O
5	O
plt	O
ct	O
-	O
396	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
03	O
*	O
*	O
]	O
06	O
:	O
00am	O
blood	O
pt	O
-	O
12	O
.	O
1	O
ptt	O
-	O
23	O
.	O
9	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
0	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
03	O
*	O
*	O
]	O
06	O
:	O
00am	O
blood	O
plt	O
ct	O
-	O
183	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
03	O
*	O
*	O
]	O
05	O
:	O
18pm	O
blood	O
pt	O
-	O
13	O
.	O
4	O
*	O
ptt	O
-	O
79	O
.	O
9	O
*	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
2	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
03	O
*	O
*	O
]	O
05	O
:	O
18pm	O
blood	O
plt	O
ct	O
-	O
172	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
04	O
*	O
*	O
]	O
03	O
:	O
15am	O
blood	O
pt	O
-	O
12	O
.	O
9	O
ptt	O
-	O
24	O
.	O
2	O
inr	O
(	O
pt	O
)	O
-	O
1	O
.	O
1	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
04	O
*	O
*	O
]	O
03	O
:	O
15am	O
blood	O
plt	O
ct	O
-	O
175	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
20	O
*	O
*	O
]	O
02	O
:	O
47am	O
blood	O
pt	O
-	O
11	O
.	O
2	O
*	O
ptt	O
-	O
26	O
.	O
3	O
inr	O
(	O
pt	O
)	O
-	O
0	O
.	O
8	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
20	O
*	O
*	O
]	O
02	O
:	O
47am	O
blood	O
plt	O
ct	O
-	O
440	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
26	O
*	O
*	O
]	O
03	O
:	O
12am	O
blood	O
pt	O
-	O
11	O
.	O
2	O
*	O
ptt	O
-	O
20	O
.	O
7	O
*	O
inr	O
(	O
pt	O
)	O
-	O
0	O
.	O
8	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
26	O
*	O
*	O
]	O
03	O
:	O
12am	O
blood	O
plt	O
ct	O
-	O
439	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
03	O
*	O
*	O
]	O
06	O
:	O
00am	O
blood	O
wbc	O
-	O
9	O
.	O
0	O
lymph	O
-	O
29	O
abs	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
823	O
*	O
*	O
]	O
-	O
2610	O
cd3%	O
-	O
88	O
abs	O
cd3	O
-	O
2303	O
*	O
cd4%	O
-	O
11	O
abs	O
cd4	O
-	O
284	O
*	O
cd8%	O
-	O
75	O
abs	O
cd8	O
-	O
1955	O
*	O
cd4	O
/	O
cd8	O
-	O
0	O
.	O
2	O
*	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
04	O
*	O
*	O
]	O
02	O
:	O
00pm	O
blood	O
wbc	O
-	O
9	O
.	O
6	O
lymph	O
-	O
19	O
abs	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
823	O
*	O
*	O
]	O
-	O
1824	O
cd3%	O
-	O
86	O
abs	O
cd3	O
-	O
1569	O
cd4%	O
-	O
14	O
abs	O
cd4	O
-	O
249	O
*	O
cd8%	O
-	O
70	O
abs	O
cd8	O
-	O
1285	O
*	O
cd4	O
/	O
cd8	O
-	O
0	O
.	O
2	O
*	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
03	O
*	O
*	O
]	O
06	O
:	O
00am	O
blood	O
glucose	O
-	O
169	O
*	O
urean	O
-	O
14	O
creat	O
-	O
0	O
.	O
9	O
na	O
-	O
136	O
k	O
-	O
3	O
.	O
6	O
cl	O
-	O
102	O
hco3	O
-	O
23	O
angap	O
-	O
15	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
04	O
*	O
*	O
]	O
03	O
:	O
15am	O
blood	O
glucose	O
-	O
113	O
*	O
urean	O
-	O
9	O
creat	O
-	O
0	O
.	O
6	O
na	O
-	O
137	O
k	O
-	O
4	O
.	O
1	O
cl	O
-	O
105	O
hco3	O
-	O
22	O
angap	O
-	O
14	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
04	O
*	O
*	O
]	O
02	O
:	O
00pm	O
blood	O
glucose	O
-	O
123	O
*	O
urean	O
-	O
8	O
creat	O
-	O
0	O
.	O
6	O
na	O
-	O
137	O
k	O
-	O
4	O
.	O
2	O
cl	O
-	O
108	O
hco3	O
-	O
22	O
angap	O
-	O
11	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
12	O
*	O
*	O
]	O
03	O
:	O
55am	O
blood	O
glucose	O
-	O
106	O
*	O
urean	O
-	O
10	O
creat	O
-	O
0	O
.	O
5	O
na	O
-	O
129	O
*	O
k	O
-	O
4	O
.	O
1	O
cl	O
-	O
99	O
hco3	O
-	O
20	O
*	O
angap	O
-	O
14	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
13	O
*	O
*	O
]	O
03	O
:	O
46am	O
blood	O
glucose	O
-	O
117	O
*	O
urean	O
-	O
10	O
creat	O
-	O
0	O
.	O
5	O
na	O
-	O
132	O
*	O
k	O
-	O
4	O
.	O
2	O
cl	O
-	O
101	O
hco3	O
-	O
20	O
*	O
angap	O
-	O
15	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
14	O
*	O
*	O
]	O
03	O
:	O
30am	O
blood	O
glucose	O
-	O
107	O
*	O
urean	O
-	O
9	O
creat	O
-	O
0	O
.	O
5	O
na	O
-	O
132	O
*	O
k	O
-	O
4	O
.	O
0	O
cl	O
-	O
101	O
hco3	O
-	O
23	O
angap	O
-	O
12	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
15	O
*	O
*	O
]	O
04	O
:	O
05am	O
blood	O
glucose	O
-	O
200	O
*	O
urean	O
-	O
9	O
creat	O
-	O
0	O
.	O
5	O
na	O
-	O
137	O
k	O
-	O
3	O
.	O
6	O
cl	O
-	O
103	O
hco3	O
-	O
24	O
angap	O
-	O
14	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
16	O
*	O
*	O
]	O
03	O
:	O
29am	O
blood	O
glucose	O
-	O
138	O
*	O
urean	O
-	O
9	O
creat	O
-	O
0	O
.	O
4	O
*	O
na	O
-	O
142	O
k	O
-	O
3	O
.	O
3	O
cl	O
-	O
106	O
hco3	O
-	O
25	O
angap	O
-	O
14	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
16	O
*	O
*	O
]	O
11	O
:	O
24am	O
blood	O
glucose	O
-	O
248	O
*	O
urean	O
-	O
11	O
creat	O
-	O
0	O
.	O
4	O
*	O
na	O
-	O
141	O
k	O
-	O
3	O
.	O
3	O
cl	O
-	O
105	O
hco3	O
-	O
25	O
angap	O
-	O
14	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
18	O
*	O
*	O
]	O
03	O
:	O
47am	O
blood	O
glucose	O
-	O
148	O
*	O
urean	O
-	O
14	O
creat	O
-	O
0	O
.	O
5	O
na	O
-	O
142	O
k	O
-	O
3	O
.	O
7	O
cl	O
-	O
105	O
hco3	O
-	O
27	O
angap	O
-	O
14	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
19	O
*	O
*	O
]	O
02	O
:	O
07am	O
blood	O
glucose	O
-	O
123	O
*	O
urean	O
-	O
16	O
creat	O
-	O
0	O
.	O
6	O
na	O
-	O
143	O
k	O
-	O
3	O
.	O
8	O
cl	O
-	O
106	O
hco3	O
-	O
28	O
angap	O
-	O
13	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
26	O
*	O
*	O
]	O
03	O
:	O
12am	O
blood	O
glucose	O
-	O
98	O
urean	O
-	O
16	O
creat	O
-	O
0	O
.	O
5	O
na	O
-	O
143	O
k	O
-	O
3	O
.	O
9	O
cl	O
-	O
105	O
hco3	O
-	O
29	O
angap	O
-	O
13	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
27	O
*	O
*	O
]	O
06	O
:	O
25am	O
blood	O
glucose	O
-	O
106	O
*	O
urean	O
-	O
10	O
creat	O
-	O
0	O
.	O
5	O
na	O
-	O
143	O
k	O
-	O
4	O
.	O
2	O
cl	O
-	O
107	O
hco3	O
-	O
28	O
angap	O
-	O
12	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
03	O
*	O
*	O
]	O
06	O
:	O
00am	O
blood	O
alt	O
-	O
26	O
ast	O
-	O
32	O
alkphos	O
-	O
71	O
amylase	O
-	O
40	O
totbili	O
-	O
0	O
.	O
3	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
22	O
*	O
*	O
]	O
06	O
:	O
00am	O
blood	O
alt	O
-	O
107	O
*	O
ast	O
-	O
26	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
03	O
*	O
*	O
]	O
05	O
:	O
18pm	O
blood	O
calcium	O
-	O
7	O
.	O
3	O
*	O
phos	O
-	O
3	O
.	O
6	O
mg	O
-	O
1	O
.	O
5	O
*	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
04	O
*	O
*	O
]	O
02	O
:	O
00pm	O
blood	O
calcium	O
-	O
7	O
.	O
5	O
*	O
phos	O
-	O
2	O
.	O
2	O
*	O
mg	O
-	O
2	O
.	O
1	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
04	O
*	O
*	O
]	O
10	O
:	O
23pm	O
blood	O
calcium	O
-	O
8	O
.	O
3	O
*	O
phos	O
-	O
1	O
.	O
8	O
*	O
mg	O
-	O
2	O
.	O
2	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
22	O
*	O
*	O
]	O
03	O
:	O
36am	O
blood	O
calcium	O
-	O
6	O
.	O
4	O
*	O
phos	O
-	O
2	O
.	O
8	O
mg	O
-	O
1	O
.	O
4	O
*	O

[	O
*	O
*	O
2013	O
-	O
06	O
-	O
26	O
*	O
*	O
]	O
03	O
:	O
12am	O
blood	O
calcium	O
-	O
9	O
.	O
1	O
phos	O
-	O
5	O
.	O
0	O
*	O
mg	O
-	O
2	O
.	O
0	O

imaging	O
:	O

ct	O
(	O
[	O
*	O
*	O
06	O
-	O
02	O
*	O
*	O
]	O
)	O
:	O
diffuse	O
subarachnoid	B
hemorrhage	I
seen	O
predominantly	O
in	O
the	O

sylvian	O
fissures	O
,	O
tentorium	O
,	O
third	O
ventricle	O
,	O
and	O
in	O
the	O
proximal	O
cervical	O
spine	O
surrounding	O
the	O
cord	O
.	O

ct	O
angiogram	O
is	O
recommended	O
for	O
further	O
evaluation	O
of	O
this	O
finding	O
,	O
or	O
a	O
conventional	O
angiogram	O
,	O
to	O
rule	O
out	O
a	O

ruptured	B
aneurysm	I
.	O

angio	O
(	O
[	O
*	O
*	O
06	O
-	O
03	O
*	O
*	O
]	O
)	O
:	O
successful	O
coil	O
embolization	O
of	O
a	O
ruptured	O
distal	O
right	O
pica	O
3	O
[	O
*	O
*	O
01	O
-	O
20	O
*	O
*	O
]	O
x	O
3	O
x	O
2	O
.	O
8	O
mm	O
aneurysm	O
with	O
gdc	O
three	O
-	O
dimensional	O
and	O
ultrasoft	O
coils	O
.	O

ct	O
(	O
[	O
*	O
*	O
06	O
-	O
04	O
*	O
*	O
]	O
)	O
:	O
a	O
ventricular	O
drainage	O
catheter	O
is	O
again	O
seen	O
.	O

there	O
is	O
interval	O
reduction	O
in	O
size	O
of	O
the	O
ventricular	O
system	O
,	O
which	O
is	O
now	O
fairly	O
slit	O
-	O
like	O
.	O

there	O
is	O
a	O
small	O
amount	O
of	O
blood	O
seen	O
within	O
the	O
third	O
and	O
fourth	O
ventricles	O
.	O

no	O
other	O
specific	O
interval	O
changes	O
are	O
seen	O
.	O

conclusion	O
:	O
status	O
post	O
coiling	O
of	O
right	O
posterior	B
-	I
inferior	I
cerebellar	I
artery	I
aneurysm	I
with	O
other	O
findings	O
as	O
noted	O
above	O
.	O

cta	O
(	O
[	O
*	O
*	O
06	O
-	O
11	O
*	O
*	O
]	O
)	O
:	O
no	O
clear	O
evidence	O
of	O
vasospasm	B
or	O
new	B
infarction	I
.	O

there	O
is	O
a	O
small	O
amount	O
of	O
hemorrhage	B
seen	O
along	O
the	O
catheter	O
tract	O
which	O
appears	O
new	O
compared	O
to	O
the	O
prior	O
study	O
.	O

layering	O
hemorrhage	B
seen	O
within	O
the	O
occipital	O
horns	O
of	O
both	O
lateral	O
ventricles	O
is	O
slightly	O
decreased	O
from	O
the	O
prior	O
study	O
.	O

cxr	O
(	O
[	O
*	O
*	O
06	O
-	O
13	O
*	O
*	O
]	O
)	O
:	O
impression	O
:	O
faint	O
opacity	B
at	O
the	O
right	O
lung	O
base	O
,	O
which	O
appears	O
improved	O
in	O

comparison	O
to	O
the	O
prior	O
study	O
,	O
and	O
likely	O
represents	O
improving	O
pneumonia	B
.	O

lenis	O
(	O
[	O
*	O
*	O
06	O
-	O
21	O
*	O
*	O
]	O
)	O
:	O
neg	O
for	O
dvt	B

cta	O
/	O
ct	O
(	O
[	O
*	O
*	O
06	O
-	O
22	O
*	O
*	O
]	O
)	O
:	O

1	O
)	O
status	O
post	O
removal	O
of	O
right	O
ventricular	O
drainage	O
catheter	O
.	O

no	O
evidence	O
of	O
hydrocephalus	B
.	O

resolution	O
of	O
previously	O
seen	O
intraventricular	B
blood	I
products	I
.	O

2	O
)	O
unchanged	O
appearance	O
of	O
the	O
cerebral	O
vasculature	O
in	O
comparison	O
with	O
cta	O
dated	O
[	O
*	O
*	O
2013	O
-	O
06	O
-	O
10	O
*	O
*	O
]	O
.	O

brief	O
hospital	O
course	O
:	O

patient	O
was	O
admitted	O
to	O
the	O
icu	O
s	O
/	O
p	O
subarchnoid	B
hemorrhage	I
with	O
hydrocephalus	B
.	O

he	O
had	O
a	O
ventricular	O
drain	O
placed	O
on	O
[	O
*	O
*	O
06	O
-	O
03	O
*	O
*	O
]	O
.	O

he	O
was	O
taken	O
to	O
angio	O
on	O
[	O
*	O
*	O
06	O
-	O
03	O
*	O
*	O
]	O
which	O
showed	O
a	O
right	O
pica	O
aneurysm	B
which	O
was	O
coiled	O
successfully	O
.	O

the	O
patient	O
was	O
then	O
monitored	O
in	O
the	O
icu	O
for	O
vasospasm	B
.	O

he	O
had	O
difficulties	O
with	O
hyponatremia	B
requiring	O
3%	O
saline	O
and	O
high	O
dose	O
hydrocortisone	O
.	O

he	O
remained	O
in	O
the	O
icu	O
until	O
[	O
*	O
*	O
06	O
-	O
25	O
*	O
*	O
]	O
when	O
he	O
was	O
transfered	O
to	O
the	O
step	O
down	O
unit	O
.	O

he	O
remained	O
neurologically	O
intact	O
throughout	O
his	O
icu	O
stay	O
.	O

he	O
was	O
in	O
step	O
down	O
unit	O
for	O
two	O
days	O
then	O
transfered	O
to	O
the	O
regular	O
floor	O
.	O

he	O
was	O
cleared	O
for	O
discharge	O
home	O
by	O
physical	O
therapy	O
and	O
was	O
discharged	O
on	O
[	O
*	O
*	O
06	O
-	O
28	O
*	O
*	O
]	O
in	O
stable	O
condition	O
with	O
followup	O
with	O
dr	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
119	O
*	O
*	O
]	O
in	O
two	O
weeks	O
.	O

medications	O
on	O
admission	O
:	O

atevol	O

celexa	O

(	O
off	O
haart	O
)	O

discharge	O
medications	O
:	O

1	O
.	O
aspirin	O
81	O
mg	O
tablet	O
,	O
chewable	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
,	O
chewable	O
po	O
daily	O
(	O
daily	O
)	O
.	O

2	O
.	O
oxycodone	O
-	O
acetaminophen	O
5	O
-	O
325	O
mg	O
tablet	O
sig	O
:	O
1	O
-	O
2	O
tablets	O
po	O
q4	O
-	O
6h	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

disp	O
:	O
*	O
40	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

3	O
.	O
phenytoin	O
100	O
mg	O
/	O
4	O
ml	O
suspension	O
sig	O
:	O
ten	O
(	O
10	O
)	O
ml	O
po	O
three	O
times	O
a	O
day	O
for	O
3	O
weeks	O
.	O

disp	O
:	O
*	O
qs	O
630	O
ml	O
*	O
refills	O
:	O
*	O
2	O
*	O

4	O
.	O
zolpidem	O
tartrate	O
5	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
hs	O
(	O
at	O
bedtime	O
)	O
.	O

disp	O
:	O
*	O
15	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

5	O
.	O
tenofovir	O
disoproxil	O
fumarate	O
300	O
mg	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

6	O
.	O
didanosine	O
250	O
mg	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

7	O
.	O
efavirenz	O
200	O
mg	O
capsule	O
sig	O
:	O
three	O
(	O
3	O
)	O
capsule	O
po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
capsule	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

8	O
.	O
nicotine	O
14	O
mg	O
/	O
24	O
hr	O
patch	O
24hr	O
sig	O
:	O
one	O
(	O
1	O
)	O
patch	O
24hr	O

transdermal	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
14	O
patch	O
24hr	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

9	O
.	O
lansoprazole	O
30	O
mg	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

sig	O
:	O
one	O
(	O
1	O
)	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O

po	O
daily	O
(	O
daily	O
)	O
.	O

disp	O
:	O
*	O
30	O
capsule	O
,	O
delayed	O
release	O
(	O
e	O
.	O
c	O
.	O
)	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
1	O
*	O

10	O
.	O

sodium	O
chloride	O
1	O
g	O
tablet	O
sig	O
:	O
one	O
(	O
1	O
)	O
tablet	O
po	O
bid	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

disp	O
:	O
*	O
60	O
tablet	O
(	O
s	O
)	O
*	O
refills	O
:	O
*	O
0	O
*	O

discharge	O
disposition	O
:	O

home	O

discharge	O
diagnosis	O
:	O

1	O
)	O
subarachnoid	B
hemorrage	I

2	O
)	O
hydrocephalus	B

3	O
)	O
pica	O
aneurysm	B

discharge	O
condition	O
:	O

good	O
,	O
improving	O

discharge	O
instructions	O
:	O

discharge	O
to	O
home	O
with	O
instructions	O
to	O
follow	O
up	O
as	O
stipulated	O
below	O
.	O

if	O
you	O
experience	O
severe	O
ha	B
,	O
visual	B
disturbances	I
,	O
nausea	B
/	O
vomitting	B
,	O
dyscoordination	B
or	O
other	O
symptoms	B
concerning	O
to	O
you	O
,	O
please	O
seek	O
medical	O
evaluation	O
at	O
a	O
convenient	O
[	O
*	O
*	O
doctor	O
first	O
name	O
45	O
*	O
*	O
]	O
.	O

you	O
may	O
resume	O
your	O
regular	O
diet	O
.	O

you	O
may	O
resume	O
your	O
home	O
medications	O
with	O
the	O
below	O
additions	O
.	O

you	O
should	O
avoid	O
moderate	O
to	O
strenuous	O
at	O
least	O
until	O
your	O
follow	O
up	O
visit	O
with	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
119	O
*	O
*	O
]	O
.	O

followup	O
instructions	O
:	O

please	O
call	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
2312	O
*	O
*	O
]	O
office	O
to	O
schedule	O
a	O
follow	O
-	O
up	O
appointment	O
:	O

(	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
2	O
)	O
1167	O
*	O
*	O
]	O
lmob	O
3b	O
neurosurgery	O

[	O
*	O
*	O
name6	O
(	O
md	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name7	O
(	O
md	O
)	O
*	O
*	O
]	O
md	O
,	O
phd	O
30	O
-	O
aav	O

completed	O
by	O
:	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
rnc	O
80	O
-	O
aku	O
[	O
*	O
*	O
2013	O
-	O
06	O
-	O
28	O
*	O
*	O
]	O
@	O
1054	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
on	O
:	O
fri	O
[	O
*	O
*	O
2013	O
-	O
07	O
-	O
05	O
*	O
*	O
]	O
8	O
:	O
39	O
pm	O

(	O
end	O
of	O
report	O
)	O

58961	O
||||	O
22891	O
||||	O
12355	O
||||	O
ecg	O
_	O
report	O
||||	O
2016	O
-	O
02	O
-	O
25	O
11	O
:	O
33	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
rhythm	I
.	O

st	B
segment	I
depression	I
and	O
t	B
wave	I
inversion	I
in	O
i	O
,	O
avl	O
and	O
v3	O
-	O
v6	O
,	O
downsloping	O
in	O
leads	O
v4	O
-	O
v6	O
.	O

findings	O
are	O
new	O
compared	O
to	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2015	O
-	O
02	O
-	O
22	O
*	O
*	O
]	O
consistent	O
with	O
acute	O
or	O
recent	O
anterolateral	B
myocardial	I
injury	I
.	O
the	O
rate	O
has	O
slowed	O
.	O

clinical	O
correlation	O
is	O
suggested	O
.	O

tracing	O
#1	O

78076	O
||||	O
23039	O
||||	O
23211	O
||||	O
ecg	O
_	O
report	O
||||	O
2018	O
-	O
03	O
-	O
05	O
08	O
:	O
06	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
rhythm	I
.	O

prolonged	B
qtc	I
interval	I
.	O

compared	O
to	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2018	O
-	O
03	O
-	O
04	O
*	O
*	O
]	O
the	O
qtc	B
interval	I
has	O
increased	O
.	O

clinical	O
correlation	O
is	O
suggested	O
.	O

tracing	O
32	O

326737	O
||||	O
23298	O
||||	O
15290	O
||||	O
radiology	O
_	O
report	O
||||	O
2012	O
-	O
06	O
-	O
19	O
10	O
:	O
57	O
:	O
00	O
.	O
0	O
||||	O
t993	O
mr	O
reconstruction	O
imaging	O
||||	O
||||	O
clip	O
#	O
314	O
-	O
9243	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2012	O
-	O
06	O
-	O
19	O
*	O
*	O
]	O
10	O
:	O
57	O
am	O

mr	O
abdomen	O
w&w	O
/	O
o	O
contrast	O
;	O
mr	O
[	O
*	O
*	O
first	O
name	O
(	O
titles	O
)	O
1159	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
titles	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
3463	O
*	O
*	O
]	O
reason	O
:	O
pre	O
-	O
transplant	O
mri	O
.	O

would	O
like	O
eval	O
of	O
vessels	O
and	O
volume	O
me	O
contrast	O
:	O
magnevist	O
amt	O
:	O
20	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

46	O
year	O
old	O
man	O
with	O
repeated	O
hepatitis	B
due	O
to	O
hep	B
b	I
virus	I
.	O

listed	O
for	O
transplant	O
.	O

reason	O
for	O
this	O
examination	O
:	O

pre	O
-	O
transplant	O
mri	O
.	O

would	O
like	O
eval	O
of	O
vessels	O
and	O
volume	O
measurements	O
.	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

mr	O
of	O
the	O
abdomen	O
:	O

indication	O
:	O
patient	O
with	O
hepatitis	B
b	I
.	O

this	O
is	O
a	O
pretransplant	O
evaluation	O
.	O

request	O
to	O
evaluate	O
for	O
liver	B
volume	I
.	O

technique	O
:	O
multiplanar	O
images	O
were	O
acquired	O
including	O
t1	O
in	O
-	O
and	O
out	O
-	O
of	O
-	O
phase	O
,	O
2d	O
tof	O
,	O
stir	O
,	O
haste	O
,	O
haste	O
with	O
fat	O
saturation	O
,	O
ir	O
,	O
precontrast	O
vibe	O
and	O
pre	O
and	O
post	O
contrast	O
turbo	O
flash	O
t1	O
images	O
.	O

comparison	O
:	O
previous	O
ultrasound	O
from	O
[	O
*	O
*	O
2012	O
-	O
06	O
-	O
14	O
*	O
*	O
]	O
.	O

findings	O
:	O
the	O
patient	O
is	O
a	O
nonbreath	O
-	O
hold	O
patient	O
evaluation	O
in	O
the	O
arterial	O
phase	O
is	O
limited	O
.	O

tiny	O
cyst	O
is	O
noted	O
within	O
the	O
liver	O
in	O
segment	O
v	O
.	O

it	O
measures	O
4	O
mm	O
.	O

otherwise	O
no	O
gross	O
focal	O
lesion	O
is	O
noted	O
within	O
the	O
liver	O
.	O

there	O
is	O
no	O
abnormal	B
focal	I
enhancement	I
within	O
the	O
liver	O
.	O

the	O
volume	O
of	O
the	O
liver	O
is	O
estimated	O
at	O
1	O
,	O
811	O
cc	O
.	O

the	O
portal	O
vein	O
is	O
widely	O
patent	O
and	O
with	O
hepatopetal	O
flow	O
.	O

the	O
intra	O
and	O
extrahepatic	O
bile	O
ducts	O
are	O
not	O
dilated	B
.	O

there	O
is	O
irregularity	O
of	O
the	O
anterior	O
wall	O
of	O
the	O
gallbladder	O
with	O
low	O
signal	O
of	O
the	O
wall	O
in	O
ir	O
and	O
haste	O
images	O
.	O

this	O
may	O
be	O
consistent	O
with	O
adenomyomatosis	O
of	O
the	O
gallbladder	O
.	O

no	O
stones	B
are	O
noted	O
.	O

no	O
varices	O
are	O
noted	O
around	O
the	O
distal	O
esophagus	O
.	O

the	O
spleen	O
is	O
enlarged	O
with	O
a	O
measurement	O
of	O
15	O
.	O
5	O
cm	O
.	O

both	O
adrenals	O
,	O
the	O
pancreas	O
and	O
the	O
upper	O
part	O
of	O
both	O
kidneys	O
are	O
unremarkable	O
.	O

a	O
tiny	O
amount	O
of	O
ascites	B
is	O
noted	O
around	O
the	O
liver	O
and	O
the	O
spleen	O
.	O

impression	O
:	O

1	O
)	O
no	O
gross	O
focal	O
lesion	O
is	O
noted	O
within	O
the	O
liver	O
.	O

2	O
)	O
the	O
portal	O
vein	O
is	O
widely	O
patent	O
with	O
hepatopetal	O
flow	O
.	O

3	O
)	O
the	O
estimated	O
volume	O
of	O
the	O
liver	O
1	O
,	O
811	O
cc	O
.	O

4	O
)	O
splenomegaly	B
.	O

5	O
)	O
adenomymatosis	O
of	O
the	O
gallbladder	O
.	O

95475	O
||||	O
23389	O
||||	O
15817	O
||||	O
echo	O
_	O
report	O
||||	O
2011	O
-	O
04	O
-	O
25	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
endocarditis	B
.	O

left	B
ventricular	I
function	I
.	O

tachycardia	B
and	O
sepsis	B
height	O
:	O
(	O
in	O
)	O
75	O

weight	O
(	O
lb	O
)	O
:	O
245	O

bsa	O
(	O
m2	O
)	O
:	O
2	O
.	O
39	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
92	O
/	O
52	O

hr	O
(	O
bpm	O
)	O
:	O
120	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2011	O
-	O
04	O
-	O
25	O
*	O
*	O
]	O
at	O
10	O
:	O
02	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
complete	O
pulse	O
and	O
color	O
flow	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
the	O
left	O
atrium	O
is	O
mildly	O
dilated	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
the	O
right	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

left	O
ventricle	O
:	O
left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
lvef>55%	O
)	O
.	O

right	O
ventricle	O
:	O
right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

aorta	O
:	O
the	O
aortic	O
root	O
is	O
normal	O
in	O
diameter	O
.	O

the	O
ascending	O
aorta	O
is	O
normal	O
in	O
diameter	O
.	O

aortic	O
valve	O
:	O
the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	B
regurgitation	I
.	O

mitral	O
valve	O
:	O
the	O
mitral	O
valve	O
leaflets	O
are	O
structurally	O
normal	O
.	O

moderate	O
to	O
severe	O
(	O
3	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

pericardium	O
:	O
there	O
is	O
no	O
pericardial	B
effusion	I
.	O

general	O
comments	O
:	O
image	O
quality	O
was	O
suboptimal	O
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
mildly	O
dilated	O
.	O

left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

the	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
probably	O
normal	O
(	O
lvef>55%	O
)	O
.	O

though	O
the	O
images	O
are	O
limited	O
,	O
suspect	O
that	O
the	O
septum	O
and	O
apex	O
may	O
be	O
hypokinetic	B
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	B
regurgitation	I
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
structurally	O
normal	O
.	O

while	O
the	O
views	O
are	O
limited	O
it	O
appears	O
that	O
there	O
is	O
moderate	O
to	O
severe	O
(	O
3	O
+	O
)	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

no	O
masses	B
are	O
seen	O
on	O
either	O
the	O
aortic	O
or	O
mitral	O
valves	O
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

would	O
recommend	O
a	O
tee	O
if	O
clinically	O
indicated	O
.	O

17830	O
||||	O
23590	O
||||	O
17919	O
||||	O
discharge	O
_	O
summary	O
||||	O
2010	O
-	O
11	O
-	O
16	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2010	O
-	O
11	O
-	O
12	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2010	O
-	O
11	O
-	O
16	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1929	O
-	O
03	O
-	O
04	O
*	O
*	O
]	O
sex	O
:	O
f	O

service	O
:	O

addendum	O
:	O

the	O
patient's	O
dry	O
weight	O
is	O
77	O
kilograms	O
.	O

the	O
patient	O
was	O
noted	O
to	O
have	O
positive	B
urinalysis	I
with	O
positive	B
nitrates	I
,	O
positive	B
leukocyte	I
esterase	I
and	O
712	O
white	O
blood	O
cells	O
with	O
moderate	O
bacteria	O
on	O
[	O
*	O
*	O
2010	O
-	O
11	O
-	O
16	O
*	O
*	O
]	O
.	O

she	O
was	O
started	O
on	O

ciprofloxacin	O
500	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
to	O
complete	O
a	O
seven	O
day	O
course	O
.	O

discharge	O
medications	O
:	O
to	O
be	O
addended	O
on	O
this	O
discharge	O
summary	O
will	O
include	O

1	O
.	O
lasix	O
20	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O

2	O
.	O
ciprofloxacin	O
500	O
mg	O
p	O
.	O
o	O
.	O
b	O
.	O
i	O
.	O
d	O
.	O
to	O
complete	O
a	O
seven	O
day	O
course	O
with	O
[	O
*	O
*	O
11	O
-	O
16	O
*	O
*	O
]	O
being	O
the	O
first	O
day	O
.	O

3	O
.	O
also	O
the	O
patient	O
was	O
discharged	O
on	O
zestril	O
20	O
mg	O
p	O
.	O
o	O
.	O
q	O
.	O
d	O
.	O
rather	O
than	O
captopril	O
37	O
.	O
5	O
mg	O
p	O
.	O
o	O
.	O
t	O
.	O
i	O
.	O
d	O
.	O

the	O
captopril	O
was	O
discontinued	O
.	O

the	O
culture	O
and	O
sensitivities	O
of	O
the	O
urine	O
will	O
be	O
followed	O
up	O
by	O
dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
and	O
called	O
into	O
the	O
rehab	O
facility	O
.	O

[	O
*	O
*	O
first	O
name11	O
(	O
name	O
pattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
initials	O
(	O
namepattern4	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern4	O
)	O
458	O
*	O
*	O
]	O
,	O
m	O
.	O
d	O
.	O
[	O
*	O
*	O
md	O
number	O
1697	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
5516	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2010	O
-	O
11	O
-	O
16	O
*	O
*	O
]	O
14	O
:	O
48	O

t	O
:	O
[	O
*	O
*	O
2010	O
-	O
11	O
-	O
16	O
*	O
*	O
]	O
15	O
:	O
03	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
5517	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
458	O
*	O
*	O
]	O
on	O
:	O
[	O
*	O
*	O
doctor	O
first	O
name	O
32	O
*	O
*	O
]	O
[	O
*	O
*	O
2010	O
-	O
11	O
-	O
25	O
*	O
*	O
]	O
1	O
:	O
12	O
pm	O
(	O
end	O
of	O
report	O
)	O

94803	O
||||	O
23893	O
||||	O
13293	O
||||	O
ecg	O
_	O
report	O
||||	O
2013	O
-	O
01	O
-	O
14	O
11	O
:	O
15	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

sinus	B
rhythm	I
.	O

left	B
atrial	I
abnormality	I
.	O

atrial	B
bigeminy	I
and	O
occasional	O
ventricular	B
ectopy	I
.	O

compared	O
to	O
the	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2013	O
-	O
01	O
-	O
14	O
*	O
*	O
]	O
sinus	B
rhythm	I
and	O
non	O
-	O
conducted	O
atrial	B
ectopy	I
and	O
ventriciular	B
ectopy	I
have	O
appeared	O
.	O
the	O
rate	B
has	O
slowed	O
.	O

tracing	O
#3	O

299900	O
||||	O
23969	O
||||	O
25350	O
||||	O
radiology	O
_	O
report	O
||||	O
2018	O
-	O
07	O
-	O
02	O
15	O
:	O
36	O
:	O
00	O
.	O
0	O
||||	O
c11	O
chest	O
(	O
pa	O
&	O
lat	O
)	O
||||	O
||||	O
clip	O
#	O
433	O
-	O
9253	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2018	O
-	O
07	O
-	O
02	O
*	O
*	O
]	O
3	O
:	O
36	O
pm	O

chest	O
(	O
pa	O
&	O
lat	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
1251	O
*	O
*	O
]	O
reason	O
:	O
evaluate	O
for	O
infiltrate	B
/	O
edema	B
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

62	O
year	O
old	O
woman	O
with	O
bilateral	O
le	B
edema	I
and	O
fatigue	B
reason	O
for	O
this	O
examination	O
:	O
evaluate	O
for	O
infiltrate	B
/	O
edema	B
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

two	O
views	O
of	O
the	O
chest	O
dated	O
[	O
*	O
*	O
2018	O
-	O
07	O
-	O
02	O
*	O
*	O
]	O

history	O
:	O
62	O
-	O
year	O
-	O
old	O
woman	O
with	O
bilateral	O
lower	B
extremity	I
edema	I
and	O
fatigue	B
;	O
evaluate	O
for	O
infiltrate	B
or	O
edema	B
.	O

findings	O
:	O
two	O
views	O
are	O
compared	O
with	O
remote	O
radiographs	O
dated	O
[	O
*	O
*	O
2015	O
-	O
01	O
-	O
10	O
*	O
*	O
]	O
,	O
as	O
well	O
as	O
more	O
recent	O
cect	O
of	O
the	O
chest	O
,	O
dated	O
[	O
*	O
*	O
2018	O
-	O
02	O
-	O
01	O
*	O
*	O
]	O
.	O

there	O
is	O
evidence	O
of	O
pulmonary	B
hyperinflation	I
and	O
"simplification"	O
suggestive	O
of	O
underlying	O
obstructive	B
airways	I
disease	I
,	O
and	O
the	O
ct	O
demonstrates	O
relatively	O
mild	O
centrilobular	B
emphysema	I
.	O

other	O
than	O
biapical	O
pleural	B
thickening	I
,	O
as	O
before	O
,	O
the	O
lungs	O
are	O
clear	O
.	O

the	O
cardiomediastinal	O
silhouette	O
is	O
within	O
normal	O
limits	O
,	O
and	O
there	O
is	O
no	O
pulmonary	B
vascular	I
congestion	I
,	O
pleural	B
effusion	I
,	O
or	O
other	O
evidence	O
of	O
chf	B
.	O

there	O
is	O
diffuse	O
osteopenia	B
,	O
but	O
no	O
thoracic	O
vertebral	B
compression	I
is	O
identified	O
.	O

impression	O
:	O
evidence	O
of	O
underlying	O
obstructive	B
lung	I
disease	I
,	O
with	O
no	O
acute	O
process	O
.	O

13472	O
||||	O
24432	O
||||	O
20265	O
||||	O
discharge	O
_	O
summary	O
||||	O
2009	O
-	O
11	O
-	O
11	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

admission	O
date	O
:	O
[	O
*	O
*	O
2009	O
-	O
10	O
-	O
10	O
*	O
*	O
]	O
discharge	O
date	O
:	O
[	O
*	O
*	O
2009	O
-	O
11	O
-	O
11	O
*	O
*	O
]	O

date	O
of	O
birth	O
:	O
[	O
*	O
*	O
1929	O
-	O
09	O
-	O
12	O
*	O
*	O
]	O
sex	O
:	O
m	O

service	O
:	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
154	O
*	O
*	O
]	O
-	O
[	O
*	O
*	O
location	O
(	O
un	O
)	O
*	O
*	O
]	O
team	O

history	O
of	O
present	O
illness	O
:	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
2761	O
*	O
*	O
]	O
was	O
a	O
pleasant	O
80	O
-	O
year	O
-	O
old	O
gentleman	O
with	O
a	O
history	O
of	O
coronary	B
artery	I
disease	I
,	O
hypertension	B
,	O
chronic	B
obstructive	I
pulmonary	I
disease	I
,	O
chronic	B
lymphocytic	I
leukemia	I
,	O
and	O
hypogammaglobinemia	B
,	O
and	O
liver	O
and	O
brain	B
metastases	I
with	O
unknown	B
primary	I
,	O
who	O
was	O
initially	O
admitted	O
with	O
a	O
brain	B
metastatic	I
bleed	I
and	O
resulting	O
seizure	B
disorder	I
.	O

he	O
was	O
once	O
admitted	O
to	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
154	O
*	O
*	O
]	O
from	O
[	O
*	O
*	O
10	O
-	O
22	O
*	O
*	O
]	O
to	O
[	O
*	O
*	O
10	O
-	O
23	O
*	O
*	O
]	O
for	O
acute	B
respiratory	I
distress	I
which	O
was	O
thought	O
to	O
be	O
secondary	O
to	O
aspiration	B
pneumonia	I
and	O
he	O
was	O
started	O
on	O
bipap	O
and	O
then	O
weaned	O
to	O
face	O
mask	O
.	O

he	O
was	O
ruled	O
in	O
,	O
also	O
,	O
for	O
an	O
mi	B
with	O
a	O
peak	O
troponin	O
of	O
greater	O
than	O
50	O
.	O

we	O
were	O
unable	O
to	O
treat	O
him	O
due	O
to	O
his	O
metastatic	B
bleed	I
in	O
his	O
[	O
*	O
*	O
last	O
name	O
(	O
lf	O
)	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
first	O
name3	O
(	O
lf	O
)	O
*	O
*	O
]	O
he	O
was	O
given	O
aspirin	O
and	O
lopressor	O
.	O

his	O
aspiration	B
pneumonia	I
was	O
treated	O
with	O
zosyn	O
,	O
vancomycin	O
,	O
and	O
flagyl	O
.	O

he	O
went	O
to	O
the	O
floor	O
on	O
[	O
*	O
*	O
10	O
-	O
23	O
*	O
*	O
]	O
and	O
was	O
started	O
on	O
hemodialysis	O
.	O

however	O
,	O
the	O
next	O
day	O
,	O
he	O
developed	O
peripheral	O
eosinophilia	B
and	O
urine	O
eosinophilia	B
which	O
was	O
thought	O
to	O
be	O
secondary	O
to	O
his	O
zosyn	O
and	O
,	O
so	O
,	O
he	O
was	O
changed	O
to	O
levofloxacin	O
for	O
one	O
dose	O
.	O

he	O
also	O
had	O
his	O
quinton	O
catheter	O
pulled	O
out	O
which	O
he	O
was	O
using	O
for	O
his	O
hemodialysis	O
on	O
[	O
*	O
*	O
10	O
-	O
25	O
*	O
*	O
]	O
because	O
an	O
av	B
fistula	I
was	O
formed	O
and	O
there	O
was	O
a	O
big	O
left	O
groin	B
hematoma	I
with	O
a	O
drop	B
in	I
blood	I
pressure	I
.	O

he	O
also	O
had	O
a	O
likely	O
aspiration	B
event	I
on	O
[	O
*	O
*	O
10	O
-	O
26	O
*	O
*	O
]	O
with	O
possible	O
sepsis	B
and	O
the	O
blood	B
loss	I
in	O
his	O
groin	B
hematoma	I
caused	O
him	O
to	O
become	O
hypotensive	B
.	O

he	O
was	O
also	O
hypoxic	B
and	O
was	O
found	O
to	O
be	O
88%	O
on	O
room	O
air	O
.	O

he	O
was	O
sent	O
to	O
the	O
[	O
*	O
*	O
hospital	O
unit	O
name	O
154	O
*	O
*	O
]	O
and	O
he	O
was	O
started	O
on	O
bipap	O
,	O
but	O
intubated	O
on	O
[	O
*	O
*	O
10	O
-	O
26	O
*	O
*	O
]	O
for	O
airway	O
protection	O
.	O

he	O
was	O
continued	O
on	O
levofloxacin	O
,	O
flagyl	O
,	O
and	O
vancomycin	O
for	O
the	O
presumed	O
line	B
sepsis	I
and	O
the	O
aspiration	B
pneumonia	I
.	O

a	O
lot	O
of	O
secretions	O
were	O
being	O
suctioned	O
out	O
.	O

a	O
ct	O
angiogram	O
was	O
also	O
done	O
to	O
rule	O
out	O
for	O
pe	B
,	O
but	O
that	O
time	O
,	O
bilateral	B
pleural	I
effusions	I
were	O
found	O
.	O

ct	O
of	O
the	O
abdomen	O
was	O
unremarkable	O
,	O
except	O
for	O
polycystic	B
kidney	I
disease	I
and	O
liver	B
metastasis	I
.	O

the	O
patient's	O
sputum	O
grew	O
mrsa	B
and	O
serratia	O
.	O

he	O
was	O
being	O
covered	O
with	O
vancomycin	O
,	O
bactrim	O
,	O
and	O
ceptaz	O
,	O
but	O
it	O
was	O
believed	O
that	O
his	O
eosinophilia	B
was	O
secondary	O
to	O
his	O
multiple	B
drug	I
interactions	I
,	O
and	O
the	O
patient	O
also	O
developed	O
a	O
drug	B
rash	I
in	O
his	O
axillary	O
area	O
which	O
was	O
also	O
thought	O
to	O
be	O
secondary	O
to	O
drug	B
reaction	I
.	O

in	O
addition	O
,	O
the	O
patient	O
was	O
still	O
spiking	B
temperatures	I
and	O
,	O
at	O
that	O
time	O
,	O
it	O
was	O
concluded	O
that	O
it	O
could	O
be	O
secondary	O
to	O
a	O
drug	B
fever	I
due	O
to	O
the	O
use	O
of	O
ceftriaxone	O
.	O

allergy	O
and	O
immunology	O
were	O
consulted	O
who	O
recommended	O
that	O
all	O
his	O
antibiotics	O
be	O
stopped	O
and	O
the	O
patient	O
was	O
started	O
on	O
tobramycin	O
.	O

the	O
patient	O
was	O
also	O
receiving	O
hemodialysis	O
three	O
times	O
a	O
week	O
.	O

despite	O
all	O
these	O
multiple	O
attempts	O
for	O
medical	O
treatment	O
,	O
the	O
patient	O
did	O
not	O
show	O
any	O
signs	O
of	O
improvement	O
.	O

the	O
patient's	O
blood	B
pressure	I
was	O
volatile	O
/	O
fluctuating	O
up	O
and	O
down	O
and	O
the	O
patient	O
was	O
repeatedly	O
spiking	B
temperatures	I
.	O

at	O
that	O
time	O
,	O
a	O
very	O
detailed	O
family	O
meeting	O
was	O
held	O
between	O
the	O
attending	O
,	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
,	O
the	O
resident	O
,	O
dr	O
.	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
4884	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
1851	O
*	O
*	O
]	O
,	O
social	O
worker	O
,	O
and	O
the	O
daughter	O
of	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
2761	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
lastname	O
2761	O
*	O
*	O
]	O
,	O
who	O
was	O
actively	O
involved	O
in	O
his	O
care	O
.	O

during	O
the	O
family	O
meeting	O
,	O
it	O
was	O
decided	O
that	O
the	O
patient	O
will	O
be	O
made	O
comfort	O
measures	O
only	O
.	O

he	O
will	O
remain	O
trached	O
and	O
we	O
are	O
going	O
to	O
continue	O
some	O
of	O
his	O
medications	O
at	O
this	O
time	O
and	O
his	O
tube	O
feed	O
and	O
try	O
to	O
make	O
him	O
as	O
comfortable	O
as	O
possible	O
.	O

this	O
was	O
decided	O
on	O
[	O
*	O
*	O
2009	O
-	O
11	O
-	O
09	O
*	O
*	O
]	O
.	O

on	O
[	O
*	O
*	O
2009	O
-	O
11	O
-	O
10	O
*	O
*	O
]	O
,	O
it	O
was	O
decided	O
that	O
we	O
could	O
start	O
slowly	O
weaning	O
off	O
his	O
medications	O
,	O
except	O
for	O
medications	O
that	O
would	O
keep	O
him	O
comfortable	O
.	O

all	O
of	O
his	O
medications	O
,	O
including	O

lopressor	O
,	O
aspirin	O
,	O
and	O
other	O
medications	O
he	O
was	O
on	O
,	O
were	O
all	O
discharged	O
and	O
the	O
patient	O
was	O
kept	O
on	O
an	O
ativan	O
drip	O
,	O
fentanyl	O
drip	O
,	O
and	O
his	O
valproic	O
acid	O
to	O
prevent	O
him	O
from	O
developing	O
any	O
seizures	B
.	O

in	O
addition	O
,	O
the	O
antibiotics	O
were	O
also	O
stopped	O
because	O
,	O
on	O
the	O
family	O
meeting	O
of	O
9	O
/	O
23	O
,	O
it	O
was	O
decided	O
that	O
the	O
patient	O
will	O
not	O
undergo	O
any	O
more	O
hemodialysis	O
and	O
,	O
since	O
tobramycin	O
was	O
cleared	O
by	O
the	O
kidney	O
,	O
all	O
antibiotics	O
were	O
stopped	O
.	O

the	O
patient's	O
tube	O
feeds	O
were	O
still	O
continued	O
,	O
but	O
they	O
were	O
decreased	O
from	O
60	O
cc	O
per	O
hour	O
to	O
10	O
cc	O
per	O
hour	O
.	O

on	O
[	O
*	O
*	O
2009	O
-	O
11	O
-	O
11	O
*	O
*	O
]	O
,	O
in	O
the	O
morning	O
,	O
it	O
was	O
decided	O
that	O
we	O
could	O
slowly	O
start	O
weaning	O
off	O
his	O
trach	O
and	O
moving	O
to	O
pressure	O
support	O
of	O
5	O
,	O
peep	O
of	O
5	O
,	O
fio2	O
of	O
21%	O
,	O
in	O
a	O
bipap	O
mode	O
and	O
continue	O
his	O
tube	O
feeds	O
at	O
10	O
cc	O
per	O
hour	O
and	O
titrate	O
up	O
the	O
fentanyl	O
and	O
the	O
ativan	O
as	O
needed	O
to	O
make	O
him	O
more	O
comfortable	O
.	O

in	O
addition	O
,	O
we	O
can	O
add	O
a	O
morphine	O
drip	O
and	O
titrate	O
that	O
up	O
,	O
as	O
well	O
,	O
as	O
needed	O
for	O
comfort	O
level	O
.	O

on	O
[	O
*	O
*	O
2009	O
-	O
11	O
-	O
11	O
*	O
*	O
]	O
at	O
7	O
:	O
45	O
p	O
.	O
m	O
.	O
,	O
the	O
patient	O
passed	O
away	O
.	O

the	O
patient	O
did	O
not	O
respond	O
to	O
sternal	B
rub	I
or	O
any	O
pain	B
sensation	I
.	O

pupils	O
were	O
fixed	O
and	O
dilated	O
and	O
did	O
not	O
respond	O
to	O
any	O
light	O
.	O

no	O
breath	B
sounds	I
were	O
heard	O
.	O

no	B
heart	I
sounds	I
were	O
heard	O
.	O

at	O
that	O
time	O
,	O
the	O
attending	O
,	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
,	O
was	O
notified	O
regarding	O
the	O
death	O
of	O
mr	O
.	O
[	O
*	O
*	O
lastname	O
2761	O
*	O
*	O
]	O
.	O

in	O
addition	O
,	O
his	O
primary	O
care	O
physician	O
,	O
dr	O
.	O
[	O
*	O
*	O
first	O
name4	O
(	O
namepattern1	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
last	O
name	O
(	O
namepattern1	O
)	O
1703	O
*	O
*	O
]	O
,	O
was	O
also	O
notified	O
about	O
his	O
expiration	O
.	O

in	O
addition	O
,	O
his	O
daughter	O
,	O
[	O
*	O
*	O
first	O
name8	O
(	O
namepattern2	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
lastname	O
2761	O
*	O
*	O
]	O
,	O
who	O
was	O
actively	O
involved	O
in	O
his	O
medical	O
care	O
,	O
was	O
also	O
notified	O
regarding	O
her	O
father's	O
death	O
.	O

she	O
refused	O
any	O
autopsy	O
.	O

dr	O
.	O
[	O
*	O
*	O
last	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
,	O
[	O
*	O
*	O
first	O
name3	O
(	O
lf	O
)	O
*	O
*	O
]	O
[	O
*	O
*	O
md	O
number	O
1045	O
*	O
*	O
]	O

dictated	O
by	O
:	O
[	O
*	O
*	O
dictator	O
info	O
*	O
*	O
]	O

medquist36	O

d	O
:	O
[	O
*	O
*	O
2009	O
-	O
11	O
-	O
11	O
*	O
*	O
]	O
20	O
:	O
55	O

t	O
:	O
[	O
*	O
*	O
2009	O
-	O
11	O
-	O
17	O
*	O
*	O
]	O
09	O
:	O
13	O

job#	O
:	O
[	O
*	O
*	O
job	O
number	O
4885	O
*	O
*	O
]	O

signed	O
electronically	O
by	O
:	O
dr	O
.	O
[	O
*	O
*	O
first	O
name	O
(	O
stitle	O
)	O
*	O
*	O
]	O
parks	O
on	O
:	O
fri	O
[	O
*	O
*	O
2009	O
-	O
11	O
-	O
20	O
*	O
*	O
]	O
11	O
:	O
53	O
am	O

(	O
end	O
of	O
report	O
)	O

98945	O
||||	O
24638	O
||||	O
8495	O
||||	O
echo	O
_	O
report	O
||||	O
2013	O
-	O
07	O
-	O
17	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
endocarditis	B
.	O

height	O
:	O
(	O
in	O
)	O
66	O

weight	O
(	O
lb	O
)	O
:	O
150	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
77	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
141	O
/	O
74	O

hr	O
(	O
bpm	O
)	O
:	O
83	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2013	O
-	O
07	O
-	O
17	O
*	O
*	O
]	O
at	O
10	O
:	O
10	O

test	O
:	O
portable	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
suboptimal	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
elongated	B
la	I
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
mildly	O
dilated	B
ra	I
.	O

left	O
ventricle	O
:	O
normal	O
lv	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
.	O

mild	O
global	O
lv	O
hypokinesis	B
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

aortic	O
valve	O
:	O
mildly	O
thickened	B
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
.	O

no	O
as	B
.	O

mitral	O
valve	O
:	O
normal	O
mitral	O
valve	O
leaflets	O
with	O
trivial	O
mr	B
.	O

tricuspid	O
valve	O
:	O
normal	O
tricuspid	O
valve	O
leaflets	O
with	O
trivial	O
tr	B
.	O

moderate	O
pa	O
systolic	B
hypertension	I
.	O

pericardium	O
:	O
no	O
pericardial	B
effusion	I
.	O

general	O
comments	O
:	O
suboptimal	O
image	O
quality	O
-	O
poor	O
echo	O
windows	O
.	O

based	O
on	O
1997	O
aha	O
endocarditis	B
prophylaxis	O
recommendations	O
,	O
the	O
echo	O
findings	O
indicate	O
a	O
low	O
risk	O
(	O
prophylaxis	O
not	O
recommended	O
)	O
.	O

clinical	O
decisions	O
regarding	O
the	O
need	O
for	O
prophylaxis	O
should	O
be	O
based	O
on	O
clinical	O
and	O
echocardiographic	O
data	O
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
mildly	O
elongated	O
.	O

left	O
ventricular	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
are	O
normal	O
.	O

there	O
is	O
mild	O
global	O
left	O
ventricular	O
hypokinesis	B
without	O
regionality	O
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	B
but	O
aortic	B
stenosis	I
is	O
not	O
present	O
.	O

trace	O
aortic	B
regurgitation	I
may	O
be	O
present	O
.	O

the	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	O
mitral	B
regurgitation	I
.	O

there	O
is	O
moderate	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

impression	O
:	O
aortic	B
valve	I
sclerosis	I
.	O

moderate	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

mild	O
global	O
left	B
ventricular	I
systolic	I
dysfunction	I
.	O

no	O
discrete	O
vegetations	B
or	O
pathologic	B
flow	I
identified	O
.	O

based	O
on	O
1997	O
aha	O
endocarditis	B
prophylaxis	O
recommendations	O
,	O
the	O
echo	O
findings	O
indicate	O
a	O
low	O
risk	O
(	O
prophylaxis	O
not	O
recommended	O
)	O
.	O

clinical	O
decisions	O
regarding	O
the	O
need	O
for	O
prophylaxis	O
should	O
be	O
based	O
on	O
clinical	O
and	O
echocardiographic	O
data	O
.	O

183267	O
||||	O
24813	O
||||	O
3148	O
||||	O
radiology	O
_	O
report	O
||||	O
2012	O
-	O
11	O
-	O
04	O
12	O
:	O
08	O
:	O
00	O
.	O
0	O
||||	O
c12	O
chest	O
(	O
portable	O
ap	O
)	O
||||	O
||||	O
clip	O
#	O
329	O
-	O
3894	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2012	O
-	O
11	O
-	O
04	O
*	O
*	O
]	O
12	O
:	O
08	O
pm	O

chest	O
(	O
portable	O
ap	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
8076	O
*	O
*	O
]	O
reason	O
:	O
eval	O
for	O
acute	B
process	I
,	O
pt	O
sob	B
,	O
tachy	B
admitting	O
diagnosis	O
:	O
perforated	B
duodenum	I

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

71	O
year	O
old	O
woman	O
with	O
septic	B
pict	O
,	O
recent	O
tension	B
ptx	I
at	O
osh	O

reason	O
for	O
this	O
examination	O
:	O

eval	O
for	O
acute	B
process	I
,	O
pt	O
sob	B
,	O
tachy	B
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

chest	O
,	O
single	O
ap	O
film	O

history	O
of	O
shortness	B
of	I
breath	I
.	O

a	O
left	O
subclavian	O
cv	O
line	O
overlies	O
the	O
proximal	O
svc	O
.	O

dual	O
-	O
chamber	O
right	O
-	O
sided	O
pacemaker	O
with	O
atrial	O
ventricular	O
leads	O
in	O
situ	O
.	O

heart	O
size	O
is	O
borderline	O
for	O
technique	O
.	O

no	O
evidence	O
for	O
chf	B
.	O

no	O
pneumothorax	B
.	O

since	O
the	O
prior	O
film	O
of	O
[	O
*	O
*	O
2012	O
-	O
10	O
-	O
27	O
*	O
*	O
]	O
,	O
there	O
has	O
been	O
significant	O
resolution	O
of	O
the	O
atelectasis	B
,	O
less	O
consolidation	O
in	O
the	O
left	O
lower	O
lobe	O
,	O
and	O
there	O
are	O
no	O
new	O
lung	B
lesions	I
.	O

impression	O
:	O
no	O
evidence	O
for	O
chf	B
.	O

significant	O
resolution	O
of	O
the	O
left	O
lower	O
lobe	O
atelectasis	B
/	O
consolidation	O
.	O

no	O
pneumothorax	B
.	O

338492	O
||||	O
25003	O
||||	O
29181	O
||||	O
radiology	O
_	O
report	O
||||	O
2014	O
-	O
07	O
-	O
22	O
13	O
:	O
37	O
:	O
00	O
.	O
0	O
||||	O
q432	O
ct	O
pelvis	O
w	O
/	O
contrast	O
||||	O
||||	O
clip	O
#	O
295	O
-	O
3909	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
22	O
*	O
*	O
]	O
1	O
:	O
37	O
pm	O

ct	O
chest	O
w&w	O
/	O
o	O
c	O
;	O
ct	O
abdomen	O
w	O
/	O
contrast	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
1621	O
*	O
*	O
]	O
ct	O
pelvis	O
w	O
/	O
contrast	O
;	O
ct	O
150cc	O
nonionic	O
contrast	O

reason	O
:	O
assess	O
pleural	O
/	O
abdominal	O
effusions	B
field	O
of	O
view	O
:	O
42	O
contrast	O
:	O
optiray	O
amt	O
:	O
150	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

58	O
year	O
old	O
man	O
with	O
reason	O
for	O
this	O
examination	O
:	O
assess	O
pleural	O
/	O
abdominal	O
effusions	B
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

medical	O
history	O
:	O
58	O
year	O
old	O
status	O
post	O
gastroesophagectomy	O
for	O
cancer	B
with	O
a	O
history	O
of	O
esophageal	B
leak	I
.	O

technique	O
:	O
helically	O
-	O
acquired	O
axial	O
images	O
were	O
obtained	O
from	O
the	O
chest	O
,	O
abdomen	O
and	O
pelvis	O
.	O

the	O
patient	O
had	O
100	O
cc	O
of	O
diluted	O
conray	O
administered	O
through	O
the	O
nasogastric	O
tube	O
to	O
evaluate	O
for	O
leak	O
at	O
the	O
anastomosis	O
.	O

contrast	O
:	O
150	O
cc	O
optiray	O
was	O
administered	O
secondary	O
to	O
patient	O
history	O
of	O
allergies	O
,	O
in	O
addition	O
to	O
oral	O
contrast	O
.	O

comparison	O
:	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
10	O
*	O
*	O
]	O
.	O

findings	O
:	O
there	O
is	O
a	O
tracheostomy	O
tube	O
present	O
and	O
a	O
nasogastric	O
tube	O
is	O
seen	O
.	O

there	O
is	O
a	O
left	O
lower	O
lung	B
consolidation	I
seen	O
with	O
a	O
loculated	O
left	O
pleural	B
effusion	I
.	O

compared	O
to	O
the	O
prior	O
study	O
,	O
these	O
findings	O
have	O
not	O
changed	O
significantly	O
in	O
extent	O
.	O

on	O
the	O
right	O
side	O
,	O
there	O
is	O
again	O
noted	O
a	O
loculated	O
hydropneumothorax	B
.	O

there	O
is	O
a	O
right	O
-	O
sided	O
pigtail	O
seen	O
in	O
the	O
collection	O
.	O

in	O
the	O
right	O
-	O
sided	O
pleural	B
effusion	I
,	O
there	O
is	O
layering	O
hyperdense	O
fluid	O
seen	O
which	O
is	O
consistent	O
with	O
contrast	O
which	O
was	O
seen	O
on	O
the	O
prior	O
study	O
and	O
was	O
from	O
extravasation	O
from	O
an	O
anastomosis	O
.	O

after	O
additional	O
dilute	O
conray	O
contrast	O
was	O
administered	O
to	O
the	O
nasogastric	O
tube	O
in	O
this	O
study	O
,	O
there	O
was	O
no	O
change	O
seen	O
in	O
this	O
layering	O
collection	O
.	O

there	O
has	O
,	O
however	O
,	O
been	O
an	O
increase	O
in	O
the	O
extent	O
of	O
the	O
right	O
lower	O
lung	B
consolidation	I
which	O
now	O
involves	O
the	O
right	O
middle	O
lung	O
.	O

there	O
is	O
shotty	O
prevascular	O
and	O
pretracheal	O
lymph	O
nodes	O
seen	O
.	O

ct	O
of	O
the	O
abdomen	O
with	O
contrast	O
:	O
the	O
liver	O
,	O
spleen	O
,	O
gallbladder	O
,	O
and	O
kidneys	O
are	O
unremarkable	O
.	O

there	O
are	O
no	O
fluid	O
collections	O
or	O
free	O
air	O
seen	O
in	O
the	O
abdomen	O
.	O

there	O
are	O
a	O
few	O
surgical	O
clips	O
present	O
.	O

ct	O
of	O
the	O
pelvis	O
with	O
contrast	O
:	O
the	O
bowel	O
is	O
normal	O
in	O
course	O
and	O
caliber	O
.	O

there	O
is	O
no	O
free	B
air	I
or	O
fat	B
stranding	I
seen	O
.	O

there	O
are	O
no	O
fluid	B
collections	I
seen	O
.	O

there	O
is	O
a	O
large	O
-	O
to	O
-	O
moderate	O
amount	O
of	O
stool	O
seen	O
throughout	O
the	O
colon	O
.	O

the	O
bladder	O
is	O
collapsed	B
and	O
cannot	O
be	O
evaluated	O
.	O

multiple	O
sub	O
-	O
cm	O
soft	B
-	I
tissue	I
densities	I
are	O
seen	O
.	O

these	O
are	O
just	O
underneath	O
the	O
skin	O
surface	O
and	O
consistent	O
with	O
injection	B
granulomas	I
.	O

bone	O
windows	O
:	O
no	O
suspicious	O
lytic	O
or	O
sclerotic	B
lesions	I
are	O
identified	O
.	O

impression	O
:	O

(	O
over	O
)	O

date	O
:	O
[	O
*	O
*	O
2014	O
-	O
07	O
-	O
22	O
*	O
*	O
]	O
1	O
:	O
37	O
pm	O

ct	O
chest	O
w&w	O
/	O
o	O
c	O
;	O
ct	O
abdomen	O
w	O
/	O
contrast	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
1621	O
*	O
*	O
]	O
ct	O
pelvis	O
w	O
/	O
contrast	O
;	O
ct	O
150cc	O
nonionic	O
contrast	O

reason	O
:	O
assess	O
pleural	O
/	O
abdominal	B
effusions	I
field	O
of	O
view	O
:	O
42	O
contrast	O
:	O
optiray	O
amt	O
:	O
150	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

(	O
cont	O
)	O

1	O
)	O
there	O
has	O
been	O
no	O
significant	O
change	O
in	O
the	O
consolidation	B
and	O
loculated	B
effusion	I
seen	O
on	O
the	O
left	O
side	O
.	O

2	O
)	O
there	O
is	O
a	O
right	O
loculated	O
hydropneumothorax	B
which	O
has	O
not	O
changed	O
significantly	O
.	O

3	O
)	O
there	O
has	O
been	O
an	O
increase	O
in	O
the	O
extent	O
of	O
the	O
right	O
lung	O
pneumonia	B
.	O

4	O
)	O
no	O
evidence	O
of	O
leak	O
from	O
the	O
anastomosis	O
.	O

5	O
)	O
there	O
is	O
a	O
right	O
adrenal	O
adenoma	B
.	O

257214	O
||||	O
25217	O
||||	O
23679	O
||||	O
radiology	O
_	O
report	O
||||	O
2013	O
-	O
06	O
-	O
09	O
14	O
:	O
53	O
:	O
00	O
.	O
0	O
||||	O
u314	O
liver	O
or	O
gallbladder	O
us	O
(	O
single	O
organ	O
)	O
||||	O
||||	O
clip	O
#	O
405	O
-	O
8573	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2013	O
-	O
06	O
-	O
09	O
*	O
*	O
]	O
2	O
:	O
53	O
pm	O

liver	O
or	O
gallbladder	O
us	O
(	O
single	O
organ	O
)	O
;	O
-	O
59	O
distinct	O
procedural	O
serviceclip	O
#	O
[	O
*	O
*	O
telephone	O
/	O
fax	O
(	O
1	O
)	O
3493	O
*	O
*	O
]	O
duplex	O
[	O
*	O
*	O
last	O
name	O
(	O
un	O
)	O
322	O
*	O
*	O
]	O
abd	O
/	O
pel	O

reason	O
:	O
duplex?thrombus	O
/	O
clot	B
admitting	O
diagnosis	O
:	O
s	O
/	O
p	O
liver	O
tx	O
asctes	B
confusion	I
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

52	O
year	O
old	O
man	O
s	O
/	O
p	O
re	O
-	O
liver	O
transplant	O
.	O
and	O
revision	O
r	O
-	O
n	O
-	O
y	O
now	O
were	O
very	O
increased	B
tb	I

reason	O
for	O
this	O
examination	O
:	O

duplex?thrombus	O
/	O
clot	B
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
52	O
-	O
year	O
-	O
old	O
man	O
status	O
post	O
re	O
-	O
liver	O
transplant	O
and	O
revision	O
roux	O
-	O
en	O
-	O
y	O
anastomosis	O
,	O
now	O
with	O
increased	B
total	I
bilirubin	I
.	O

comparison	O
:	O
[	O
*	O
*	O
2013	O
-	O
06	O
-	O
03	O
*	O
*	O
]	O
.	O

liver	O
ultrasound	O
with	O
doppler	O
examination	O
:	O
the	O
liver	O
parenchyma	O
is	O
normal	O
in	O
echotexture	O
,	O
without	O
focal	O
nodules	O
or	O
masses	O
identified	O
.	O

the	O
previously	O
noted	O
hemangioma	B
in	O
segment	O
vii	O
is	O
not	O
imaged	O
on	O
today's	O
study	O
.	O

there	O
is	O
a	O
small	O
amount	O
of	O
perihepatic	O
ascites	B
.	O

imaging	O
for	O
dilated	B
bowel	I
segments	I
within	O
the	O
region	O
of	O
the	O
portahepatus	O
is	O
not	O
appreciated	O
.	O

the	O
portal	O
vein	O
is	O
patent	O
with	O
hepatopetal	O
flow	O
.	O

however	O
,	O
flow	O
is	O
turbulent	O
with	O
increased	O
velocity	O
at	O
the	O
level	O
of	O
the	O
anastomosis	O
measuring	O
up	O
to	O
225	O
cm	O
/	O
sec	O
.	O

this	O
was	O
not	O
clearly	O
demonstrated	O
on	O
the	O
prior	O
study	O
.	O

flow	O
within	O
the	O
anterior	O
right	O
,	O
posterior	O
right	O
,	O
and	O
left	O
portal	O
vein	O
is	O
normal	O
,	O
with	O
appropriate	O
direction	O
of	O
flow	O
.	O

the	O
right	O
middle	O
and	O
left	O
hepatic	O
veins	O
are	O
patent	O
with	O
normal	O
respiratory	O
variation	O
.	O

waveforms	O
within	O
the	O
main	O
,	O
right	O
,	O
and	O
left	O
hepatic	O
arteries	O
demonstrate	O
sharp	O
systolic	O
upstroke	O
,	O
which	O
is	O
improved	O
from	O
this	O
prior	O
study	O
.	O

however	O
,	O
resistive	B
indices	I
remain	I
low	I
measuring	O
0	O
.	O
52	O
,	O
0	O
.	O
45	O
,	O
and	O
0	O
.	O
42	O
within	O
the	O
middle	O
,	O
right	O
,	O
and	O
left	O
hepatic	O
arteries	O
respectively	O
.	O

impression	O
:	O

1	O
.	O
turbulent	B
flow	I
within	O
the	O
proximal	O
portal	O
vein	O
,	O
at	O
the	O
level	O
of	O
the	O
anastomosis	O
.	O

high	O
velocities	O
may	O
represent	O
a	O
stenosis	B
in	O
this	O
area	O
.	O

2	O
.	O
low	O
resistive	B
indices	I
across	O
all	O
hepatic	O
arteries	O
may	O
indicate	O
a	O
focal	O
arterial	B
anastomotic	I
stenosis	I
.	O

however	O
,	O
when	O
compared	O
with	O
the	O
prior	O
study	O
,	O
the	O
waveforms	O
now	O
demonstrate	O
a	O
sharp	O
systolic	O
upstroke	O
compared	O
with	O
a	O
tardus	O
parvus	O
waveform	O
on	O
the	O
prior	O
study	O
.	O

3	O
.	O
small	O
perihepatic	O
ascites	B
.	O

4	O
.	O
segment	O
vii	O
liver	B
hemangioma	I
identified	O
on	O
prior	O
study	O
is	O
not	O
clearly	O
seen	O
on	O
today's	O
study	O
.	O

96953	O
||||	O
25497	O
||||	O
22794	O
||||	O
echo	O
_	O
report	O
||||	O
2016	O
-	O
02	O
-	O
08	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
massive	O
pulmonary	B
embolism	I
.	O

evaluate	O
right	B
ventricular	I
function	I
.	O

weight	O
(	O
lb	O
)	O
:	O
120	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
102	O
/	O
70	O

hr	O
(	O
bpm	O
)	O
:	O
128	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2016	O
-	O
02	O
-	O
08	O
*	O
*	O
]	O
at	O
12	O
:	O
03	O

test	O
:	O
portable	O
tte	O
(	O
focused	O
views	O
)	O

doppler	O
:	O
limited	O
doppler	O
and	O
no	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
normal	O
la	O
size	O
.	O

left	O
ventricle	O
:	O
normal	O
lv	O
wall	O
thickness	O
,	O
cavity	O
size	O
,	O
and	O
systolic	O
function	O
(	O
lvef>55%	O
)	O
.	O

right	O
ventricle	O
:	O
moderately	O
dilated	B
rv	I
cavity	O
.	O

normal	O
rv	O
systolic	O
function	O
.	O

abnormal	B
septal	I
motion	I
/	O
position	O
consistent	O
with	O
rv	O
pressure	O
/	O
volume	O
overload	O
.	O

aortic	O
valve	O
:	O
normal	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
.	O

no	O
as	B
.	O

no	O
ar	B
.	O

mitral	O
valve	O
:	O
normal	O
mitral	O
valve	O
leaflets	O
with	O
trivial	O
mr	B
.	O

tricuspid	O
valve	O
:	O
normal	O
tricuspid	O
valve	O
leaflets	O
.	O

mild	O
to	O
moderate	O
[	O
[	O
*	O
*	O
02	O
-	O
16	O
*	O
*	O
]	O
+	O
]	O
tr	B
.	O

moderate	O
pa	O
systolic	B
hypertension	I
.	O

pericardium	O
:	O
no	O
pericardial	B
effusion	I
.	O

general	O
comments	O
:	O
emergency	O
study	O
performed	O
by	O
the	O
cardiology	O
fellow	O
on	O
call	O
.	O

results	O
were	O
reviewed	O
with	O
the	O
cardiology	O
fellow	O
involved	O
with	O
the	O
patient's	O
care	O
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

left	O
ventricular	O
wall	O
thickness	O
,	O
cavity	O
size	O
,	O
and	O
systolic	O
function	O
are	O
normal	O
(	O
lvef>55%	O
)	O
.	O

the	O
right	O
ventricular	O
cavity	O
is	O
moderately	O
dilated	O
.	O

right	O
ventricular	O
systolic	O
function	O
is	O
normal	O
.	O

there	O
is	O
abnormal	B
septal	I
motion	I
/	O
position	O
consistent	O
with	O
right	O
ventricular	O
pressure	O
/	O
volume	O
overload	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	B
regurgitation	I
.	O

the	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	O
mitral	B
regurgitation	I
.	O

there	O
is	O
moderate	O
to	O
severe	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

impression	O
:	O
right	O
ventricular	O
cavity	O
enlargement	O
with	O
preserved	O
systolic	O
function	O
.	O

moderate	O
pulmonary	O
artery	O
systolic	B
hypertension	I
.	O

58370	O
||||	O
25585	O
||||	O
29251	O
||||	O
ecg	O
_	O
report	O
||||	O
2015	O
-	O
08	O
-	O
13	O
08	O
:	O
48	O
:	O
00	O
.	O
0	O
||||	O
||||	O
||||	O
||||	O

regular	O
rhythm	O

marked	O
left	B
axis	I
deviation	I

rbbb	I
with	O
left	B
anterior	I
fascicular	I
block	I

since	O
previous	O
tracing	O
of	O
[	O
*	O
*	O
2015	O
-	O
08	O
-	O
12	O
*	O
*	O
]	O
,	O
no	O
significant	O
change	O

97135	O
||||	O
25844	O
||||	O
8722	O
||||	O
echo	O
_	O
report	O
||||	O
2018	O
-	O
11	O
-	O
14	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
endocarditis	B
.	O

height	O
:	O
(	O
in	O
)	O
64	O

weight	O
(	O
lb	O
)	O
:	O
130	O

bsa	O
(	O
m2	O
)	O
:	O
1	O
.	O
63	O
m2	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
114	O
/	O
65	O

hr	O
(	O
bpm	O
)	O
:	O
71	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2018	O
-	O
11	O
-	O
14	O
*	O
*	O
]	O
at	O
14	O
:	O
50	O

test	O
:	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
full	O
doppler	O
and	O
color	O
doppler	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
mild	O
la	B
enlargement	I
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
normal	O
ra	O
size	O
.	O

left	O
ventricle	O
:	O
normal	O
lv	O
wall	O
thickness	O
,	O
cavity	O
size	O
,	O
and	O
systolic	O
function	O
(	O
lvef>55%	O
)	O
.	O

normal	O
regional	O
lv	O
systolic	O
function	O
.	O

right	O
ventricle	O
:	O
normal	O
rv	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

aorta	O
:	O
normal	O
aortic	O
root	O
diameter	O
.	O

aortic	O
valve	O
:	O
normal	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
.	O

no	O
as	B
.	O

no	O
ar	B
.	O

mitral	O
valve	O
:	O
normal	O
mitral	O
valve	O
leaflets	O
with	O
trivial	O
mr	B
.	O

tricuspid	O
valve	O
:	O
normal	O
tricuspid	O
valve	O
leaflets	O
with	O
trivial	O
tr	B
.	O

pericardium	O
:	O
no	O
pericardial	B
effusion	I
.	O

conclusions	O
:	O

1	O
.	O
the	O
left	O
atrium	O
is	O
mildly	O
dilated	O
.	O

2	O
.	O
left	O
ventricular	O
wall	O
thickness	O
,	O
cavity	O
size	O
,	O
and	O
systolic	O
function	O
are	O
normal	O
(	O
lvef>55%	O
)	O
.	O

regional	O
left	O
ventricular	O
wall	O
motion	O
is	O
normal	O
.	O

3	O
.	O
no	O
evidence	O
of	O
endocarditis	B
seen	O
.	O

160092	O
||||	O
25950	O
||||	O
21413	O
||||	O
radiology	O
_	O
report	O
||||	O
2012	O
-	O
10	O
-	O
12	O
16	O
:	O
53	O
:	O
00	O
.	O
0	O
||||	O
q1212	O
ct	O
head	O
w	O
/	O
&	O
w	O
/	O
o	O
contrast	O
||||	O
||||	O
clip	O
#	O
276	O
-	O
1074	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2012	O
-	O
10	O
-	O
12	O
*	O
*	O
]	O
4	O
:	O
53	O
pm	O

ct	O
head	O
w	O
/	O
&	O
w	O
/	O
o	O
contrast	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
2049	O
*	O
*	O
]	O
reason	O
:	O
s	O
/	O
p	O
gsw	B
now	O
with	O
fevers	B
r	O
/	O
o	O
abcess	B

contrast	O
:	O
optiray	O
amt	O
:	O
100cc	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

44	O
year	O
old	O
woman	O
with	O
gsw	B
to	O
head	O
.	O

now	O
with	O
fevers	B
,	O
?	O
abcess	B
related	O
to	O
gsw	B
reason	O
for	O
this	O
examination	O
:	O

s	O
/	O
p	O
gsw	B
now	O
with	O
fevers	B
r	O
/	O
o	O
abcess	B

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

ct	O
of	O
head	O
without	O
and	O
with	O
iv	O
contrast	O
[	O
*	O
*	O
2012	O
-	O
10	O
-	O
12	O
*	O
*	O
]	O
.	O

indication	O
:	O
status	O
post	O
gunshot	B
wound	I
to	O
head	O
with	O
fevers	B
,	O
evaluate	O
for	O
abscess	B
.	O

comparison	O
:	O
[	O
*	O
*	O
2012	O
-	O
10	O
-	O
10	O
*	O
*	O
]	O
.	O

technique	O
:	O
ct	O
of	O
head	O
without	O
and	O
with	O
iv	O
contrast	O
.	O

100	O
cc	O
optiray	O
was	O
administered	O
.	O

optiray	O
was	O
selected	O
secondary	O
to	O
trauma	B
history	O
.	O

findings	O
:	O
there	O
has	O
been	O
interval	O
decrease	O
in	O
extent	O
of	O
pneumocephalus	B
with	O
a	O
small	O
amount	O
of	O
residual	B
air	I
located	O
anterior	O
to	O
the	O
left	O
frontal	O
lobe	O
as	O
well	O
as	O
air	B
bubbles	I
within	O
the	O
surgical	O
bed	O
in	O
the	O
region	O
of	O
the	O
temporal	O
lobe	O
.	O

there	O
continues	O
to	O
be	O
areas	O
of	O
low	O
density	O
fluid	O
in	O
the	O
surgical	O
bed	O
.	O

there	O
continues	O
to	O
be	O
mass	B
effect	I
on	O
the	O
midline	O
structures	O
with	O
shift	O
of	O
the	O
normal	O
midline	O
structures	O
to	O
the	O
contralateral	O
side	O
.	O

this	O
extent	O
of	O
shift	O
does	O
not	O
appear	O
to	O
have	O
changed	O
significantly	O
.	O

additionally	O
there	O
is	O
no	O
significant	O
change	O
in	O
the	O
size	O
of	O
the	O
ventricles	O
.	O

the	O
fourth	O
ventricle	O
is	O
patent	O
.	O

there	O
is	O
no	O
distinct	O
pathologically	O
enhancing	O
lesion	B
.	O

specifically	O
there	O
is	O
no	O
evidence	O
of	O
an	O
abscess	B
.	O

the	O
osseous	O
structures	O
are	O
unchanged	O
.	O

there	O
continues	O
to	O
be	O
partial	O
opacification	B
of	O
the	O
maxillary	O
sinuses	O
bilaterally	O
.	O

impression	O
:	O

1	O
.	O
no	O
evidence	O
of	O
intracranial	B
abscess	I
.	O

2	O
.	O
no	O
significant	O
change	O
compared	O
with	O
the	O
prior	O
study	O
.	O

101545	O
||||	O
26136	O
||||	O
1465	O
||||	O
echo	O
_	O
report	O
||||	O
2016	O
-	O
04	O
-	O
21	O
00	O
:	O
00	O
:	O
00	O
.	O
0	O
||||	O
||||	O

patient	O
/	O
test	O
information	O
:	O

indication	O
:	O
endocarditis	B
.	O

hypertension	B
.	O

valvular	B
heart	I
disease	I
.	O

bp	O
(	O
mm	O
hg	O
)	O
:	O
120	O
/	O
50	O

status	O
:	O
inpatient	O

date	O
/	O
time	O
:	O
[	O
*	O
*	O
2016	O
-	O
04	O
-	O
21	O
*	O
*	O
]	O
at	O
13	O
:	O
32	O

test	O
:	O
tte	O
(	O
complete	O
)	O

doppler	O
:	O
complete	O
pulse	O
and	O
color	O
flow	O

contrast	O
:	O
none	O

technical	O
quality	O
:	O
adequate	O

||||	O
||||	O

interpretation	O
:	O

findings	O
:	O

left	O
atrium	O
:	O
the	O
left	O
atrium	O
is	O
mildly	O
dilated	O
.	O

right	O
atrium	O
/	O
interatrial	O
septum	O
:	O
the	O
right	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

left	O
ventricle	O
:	O
there	O
is	O
moderate	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

the	O
left	O
ventricular	O
cavity	O
is	O
unusually	O
small	O
.	O

left	O
ventricular	O
systolic	O
function	O
is	O
hyperdynamic	O
(	O
ef>75%	O
)	O
.	O

there	O
is	O
an	O
abnormal	O
systolic	O
flow	O
contour	O
at	O
rest	O
,	O
but	O
no	O
left	B
ventricular	I
outflow	I
obstruction	I
.	O

right	O
ventricle	O
:	O
right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

aorta	O
:	O
the	O
aortic	O
root	O
is	O
normal	O
in	O
diameter	O
.	O

there	O
are	O
focal	O
calcifications	B
in	O
the	O
aortic	O
root	O
.	O

aortic	O
valve	O
:	O
the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	O
but	O
not	O
stenotic	O
.	O

mitral	O
valve	O
:	O
the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

there	O
is	O
no	O
mitral	B
valve	I
prolapse	I
.	O

there	O
is	O
mild	O
mitral	B
annular	I
calcification	I
.	O

there	O
is	O
moderate	O
thickening	O
of	O
the	O
mitral	O
valve	O
chordae	O
.	O

the	O
tips	O
of	O
the	O
papillary	O
muscles	O
are	O
calcified	B
.	O

there	O
is	O
no	O
significant	O
mitral	B
stenosis	I
.	O

trivial	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

tricuspid	O
valve	O
:	O
the	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

physiologic	O
tricuspid	B
regurgitation	I
is	O
seen	O
.	O

the	O
pulmonary	O
artery	O
systolic	O
pressure	O
could	O
not	O
be	O
determined	O
.	O

pericardium	O
:	O
there	O
is	O
no	O
pericardial	B
effusion	I
.	O

conclusions	O
:	O

the	O
left	O
atrium	O
is	O
mildly	O
dilated	O
.	O

there	O
is	O
moderate	O
symmetric	O
left	B
ventricular	I
hypertrophy	I
.	O

the	O
left	O
ventricular	O
cavity	O
is	O
small	O
.	O

left	B
ventricular	I
systolic	I
function	I
is	I
hyperdynamic	I
(	O
ef>75%	O
)	O
.	O

there	O
is	O
an	O
abnormal	O
systolic	O
flow	O
contour	O
at	O
rest	O
,	O
but	O
no	O
left	B
ventricular	I
outflow	I
obstruction	I
.	O

right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

the	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	O
thickened	O
but	O
not	O
stenotic	O
.	O

the	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

there	O
is	O
no	O
mitral	B
valve	I
prolapse	I
.	O

there	O
is	O
moderate	O
thickening	O
of	O
the	O
mitral	O
valve	O
chordae	O
.	O

trivial	O
mitral	B
regurgitation	I
is	O
seen	O
.	O

the	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

the	O
pulmonary	O
artery	O
systolic	O
pressure	O
could	O
not	O
be	O
determined	O
.	O

there	O
is	O
no	O
pericardial	B
effusion	I
.	O

compared	O
to	O
the	O
previous	O
study	O
of	O
[	O
*	O
*	O
2013	O
-	O
06	O
-	O
24	O
*	O
*	O
]	O
,	O
the	O
left	O
ventricle	O
is	O
now	O
more	O
hypertrophic	B
and	O
hyperdynamic	O
,	O
with	O
significantly	O
smaller	O
cavity	O
dimension	O
and	O
stroke	O
volume	O
.	O

226973	O
||||	O
26176	O
||||	O
4475	O
||||	O
radiology	O
_	O
report	O
||||	O
2014	O
-	O
04	O
-	O
27	O
11	O
:	O
37	O
:	O
00	O
.	O
0	O
||||	O
c12	O
chest	O
(	O
portable	O
ap	O
)	O
||||	O
||||	O
clip	O
#	O
285	O
-	O
3141	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2014	O
-	O
04	O
-	O
27	O
*	O
*	O
]	O
11	O
:	O
37	O
am	O

chest	O
(	O
portable	O
ap	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
4195	O
*	O
*	O
]	O
reason	O
:	O
r	O
/	O
o	O
pneumoniae	B

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

71	O
year	O
old	O
man	O
s	O
/	O
p	O
dual	O
chamber	O
icd	O
implant	O
on	O
[	O
*	O
*	O
04	O
-	O
21	O
*	O
*	O
]	O
with	O
bleeding	B
around	O
pacer	O
after	O
the	O
procedure	O

r	O
/	O
o	O
pneumonia	B

reason	O
for	O
this	O
examination	O
:	O

r	O
/	O
o	O
pneumoniae	B

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
s	O
/	O
p	O
dual	O
chamber	O
icd	O
implant	O
with	O
bleeding	B
around	O
the	O
pacer	O
,	O
rule	O
out	O
pneumonia	B
.	O

comparison	O
:	O
[	O
*	O
*	O
2014	O
-	O
04	O
-	O
22	O
*	O
*	O
]	O
.	O

ap	O
chest	O
:	O
the	O
icd	O
pacer	O
is	O
identified	O
with	O
all	O
three	O
leads	O
in	O
appropriate	O
position	O
,	O
unchanged	O
from	O
the	O
prior	O
study	O
.	O

sternal	O
wires	O
are	O
present	O
.	O

a	O
left	O
femoral	O
vein	O
pulmonary	O
artery	O
catheter	O
tip	O
is	O
in	O
a	O
left	O
interlobar	O
artery	O
.	O

the	O
cardiac	B
silhouette	I
is	O
enlarged	O
,	O
but	O
not	O
changed	O
compared	O
to	O
the	O
prior	O
study	O
.	O

the	O
mediastinal	O
and	O
hilar	O
contours	O
are	O
within	O
normal	O
limits	O
.	O

there	O
is	O
increased	O
opacification	B
within	O
the	O
left	O
lower	O
lobe	O
likely	O
relating	O
to	O
atelectasis	B
.	O

the	O
pulmonary	O
vascularity	O
has	O
not	O
changed	O
compared	O
to	O
the	O
prior	O
study	O
.	O

there	O
is	O
minimal	O
if	O
any	O
evidence	O
of	O
pulmonary	B
edema	I
.	O

the	O
osseous	O
structures	O
are	O
unchanged	O
.	O

impression	O
:	O
1	O
)	O
new	O
opacity	B
in	O
the	O
left	O
lower	O
lobe	O
likely	O
representing	O
atelectasis	B
however	O
an	O
underlying	O
pneumonia	B
could	O
not	O
be	O
excluded	O
.	O

2	O
)	O
cardiomegaly	B
without	O
definite	O
evidence	O
of	O
failure	B
.	O

3	O
)	O
lines	O
and	O
tubes	O
in	O
appropriate	O
position	O
.	O

387055	O
||||	O
26563	O
||||	O
18146	O
||||	O
radiology	O
_	O
report	O
||||	O
2009	O
-	O
01	O
-	O
26	O
15	O
:	O
08	O
:	O
00	O
.	O
0	O
||||	O
c12	O
chest	O
(	O
portable	O
ap	O
)	O
||||	O
||||	O
clip	O
#	O
282	O
-	O
0776	O
actual	O
report	O
||||	O

date	O
:	O
[	O
*	O
*	O
2009	O
-	O
01	O
-	O
26	O
*	O
*	O
]	O
3	O
:	O
08	O
pm	O

chest	O
(	O
portable	O
ap	O
)	O
[	O
*	O
*	O
clip	O
number	O
(	O
radiology	O
)	O
7881	O
*	O
*	O
]	O
reason	O
:	O
r	O
/	O
o	O
ptx	B
,	O
s	O
/	O
p	O
aicd	O
removal	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

underlying	O
medical	O
condition	O
:	O

57	O
year	O
old	O
man	O
with	O
pleural	B
effusion	I
.	O

reason	O
for	O
this	O
examination	O
:	O

r	O
/	O
o	O
ptx	B
,	O
s	O
/	O
p	O
aicd	O
removal	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

final	O
report	O

indication	O
:	O
57	O
y	O
/	O
o	O
male	O
with	O
pleural	B
effusion	I
,	O
rule	O
out	O
pneumothorax	B
,	O
status	O
post	O
aicd	O
removal	O
.	O

findings	O
:	O
a	O
single	O
portable	O
chest	O
radiograph	O
is	O
compared	O
with	O
a	O
portable	O
study	O
done	O
earlier	O
today	O
.	O

the	O
right	O
subclavian	O
line	O
is	O
redemonstrated	O
and	O
in	O
appropriate	O
position	O
.	O

there	O
is	O
no	O
evidence	O
for	O
pneumothorax	B
.	O

the	O
aicd	O
has	O
been	O
removed	O
in	O
the	O
interim	O
.	O

the	O
heart	O
is	O
mildly	O
enlarged	O
when	O
adjusting	O
for	O
technique	O
.	O

there	O
is	O
evidence	O
for	O
mild	O
pulmonary	B
vascular	I
redistribution	I
.	O

there	O
has	O
been	O
interval	O
increase	O
in	O
the	O
size	O
of	O
the	O
right	O
pleural	B
effusion	I
.	O

the	O
patient	O
is	O
status	O
post	O
sternotomy	O
.	O

impression	O
:	O
1	O
)	O
status	O
post	O
aicd	O
removal	O
without	O
evidence	O
for	O
pneumothorax	B
.	O

2	O
)	O
findings	O
consistent	O
with	O
worsening	O
chf	B
.	O

3	O
)	O
interval	O
increase	O
in	O
the	O
size	O
of	O
the	O
right	O
pleural	B
effusion	I
.	O

